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The 2-oxoacid dehydrogenase multienzyme complexes (OADHCs) catalyse the following 
reaction: 
2-Oxoacid + NAD+ + CoASH → Acyl-SCoA + CO2 + NADH + H
+ 
These 5-10 MDa complexes comprise multiple copies of three enzymes: E1, E2, and E3.  
The structural core of the OADHC is usually composed of either 24 (cubic) or 60 
(dodecahedral) E2 polypeptides, around which the E1 and E3 enzymes associate non-
covalently. 
Due to a lack of detectable activity in cell extracts, it was originally thought that Archaea 
did not possess any OADHCs; instead they utilised the smaller ferredoxin oxidoreductase 
(FOR) family of enzymes.  However, the OADHC genes have since been identified in an 
increasing number of aerobic archaea, and given that the genomes of these organisms 
have been streamlined to remove any unnecessary genes, these two observations suggest 
that archaea may utilise both FORs and OADHC. 
The Thermoplasma acidophilum OADHC component enzymes have been recombinantly 
expressed and assembled, resulting in a thermostable and thermoactive branched-chain 
OADHC.  This complex provides a model to investigate stability, not only of the individual 
enzymes but also of a multi-protein complex and its assembly.  The structure of this 
hyper-thermostable E2 core is crucial to the thermostability of the entire complex.  The 
Tp. acidophilum E2 structure has been solved by analytical ultra-centrifugation, X-ray 
crystallography and small-angle X-ray scattering; these data have shown that this E2 
assembles into a novel 42-mer structure, comprising 14 trimers, with both square and 
pentagonal faces, rather than either of the expected cubic 24-mer or dodecahedral 60-
mer structures. 
Analysis of the Tp. acidophilum E2 structure has identified an isoleucine ‘anchor’ residue 
that is key to the formation of the trimer-trimer interactions.  The isoleucine side-chain 
extends from the C-terminal helix of one trimer into a hydrophobic pocket of the adjacent 
trimer and vice versa.  The putative anchor residue has been removed by the insertion of 
a premature stop codon, resulting in E2 trimers that no longer assemble into a 42mer.  
This mutation has no affect on the tertiary structure of the trimers or its acyltransferase 
activity; moreover, the trimeric E2 retains the ability to bind the E1 and E3 enzymes, 
resulting in the first example of a functional trimeric OADHC. 
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List of abbreviations 
Abbreviation Definition 
∆H Change in enthalpy 
∆S Change in entropy 
A  Arrhenius constant 
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residues (IIYEI) 
E2cat E2 catalytic domain 
E2cat-trunc Truncated version of the E2 catalytic domain, missing the final 5 C-
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E3 Dihydrolipoamide dehydrogenase 
Ea  Activation energy 
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min Minute 
Mw Molecular weight 
NAD Nicotinamide adenine dinucleotide 
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U Enzyme units - 1U is defined as the amount of the enzyme required 
to convert 1µmole of substrate to product per min.  
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Chapter 1: General introduction 
1.1 Archaea 
1.1.1 The three Domains of life 
The three Domains of Life comprise Bacteria, Archaea and Eukarya.  This classification 
system was proposed by Carl Woese et al. (1990) based on 16S ribosomal RNA sequences.  
The three Domains classification system replaces the phylogenetically inaccurate five 
Kingdom system, in which Archaea and Bacteria were grouped together, as Prokaryotes, 
owing to their similar appearances.  Molecular characterisation of the Archaea supports 
their being placed on their own distinct evolutionary branch, separate from Bacteria and 
closer to the Eukarya branch (Figure 1.1) (Winker and Woese, 1991). 
 
Figure 1.1 Phylogenetic tree, based on the 16S rRNA sequences, illustrating the three 
Domains of life: Bacteria, Archaea and Eukarya (Jurgens, 2002). 
 
The Domain Archaea comprise two main phyla: Crenarchaeota and Euryarchaeota; a 
further two phyla, Korarchaetota and Nanoarchaeota, have tentatively been proposed 
based on unculturable environmental samples (Barns et al., 1996, Huber et al., 2002).  
Metagenomics is now beginning to identify a vast number of unculturable archaeal 
species; it has been suggested that up to 20% of all picoplankton cells in the world's 
oceans are Crenarchaeota (Karner et al., 2001).  The exact arrangement of the phyla 
within the archaea may become more accurately described as an increasing number of 





1.1.2 Enzymes from extremophiles 
Species of archaea and bacteria can be found in some of the world's most hostile 
environments, including extreme temperatures (-2°C to 15°C and 60°C to 110°C), high 
salinity (2-5M NaCl) and extreme pH (<4 and >9) (Hough and Danson, 1999).  These 
extremophiles have evolved to thrive in these conditions; as a result they are now a 
source of novel extremophilic enzymes (extremozymes), of interest to both industry and 
academia.  Enzymes from extreme temperatures have been characterised in an attempt 
to understand protein thermostability, and exploited due to their industrially favourable 
properties.  Extremozymes currently in regular use include: the thermophilic Taq DNA 
polymerase from Thermus aquaticus, and the psychrophilic Cpn10 and Cpn60 chaperonins 
from Oleispira antarctica that are utilised by the ArcticExpress™ E. coli expression system 
(Stratagene. U.K.) in order to increase the recombinant protein yield.  The production 
method of the industrial thermophilic enzymes can vary; for example, the starch-
processing industry utilises recombinant amylases and other hydrolases in the conversion 
of starch into high-fructose corn syrup (Vieille and Zeikus, 2001); whereas, the 
thermophilic bacterium Geobacillus thermoglucosidasius is used as a whole organism, by 
TMO Renewables Ltd, to generate bioethanol from waste carbohydrates (Cripps et al., 
2009). 
 
1.1.2.1 Protein folding, unfolding and stability 
The process of protein thermal denaturation can be described as a reversible equilibrium 
between the folded (F), and unfolded (U) form, coupled to the essentially irreversible 
conversion of the unfolded protein to the thermally denatured (D) form: 
F  U→ D 
Figure 1.2 illustrates the activation energy (ΔG*) of the inter-conversion between the 
folded and unfolded forms of a protein; that is, ΔG* determines the rate at which the 
equilibrium is reached and therefore influences the kinetic stability of a protein.  The free 
energy difference (ΔG) between the folded and unfolded forms of a protein determines 
the position of the equilibrium, and thus describes the thermodynamic stability of a 
protein.  The ΔG value is influenced by the entropy, enthalpy and temperature of the 
unfolding process, shown by the following equation: 




Protein thermostability can be increased by: 
 1) Increasing the free energy of the unfolded form, this makes U less 
thermodynamically favourable compared to F. 
 2) Increasing the ΔG*, this decreases the rate of conversion between F and U, 
resulting in a more kinetically stable protein. 
 3) Decreasing the free energy of the folded form, this increases the ΔG and ΔG* 
making the protein more thermodynamically and kinetically stable (Figure 1.2) (Daniel et 
al., 2008). 
 
Figure 1.2 Gibbs free energy diagram illustrating the thermodynamic and kinetic 
contributions to protein stability.  F and U denote the folded and unfolded protein 
respectively.  The free energy change (ΔG) and activation energy (ΔG*) of this equilibrium 
are shown by the black arrows.  The dashed arrows indicate energy changes required to 
increase the stability of a protein. 
 
1.1.2.2 Structural basis of protein thermostability 
The structural basis of protein thermostability has been investigated by comparisons of 
homologous proteins from psychrophilic, mesophilic and thermophilic organisms.  The 
three dimensional structures of these different temperature homologs are often similar, 
leading to the suggestion that thermostability is achieved by a number of small subtle 
changes, rather than larger global changes in the proteins structure, (Bell et al., 2002, 
Daniel et al., 2008) including: 
 Increased hydrophobicity, 
 Increased number of ionic bonds, 
 Increased compactness, 
 Reduced loop length and flexibility, 
 Stronger N- and C-termini interactions, 




Thermostable proteins tend to have an increased number of buried hydrophobic residues 
(Vieille and Zeikus, 2001); the increased hydrophobicity stabilises the structure both 
enthalpically, through the formation of van der Waals bonds, and entropically, as the bulk 
water becomes increasingly disordered as a result of the burial of hydrophobic side 
chains.  Increased hydrophobicity is less significant in the stabilization of hyper-
thermostable proteins; above 80°C the bulk water becomes more disordered, and 
therefore the entropy increase as a result of the burial of the hydrophobic residues 
becomes less significant. 
 
Ionic interactions 
Ionic interactions and networks, unlike hydrophobic interactions, increase in strength at 
higher temperatures.  The formation of a single ionic interaction is a balance between the 
energy required to desolvate two ions, the gain in stability as a result of the formation of a 
salt bridge, and any changes to the protein region surrounding the ion:  
ΔGTotal = ΔGDesolvation + ΔGElectrostatic + ΔGprotein 
The formation of a single bond requires the desolvation of two ions, and thus at lower 
temperatures a single ionic interaction may have little effect on protein stability.  At 
higher temperatures, ionic interactions become increasingly important to protein 
stabilisation; as the surrounding water becomes more disordered the desolvation penalty 
decreases, and therefore the formation of an ionic bond becomes more favourable.  The 
formation of ionic networks is another method of decreasing the desolvation penalty; 
ionic networks only require the desolvation of a single additional ion to create a second 
ionic bond. 
Packing density and conformational flexibility 
Thermophilic enzymes tend to be more compact than their mesophilic homologs; this 
increases the stability of the folded form of the protein, by increasing the number of van 
der Waals interactions within the core of the protein (Vieille and Zeikus, 2001).  Flexible 
surface loops or free N- and C- termini can be initiator sites for protein thermal 
denaturation.  Thermophilic proteins tend to have shorter loops and termini than their 
mesophilic homologs; loop flexibility can also be reduced by extra interactions or the 
presence of additional metal ions not found in mesophilic homologs (Vieille and Zeikus, 
2001, Li et al., 2005).  The reduced conformational flexibility of thermophilic proteins at 
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lower temperature enables them to remain stable at higher temperatures, preserving 
catalytic activity and specificity (Daniel et al., 2008). 
 
Amino acid bias 
Amino acid usage varies with temperature; above 85°C the amino acids cysteine, 
methionine, serine, threonine, asparagine, and glutamine can be chemically degraded if 
they are free in solution.  However, these residues are still used by hyper-thermophilic 
proteins, but they tend to be found in conformationally-stable locations and shielded 
from the surrounding solvent (Daniel et al., 2008).  An increase in the number of proline 
residues can stabilise a protein; prolines can only adopt a limited number of 
conformations, this limits the entropy of the unfolded protein, increasing the favourability 
of the folded form (Vieille and Zeikus, 2001).  Increasing the number of intra-polypeptide 
disulphide bonds is another technique used to decrease the flexibility of the unfolded 
protein and thus promote refolding (Li et al., 2005). 
 
1.1.3 Thermoplasma acidophilum 
Thermoplasma acidophilum is a thermophilic Euryarchaeota, first isolated in 1970 from a 
coal refuse pile at the Friar Tuck mine in south-western Indiana, by Darland et al. (1970). 
Tp. acidophilum is an aerobic archaea that grows optimally at 60°C and between pH 1-2; 
however, it should be noted that the cell's internal pH is approximately pH 5.5 (Searcy, 
1976).  The 1.5Mb genome of Tp. acidophilum has been sequenced, and 1509 open 
reading frames identified (Ruepp et al., 2000).  The Tp. acidophilum genes encoding a 
predicted 2-oxoacid dehydrogenase multienzyme complex have been identified, cloned 




1.2 Carbon metabolism 
The pathways involved in central carbon metabolism have many common features in all 
three-domains of life; these pathways not only catabolise compounds to release energy, 
but are also anabolic in nature, creating many of the starting substrates required for 
biosynthesis.  This project focuses on the 2-oxoacid dehydrogenase multienzyme complex 
(OADHC) family of enzymes that are involved in central carbon metabolism. 
There are several enzyme pathways that convert glucose into pyruvate, the three main 
ones are: the classical Embden-Meyerhof (EM), the non-phosphorylative Entner-
Doudoroff (ED) or the pentose P pathway (Danson et al., 2007).  The resulting pyruvate is 
then converted into acetyl-CoA by the action of either a pyruvate dehydrogenase 
multienzyme complex or a pyruvate ferredoxin oxidoreductase (FOR) before it enters the 
citric acid cycle.  The citric acid cycle is a series of oxidative reactions carried out by 
aerobic organisms to generate NADH+H+ and FADH2, coupled with the release of CO2 
(Figure 1.3). The re-oxidation of the NADH+H+ and FADH2 via the electron transport chain 





















Figure 1.3. The citric acid cycle. Enzymes that catalyse each step are: [1] Pyruvate 
dehydrogenase complex/FOR, [2] Citrate synthase, [3] Aconitase, [4] Isocitrate 
dehydrogenase, [5] 2-Oxoglutarate dehydrogenase complex/FOR, [6] Succinate 
thiokinase, [7] Succinate dehydrogenase, [8] Fumarase, [9] Malate dehydrogenase. The 
numbers in bold italics are the reactions catalysed by either a 2-oxoacid dehydrogenase 
multienzyme complex or a ferredoxin oxidoreductase. 
  
H2O 






















  FADH2 
 
         FAD 






NAD+ + CoA 
NADH+ H+ + CO2 
         NAD+ + CoA 




    NTP + CoA 
               NDP + Pi 
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1.2.1 The conversion of 2-oxoacids to acyl-CoAs 
Within central metabolism there are several steps that require the conversion of a 2-
oxoacid to its corresponding acyl-CoA; these reactions can be catalysed by two different 
enzymatic systems, either the 2-oxoacid ferredoxin oxidoreductase or the 2-oxoacid 
dehydrogenase multienzyme complex.  The structure and reaction mechanism of these 
two enzymatic systems are discussed later in Sections 1.2.3 and 1.2.4, respectively. 
There are four main reactions requiring the conversion of a 2-oxoacid into its 
corresponding acyl-CoA (Figure 1.4).  The first links glycolysis with the citric acid cycle, 
with pyruvate being converted into acetyl-CoA.  The second reaction is found within the 
citric acid cycle, and involves the conversion of 2-oxoglutarate into succinyl-CoA.  A third 
OADHC produces acetyl-CoA from acetoin; acetoin is a neutral molecule that can be used 
to store pyruvate and prevent over acidification of the cytoplasm by balancing the ratio of 
NAD+ and NADH+H+.  The branched-chain amino acids, valine, leucine and isoleucine, can 
be deaminated to produce branched-chain 2-oxoacids, which can then be converted into 
their corresponding acyl-CoAs and on via a series of reactions into acetyl-CoA, 









Figure 1.4 Diagram of central metabolism indicating the location of the conversions of 2-
oxoacids to their corresponding acyl-CoAs.  The reactions highlighted by bold black 
arrows are catalysed by either a ferredoxin oxidoreductase or 2-oxoacid dehydrogenase 
multienzyme complex highlighted.  The dashes lines indicate the multiple reactions 
required to convert the branched chain acyl-CoAs into molecules such as acetyl-CoA and 
succinyl-CoA that can then enter the citric acid cycle.  The dashed and dotted line 
indicates the multiple reactions required to convert pyruvate to acetoin. 
Pyruvate 
Leu, Val, Ile 
 










1.2.2 The branched-chain amino acids and their corresponding 2-oxoacids and acyl-CoAs 
The branched-chain 2-oxoacids are produced by the deamination of the branched-chain 
amino acids Val, Leu and Ile; these 2-oxoacids are then converted into their corresponding 
acyl-CoAs, the chemical structures of each of these molecules are shown in Table 1.1.  The 
branched-chain acyl-CoAs then enter into the citric acid cycle via a specific pathway for 
each acyl-CoA; these pathways are shown in Figure 1.4.  Leucine and isoleucine can be 
converted into acetyl-CoA and either acetoacetate or succinyl-CoA, and valine is 
converted into succinyl-CoA.  The resulting succinyl-CoA and acetyl-CoA can then enter 
the citric acid cycle. 
 


















Table 1.1 Summary of the structure of the branched-chain amino acid, and the 


























Figure 1.5 Flow diagram of the metabolism of branched-chain amino acids to acetyl-
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Figure 1.5 Flow diagram of the metabolism of branched-chain amino acids to acetyl-
CoA, succinyl-CoA, and acetoacetate.  The conversion of the various 2-oxoacids to their 
corresponding acyl-CoAs can be catalysed by a 2-oxoacid dehydrogenase multienzyme 
complex or a 2-oxoacid ferredoxin oxidoreductase.  The enzyme responsible for catalysing 
each step, unless otherwise labelled, are numbered as following: [1] Isovaleryl-CoA 
dehydrogenase; [2] Methylcrotonyl-CoA carboxylase; [3] γ-Carboxygeranoyl-CoA 
hydratase; [4] hydroxymethylglutaryl-CoA lyase; [5] Acyl-CoA dehydrogenase; [6] 3-
Hydroxyacyl-CoA dehydrogenase; [7] 3-hydroxyacyl-CoA dehydrogenase; [8] Acyl-CoA 
thiolase; [9] Propionyl-CoA carboxylase; [10] Methylmalonyl-CoA epimerase; [11] 
Methylmalonyl-CoA mutase; [12] Butyryl-CoA dehydrogenase; [13] 3-Hydroxyacyl-CoA 
dehydrogenase; [14] 3-Hydroxyisobutyryl-CoA hydrolase; [15] 3-Hydroxyacyl-CoA 
dehydrogenase; and [16] methylmalonate-semialdehyde dehydrogenase.  * and ** 
indicate that the product can be diverted into propanoate and pyrimidine metabolism 




1.2.3 Ferredoxin oxidoreductase 
The conversion of 2-oxoacids to their corresponding acyl-CoAs in archaea and anaerobic 
bacteria is catalysed by a family of 2-oxoacid FOR enzymes including the pyruvate FOR (EC 
1.2.7.1), 2-oxoglutarate FOR (EC 1.2.7.3) and the branched-chain 2-oxoacid FOR (EC 
1.2.7.7).  These enzymes can be promiscuous, exhibiting catalytic activity with a range of 
2-oxoacids; for example, the 2-oxoglutarate FOR from Sulfolobus solfataricus P1 is capable 
of also utilising pyruvate and 2-oxobutyrate (Park et al., 2006).  
The catalytic mechanism utilised by these enzymes is shown in Figure 1.6, as initially 
determined for the 2-oxoacid FOR from Halobacterium halobium by Kerscher and 
Oesterhelt (1981).  The 2-oxoacid binds to the enzyme and is decarboxylated, leaving a 
reduced enzyme-bound iron-sulphur cluster, this is then reoxidised by ferredoxin and a 
TPP-acyl intermediate radical.  Co-enzymeA (CoA) binds to the enzyme, resulting in the 
transfer of the acyl group from the TPP cofactor and the transfer of a second electron via 
an iron-sulphur centre onto a second ferredoxin molecule (Kerscher and Oesterhelt, 
1981). 
 
Net reaction: Pyruvate + Fdox + CoA →Acetyl-CoA + CO2 + Fdred +2H
+ 
Figure 1.6 A reaction scheme of the 2-oxoacid ferredoxin oxidoreductase enzyme used 
by archaea and anaerobic bacteria.  The enzyme utilises a thiamine pyrophosphate (TPP) 
cofactor to decarboxylate the 2-oxo-acid, and the resulting acyl-group is subsequently 
transferred to Co-enzymeA (CoASH) with the concomitant transfer of the reducing 
equivalents via iron-sulphur centres (FeS) to ferredoxin (Fd).  Diagram was provided by 




The FORs comprise multiple copies of between two and eight polypeptides; the number 
and combination of these polypeptides varies depending on the organism.  Thermophilic 
organisms tend to contain FORs comprising four subunit types, for example the 
Thermococcus profundus branched-chain 2-oxoacid FOR is a hetero-octamer (αβγδ)2.  On 
the other hand, mesophilic FORs tend to be dimers such as the Desulfovibrio africanus 
(Figure 1.7) FOR that has two large A subunits.  The large mesophilic subunits have 
possibly evolved by the fusion of the genes encoding the various smaller polypeptides 
(Ozawa et al., 2005). 
 
Figure 1.7 Crystal structure of the Desulfovibrio africanus pyruvate ferredoxin 
oxidoreductase.  The ribbon dimer is composed of two identical polypeptides coloured 




1.2.4 The 2-oxoacid dehydrogenase multienzyme complex 
The 2-oxoacid dehydrogenase multienzyme complexes (OADHC) catalyse the conversion 
of 2-oxoacids to their corresponding acyl CoAs, along with the release of CO2; unlike the 
FORs, the reducing equivalents are transferred onto NAD+ rather than ferredoxin.  It has 
been suggested that the OADHCs evolved after the evolution of oxidative 
phosphorylation, due to the presence of OADHCs only in aerobic organisms, whereas the 
FORs are utilised by anaerobic bacteria and archaea (Kerscher and Oesterhelt, 1982).  It 
was originally thought that both aerobic and anaerobic archaea utilise only the FOR 
enzymes to catalyse the conversion of 2-oxoacids into their corresponding acyl-CoAs; but 
the discovery of the OADHC genes in several archaeal species opens up the possibility that 
archaea utilise both systems (discusses later in Chapter 1.3).  
Structurally the FORs and OADHCs are very different; the FORs are smaller and simpler 
than OADHCs, which can be up to 10 MDa in size.  The OADHCs comprise multiple copies 
of three enzymes: E1, E2, and E3.  The E2 enzyme forms the structural core of the 
complex, 8 or 20 E2 trimers form a cubic or dodecahedral hollow cage like structure, to 
which the E1 and E3 enzymes associate non-covalently (Figure 1.8) (Perham, 2000).  
 
Figure 1.8 The structure of a 24-mer 2-oxoacid dehydrogenase multienzyme complex.  
The 8 E2 trimers (red circles) form the central core of the complex, and the E1 (yellow) 













The E1 enzyme is a 2-oxoacid decarboxylase.  The 2-oxoacid is decarboxylated and then 
the acyl group is transferred onto the lipoic acid moiety attached to the end of the E2 
swinging arm (E2 details in 1.2.4.2).  The acyl group is then transferred from the lipoic acid 
onto CoA by the E2 dihydrolipoamide transacylase enzyme; this process leaves the lipoic 
acid moiety disulphide bond in its reduced form, this is then reoxidised and thus 
regenerated by the E3 dihydrolipoamide dehydrogenase enzyme. 
 
Net reaction:  2-oxoacid + CoA + NAD+ → Acyl-CoA CO2 + NADH+H
+ 
Figure 1.9 A generalised reaction scheme of the 2-oxoacid dehydrogenase multienzyme 
complex.  The three enzymes, E1 (blue), E2 (red) and E3 (green), catalyse consecutive 
reactions. Courtesy of Professor M.J. Danson (University of Bath) 
 
1.2.4.1 E1 - 2-oxoacid decarboxylase 
The E1, 2-oxoacid decarboxylase, enzyme (EC 1.2.4.1, 1.2.4.2 or 1.2.4.4), catalyses the 
decarboxylation of a 2-oxoacid, along with the concomitant reductive acylation of an E2-
lipoic acid moiety and the liberation of CO2.  The E1 enzymes are arranged as either 
homodimers (α2), or heterotetramers (α2β2) (Figure 1.10).  The homodimeric α-subunit 
(Figure 1.10A) is thought to have evolved from the fusion of the original α and β genes; 
thus, the Pseudomonas putida branched-chain OADHC E1α and β chains (Figure 1.10B) 
contain 410 and 339 residues respectively, in comparison to the E. coli PDHC homodimeric 
E1α that comprises 886 amino acids (Ævarsson et al., 1999, Arjunan et al., 2002).  The Tp. 
acidophilum E1 and, based on gene structures, the E1 enzymes from all other archaea 
comprise E1α and E1β subunits; therefore, the structure and mechanism of only the 






Figure 1.10 The crystal structures of A) the homodimeric E1 from E. coli PHDC and B) the 
heterotetrameric E1 from Pseudomonas putida branched-chain OADHC.  The E. coli 
monomer ribbon diagrams are shown in yellow and green [PDB access code 1L8A 
(Arjunan et al., 2002)].  The P. putida α2β2 ribbon diagram is shown with the α subunits 
coloured red and magenta and the β subunits coloured blue and cyan (PDB access code 
1QS0 (Ævarsson et al., 1999)). Both images were created using PyMOL. 
 
The structures of the E1α and β subunits mainly comprise α/β-fold domains.  The α-
subunit comprises one large α/β domain, a small C-terminal α-helical domain and an N-
terminal extension; the β-subunit comprises two α/β domains connected by an extended 
loop region.  The four polypeptides are arranged so that the two β-subunits are held in a 
vice like grip between the small C-terminal domains of the two α-subunits; the two E1α 
subunits are secured to each other by their N-terminal extensions (Figure 1.10) (Ævarsson 
et al., 1999).  The E1 enzyme associates non-covalently with the E2 core of the OADHC, via 
the enthalpy driven, water-mediated interactions between the E1β subunits and the E2 
peripheral subunit binding domain (PSBD).  The binding of the PSBD to the E1 does not 
change the structure of the E1 and is not required for 2-oxoacid decarboxylase activity 
(Frank et al., 2005, Jung et al., 2002). 
The E1, as the first enzyme in the OADHC, is responsible for conferring the 2-oxoacid 
substrate specificity of the complex; unlike the E2 and E3 enzymes which can accept 
exogenous lipoic acid, the E1 enzyme can only utilise lipoyl groups attached to its cognate 
E2 (discussed in Chapter 1.2.4.2/Figure 1.15).  There are two active sites per E1α2β2 
located at the interface between the α- and β-subunits (Figure 1.11A); the active site 
containing the Mg2+ and TPP cofactors is accessed via a hydrophobic tunnel (Ævarsson et 
al., 1999).  The TPP cofactor is bound in the active site in a V-shaped formation; the 
phosphate end of the TPP molecule binds to the Mg2+ and the E1α-subunit's TPP binding 
A)           B) 
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motif (GDG(X)20+-NN) (Hawkins et al., 1989); the aminopyrimidine end of the TPP binds to 
the E1β-subunit (Ævarsson et al., 1999).  Forcing the TPP cofactor into a V-shaped 
formation, along with the abstraction of a proton by a nearby glutamate residue, acts to 
convert the cofactor into a highly reactive carbanion/ylide (Pei et al., 2008).  The E1 
catalyses the essentially irreversible decarboxylation and transfer of the acyl group by a 
two step ping-pong mechanism (Fries et al., 2003).  The first reaction is the nucleophilic 
attack of the TPP carbanion on the 2-oxoacid, resulting in the liberation of CO2 and the 
formation of an unstable acyl-TPP intermediate.  The second reaction is the reductive 
acylation of the lipoic acid moiety, attached to the E2 lipoyl domain; it is this step that is 
rate limiting in the overall oxidative decarboxylation of the 2-oxoacids by an OADHC 
[Reviewed in Fries et al. (2003) and Pei et al. (2008)]. 
The X-ray crystal structure of the Geobacillus stearothermophilus PDHC E1α2β2 shows 
asymmetry between the two αβ dimers, with one dimer in an "open" accessible 
conformation and the other in a "closed" confirmation; in the closed state, the entrance 
to the E1 active site is obscured by a surface loop (Frank et al., 2005).  This asymmetry in 
the X-ray structure, along with the apparent increase in E1 activity after limited 
proteolysis, has led to the suggestion that the E1 active sites communicate with each 
other, allowing only one site to be functional at any one time (Chauhan et al., 2000).  The 
two active sites are linked via a water-filled cavity and a chain of acidic residues (Figure 
1.11B); it has been suggested that a "proton wire" allows the transfer of a proton from 
the activated TPP in one active site to the cofactor in the adjacent site, thus preventing 
activation of the second TPP (Frank et al., 2004).  Mutation of G. stearothermophilus E1 
Asp180 to Asn and Glu183 to Gln, two of the acidic residues located within the tunnel, 
reduced the rate of the E1 catalysed reaction (Frank et al., 2004), and similar studies on 
the E. coli PHDC E1α2 found that mutation of the acidic residues prevented transfer of 
information between the two active sites and reduced the binding of TPP in the correct 





Figure 1.11 The crystal structure of the G. stearothermophilus PDHC E1 heterotetramer.   
A) E1α2β2 ribbon diagram with the TPP cofactor shown in red; B) magnified view of the 
above structure rotated 90° to the right, showing the water-filled channel linking the two 
active site TPPs.  The α- and β-subunits are shown in yellow and blue, respectively.  PDB 













1.2.4.2 E2 - Dihydrolipoamide transacylase 
The E2, dihydrolipoamide transacylase (EC 2.3.1.12 or 2.3.1.61), catalyses the transfer of 
the lipoamide-attached acyl group onto CoA, releasing acyl-CoA and reducing the lipoyl 
disulphide.  Each E2 polypeptide comprises three separate domains connected by two 
flexible linker regions (Figure 1.12) (Perham, 2000):  
 An N-terminal lipoyl domain (~80 residues) that transfers the intermediates 
between active sites via its covalently-attached lipoyl group,  
 A peripheral subunit binding domain (PSBD) (~40 residues) that is responsible for 
the non-covalent association of the E1 and E3 enzymes with the E2 core 
 A C-terminal catalytic domain (~230 residues) that has two roles: it contains the 
E2 acyltransferase active site, and this domain also forms the structural E2 core of 
the OADHC. 
 
The flexible linkers play a crucial role, the N-terminal linker allows the lipoyl domain to 
move between active sites and thus transfer the reaction intermediates.  The spatial 
arrangement of the E1 and E3 enzymes relative to the E2 core is controlled by the C-
terminal linker region, this region adopts an extended conformation, resulting in a shell of 
E1 and E3 enzymes 75-90Å away from the E2 core (Lengyel et al., 2008) (Figure 1.12). 
 
Figure 1.12 Diagram of the domain structure of the E2 protein.  The eight catalytic 
domain trimers are represented in red, the PSDB (blue), lipoyl domain (yellow) and linker 




The C-terminal E2 catalytic domain 
There are several structures available for the E2 catalytic domain (E2cat) including E. coli 
succinyltransferase (PDB access code: 1E2O), Geobacillus. stearothermophilus and 
Azotobacter vinelandii acetyltransferase (1B5S and 1EAA, respectively), and 
Pseudomonas putida and Bos taurus branched-chain acyl-transferases (1QS0 and 2IHW).  
The E2cat monomers initially form trimers, and then either 8 or 20 trimers associate into a 
cubic 24-mer (Figure 1.13A) or a dodecahedral 60-mer (Figure 1.13B) respectively, 
depending on the organism and the complex.  The E2 24- and 60-mers are both hollow 
cage-like structures comprising either square or pentagonal faces, with a large opening in 
the centre of each face, allowing free movement of substrates and products into and out 
of the interior of the E2 structure (Mattevi et al., 1992).  The 24-and 60-mer structures are 
both Euclidean shapes, in which all subunits are in identical environments: the 24-mer 
displays octahedral 4,3,2 symmetry and the 60-mer displays icosahedral 5,3,2 symmetry; 
the only other form of cubic symmetry is tetrahedral 3,2 symmetry (Caspar and Klug, 
1962).  It is not possible to arrange more than 60 subunits into a perfectly symmetrical 
structure, in which all monomers are in identical environments.  In the case of virus 
capsids which can comprise over 60 polypeptides, the structures are said to be quasi-
symmetrical arrangements, the subunits inhabit slightly differing environments. 
         
 
Figure 1.13 A Surface representation of A) the cubic 24-mer, and B) the dodecahedral 
60-mer.  The cubic 24-mer is the pyruvate dehydrogenase complex from Azotobacter 
vinelandii (PDB code: 1EAF) (Mattevi et al., 1992) and the 60-mer is the pyruvate 
dehydrogenase complex from Geobacillus stearothermophilus (PDB code: 1B5S) (Izard et 
al., 1999).  The maximum diameter is shown below each structure (Image created with 
PyMOL). 




The E2cat monomers have a structure similar to the chloramphenicol acetyltransferase 
enzyme (Knapp et al., 1998); they comprise a large β-sheet, surrounded by five α-helices 
and a C-terminal 310 helix (Mattevi et al., 1992).  The construction of trimers from the 
individual A. vinelandii E2 monomers is accompanied by the formation of 12 hydrogen 
bonds and the burial of 25% of the monomer surface area (Mattevi et al., 1992).  The 
trimer structure of the 24- and 60-mers are identical, and it is the angle at which the 
trimers interact with one another that influences the overall structure.  The inter-trimer 
interactions are mediated via a hydrophobic "anchor residue"; this residues, either a Met, 
Leu or Ile, is located a few residues in from the C-terminus of the protein on the 310 helix 
(Izard et al., 1999); the hydrophobic side chain extends from one trimer into a 
hydrophobic pocket of a second trimer and vice versa.  No correlation between the 
oligomeric nature of the E2 assemblies and the E2cat sequence have been identified; 
instead, it has been suggested that small changes in the interactions between the anchor 
residue and the side chains within the pocket may influence the angle of inter-trimer 
interactions, and thus the assembly of the E2 core (Izard et al., 1999).  The importance of 
the anchor residue has been demonstrated by Peng et al. (2012), as the removal of the 310 
helix containing the Met 425 anchor residue from the G. stearothermophilus E2cat 
resulted in a protein that no longer assembled into a 60-mer. 
The E2 transacylase active site is located within a ~30Å channel, situated at the intra-
trimer monomer interfaces, and each of the three active sites contains residues 
contributed by two monomers.  The channel traverses the trimers with an opening on 
both the inside and the outside of the assembled E2; the acylated lipoic acid enters the 
active site from the outside, and the CoA enters from the interior of the E2 cage (Mattevi 
et al., 1993).  Binding of substrates to the A. vinelandii and E. coli E2 has no effect on the 
structure.  However, there are differences between the bovine branched-chain E2 crystal 
structures with and without CoA bound, and it has been suggested that the eukaryotic E2 
may have a substrate-gating mechanism (Kato et al., 2006).  In the absence of CoA, a 
cluster of residues (Leu 93, Val 295 and Leu 353) prevent the acylated-lipoamide from 
entering the active site channel; however, upon binding of CoA to the active site a 
conformational change rotates these gating residues away from the channel entrance, 
thus exposing the lipoamide binding site.  The role of this gating mechanism is possibly to 
increase the efficiency of the E2 enzyme, by only allowing the acylated-lipoamide to enter 
active sites that already have a CoA present.  This adaptation may increase efficiency by 
reducing the chance of acyl groups being lost by hydrolysis in the absence of CoA and/or 
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to reduce the time that each lipoamide spends bound to an E2 waiting to be deacylated 
(Kato et al., 2006). 
The E2 is thought to catalyse the transfer of the acyl group from the lipoic acid moiety 
onto CoA via a mechanism similar to that used by the chloramphenicol acetyltransferase 
(Guest, 1987).  The CoA thiol group is first deprotonated by a histidine imidazole side 
chain.  The negatively-charged CoAS- then attacks the acylated lipoic acid, resulting in a 
tetrahedral intermediate that is stabilised by a Thr or Ser residue, and correctly orientated 
by an Asp (Knapp et al., 1998); this intermediate then collapses, resulting in the formation 
of acyl-CoA and a reduced E2 bound lipoic acid. 
Following the determination of the G. stearothermophilus E2 structure by Izzard et 
al. (1999), one branch of research has focused on the potential medical applications this 
protein may have.  One possibility is to replace the PSBD and lipoyl domains with a viral 
protein or protein motifs, in order to create a vaccine for HIV (Domingo et al., 2001).  The 
advantage of using the E2 to present antigens is that multiple viral protein motifs and 
immune cell activating proteins can be displayed on a single 60-mer, resulting in a 
synergistic immune response (Caivano et al., 2010).  Another potential use of the E2 
protein being investigated is the ability of the E2 catalytic domain to encapsulate a drug 
molecule whilst display targeting molecules on its outer surface (Dalmau et al., 2008).  
This research aims to add a solvent-accessible Cys residue to the interior surface of the 
E2cat protein, so that a drug molecule can be attached to the inside of the cage, thus 
encapsulating and sequestering it.  The addition of a targeting protein to the surface could 
then target the encapsulated drug to a certain cell type.  The next stage of this research 
was to modify the E2 structure by the addition of histidine residues at the trimer-trimer 
interfaces.  The aim is to create an E2 capsule that sequesters the drugs until the protein 
is endocytosed; during endocytosis the acidification of the vesicle causes the imidazole 
side chains at the trimer-trimer interface to become positively charged, repel each other 
and trigger disassembly of the E2 protein along with the release of the sequestered drug.  
Currently, the pH-dependent disassembly of this E2 protein is unfortunately coupled with 




The peripheral subunit binding domain (PSBD) 
The PSBD is located between the N-terminal lipoyl domain and the C-terminal catalytic 
domain; this small domain, comprising 40-50 residues, is responsible for the non-covalent 
association of the E1 and E3 enzymes with the OADHC E2 core.  This domain and its role in 
OADHC assembly, were determined by limited proteolysis of the E2 in the presence of the 
E1 and E3 enzymes; gel filtration of the resulting protein fragments found that a small E2 
domain remained attached to the E1 and E3 proteins (Duckworth et al., 1982).  The 
structure of this domain was solved by NMR, using a 43-residue synthetic peptide based 
on the G. stearothermophilus sequence.  The PSBD structure is a compact domain (25Å x 
20Å x 20Å) comprising two short α-helices and one 310 helix (Kalia et al., 1993).  The 
structure of the recombinantly expressed G. stearothermophilus PSBD in complex with the 
E3 has since been determined by X-ray crystallography (Figure 1.14) (Allen et al., 2005).  
The PSBD is one of the smallest known independently-folding protein domains with a 
stable tertiary structure; this along the short sequence allowing for synthetic production 
and thus the ability to incorporate non-natural amino acids, has meant that the PSBD has 
been an ideal model for studying the energetics and physical processes involved in protein 
folding and unfolding (Sharpe et al., 2008, Spector et al., 1998, Ferguson et al., 2005). 
 
Figure 1.14 The X-ray crystal structure of the G. stearothermophilus PSBD domain.  The 
two α-helices and the 310 helix are shown in red and yellow respectively; the loop regions 
are shown in blue (Allen et al., 2005).  (PDB access code: 1W3D). 
 
The E1 and E3 enzymes bind competitively to the PSBD.  The E1α2β2 interaction is 
mediated via the β-subunits; the G. stearothermophilus E1β has been shown to bind to 
the PSBD without the E1α subunit.  The E1 tetramers and E3 dimers have both been 
shown to bind separately to the PSBD in a stoichiometry of 1:1 (Lessard and Perham, 
1995, Hipps et al., 1994), with the E1 binding more strongly than the E3 (Jung et al., 2003).  
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The biophysical data and the X-ray crystallographic structures of the PSBD, bound to 
either the E1 or E3 (Figure 1.15), confirm that E1 binds to only one PSBD at the E1β 
interface (Frank et al., 2004), and the E3 dimers also bind to only one PSBD at the 
dimerisation interface (Mande et al., 1996).  Mutagenesis studies of the 
G. stearothermophilus PSBD have identified two Arg residues (Arg 135 and 156) as vital in 
the formation of interactions between the PSBD and the E1 or E3.  Met 131 has also been 
identified as crucial for the formation of the E1-PSBD interactions but is not required for 
E3 binding (Jung et al., 2003); these data suggest that the PSBD has two overlapping 
binding sites for the E1 and E3 enzymes. 
 
 
Figure 1.15 The crystal structures of the G. stearothermophilus PDHC PSBD bound to A) 
the E1α2β2 and B) the E3α2 enzymes shown as ribbon diagrams.  The PSBD α helices and 
310 helix are shown in dark and light blue, respectively.  A) The E1 α- and β-subunits are 
shown in magenta and red, respectively.  B) The two monomers of the E3α2 structure are 
shown in yellow and orange.  E1 PDB access code: 1W88 (Frank et al., 2004); E3 PDB 
access code: 1EBD (Mande et al., 1996). 
 
The situation in eukaryotes is slightly different, as only the E1 binds to the E2-PSBD; the E3 
binds instead to an E3-binding protein (E3BP).  The E3BP comprises a single lipoyl domain, 
an E3-binding domain and a non-catalytic core.  The non-catalytic E3BP core domain, 
along with the E2 catalytic domain, assemble into a 60-mer; the exact stoichiometry in 
vivo is not clear but a ratio of 48:12 E2:E3BP has been suggested (Brautigam et al., 2009).  
It has been proposed that the human E3BP integrates into the OADHC by replacing some 
E2 subunits (Yu et al., 2008).  The mammalian E2 and E3BP are closely related 
homologues; however, the E2 active site His is replaced in the E3BP by a Ser, the E3BP 
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also has only one lipoyl domain unlike the E2 which has three (Hiromasa et al., 2004).  This 
alternative eukaryotic arrangement, may allow for increased control of the stoichiometry 
of E1 and E3 enzymes in the assembled OADHC, in a more subtle manner than by simply 
controlling expression levels of the two proteins. 
 
The N-terminal lipoyl domain 
The N-terminal lipoyl domain has a lipoic acid moiety covalently attached to a lysine 
residue; this chemical modification allows the OADHC reaction intermediates to bind to 
this domain and be transferred between the active sites.  The number of lipoyl domains 
can vary between one and three depending on the complex and the organism: 
Tp. acidophilum OADHC has one, Neisseria meningitidis and Alcaligenes eutrophus PDHCs 
have two and the A. vinelandii and E. coli PDHCs have three (Perham, 2000). 
The structure of this domain has been determined by NMR.  The lipoyl domain comprises 
two β-sheets; a lipoic acid moiety is covalently attached to a lysine residue that is located 
on a exposed surface loop flanked by moderately-conserved Asp and Ala residues (Figure 
1.16) (Reche and Perham, 1999, Perham, 2000).  It has been shown that the 
G. stearothermophilus E1 enzyme recognises the lipoylated lipoyl domain preferentially 
over either a non-lipoylated domain or free lipoic acid; thus, the E1 active site interacts 
with the β-turn and surface loop of the lipoyl domain, in addition to the lipoic acid.  The 
E3 enzyme also preferentially accepts lipoic acid tethered to a lipoyl domain, but in this 
case the active site interacts only with the lysine and two adjacent amino acids (Figure 







Figure 1.16 The G. stearothermophilus PDHC E2 lipoyl domain ribbon diagram.  The 
lysine residue to which the lipoic acid is attached is highlighted in red.  The magenta 
regions are the residues either side of the Lys that the E1 and E3 active sites recognise; 
the orange regions are the residues recognised by the E1 active site in addition to the pink 




Lipoylation of the E2 lipoyl domain lysine can occur via two pathways in E. coli depending 
on the availability of exogenous lipoic acid.  When lipoic acid is exogenously available, 
LplA (EC: 2.7.7.63), an ATP-dependant lipoate protein ligase, catalyses the formation of an 
amide bond between the lipoic acid and the Lys ε-amino group (Morris et al., 1994).  A 
second pathway is utilised when lipoic acid is not freely available; in this case, octanoic 
acid, produced by the fatty acid biosynthesis pathway, is attached to the lipoyl domain by 
LipB, a lipoyl (octanoyl) transferase (EC 2.3.1.181).  The octanoic acid is then converted via 
octanoyl-ACP into lipoyl-ACP by LipA, a lipoyl synthase (EC 2.8.1.8) (Morris et al., 1994). 
The flexible linker region connecting the lipoyl domain and the PSBD lets the lipoyl 
domain to move freely between the active site of the OADHC (Perham, 1991); allowing 
the covalently attached reactive intermediates to be stabilised and efficiently transported 
between active sites.  The efficiency of the OADHC is also increased by the lipoyl domains 
ability to transfer intermediates onto other lipoyl domains, and thus channel substrates 
around the complex; at low substrate concentrations this ability allows the sequential 
OADHC reactions to occur, even if the substrates were initially dispersed around the 
complex (Danson et al., 1978). 
 
1.2.4.3 E3 - Dihydrolipoamide dehydrogenase 
The E3 dihydrolipoamide dehydrogenase catalyses the following reaction: 
E2-Lip(SH)2 + NAD
+  E2-LipS2 + NADH +H
+ 
The homodimeric E3 enzyme is part of a family of dehydrogenases including the 
glutathione, trypanothione and mercuric reductases, all of which have a similar overall 
structure and have a reaction mechanism that utilises an active-site disulphide bond.  The 
A. vinelandii E3 structure has been determined to a resolution of 2.2Å by Mattevi et 
al. (1991a); each E3 monomer comprises 4 domains: the FAD+ and NAD+ binding domains 
(amino acids 1-150, and 151-280 respectively), a central domain (281-349) and an 
interface domain (350-466).  The two active sites are located at the interface between the 
two dimers, with each monomer contributing residues to both sites.  The active-site 
disulphide bond is formed between Cys48 and Cys53 (Figure 1.17).  The two Cys residues 
are located on an α-helix with an extended turn; the distortion in the α-helix brings the 
two sulphurs to within 4.2Å, rather than 8.8Å without the distortion, allowing the 





Figure 1.17 The structure of the homodimeric A. vinelandii E3.  The two subunits are 
shown in blue and green in Image A.  Image B is a magnified view of the active site of the 
blue monomer; the FAD cofactor is shown in black, the active-site disulphide between 
Cys48 and Cys53 is shown in yellow, and the catalytic His450', contributed by the green 
subunit, is shown in red.  PDB access code 3LAD (Mattevi et al., 1991a) (Image created 
with PyMOL). 
The lipoamide dehydrogenation reaction occurs in two steps: the oxidation of the lipoic 
acid moiety by the E3 enzyme, followed by the oxidation of the enzyme by NAD+ (Thorpe 
and Williams Jr, 1981): 
Reaction 1: E + Lip(SH)2    EH2 + Lip(S)2 
Reaction 2: EH2 + NAD
+    E + NADH+H+ 
The reduced lipoamide enters the active site via a narrow channel, where it reduces the 
enzyme’s disulphide bond (Cys48-Cys53).  Cys48 and the active site His450' are 
protonated, while the negative charge on Cys53 is stabilised by the formation of a charge 
transfer complex with the enzyme bound FAD+.  The oxidised lipoamide then leaves the E3 
active site and, in the second part of the reaction, the reducing equivalents are 
transferred onto NAD+, thus regenerating the enzyme and releasing NADH + H+ (reviewed 










1.3 The OADHCs in Archaeal carbon metabolism  
1.3.1 Evidence of OADHCs in Archaea 
Archaea were originally thought to utilise only FORs to convert all the 2-oxoacids to their 
corresponding acyl-CoAs (Kerscher et al., 1982); however evidence has emerged that 
aerobic archaea may utilise both FORs and OADHCs (Smith et al., 1987). 
1.3.1.1 The detection of dihydrolipoamide dehydrogenase activity in archaeal cell 
lysates 
The first indication that aerobic archaea may utilise an OADHC, in addition to the FOR, 
was the detection of dihydrolipoamide dehydrogenase activity in cell lysates from 
Halobacterium halobium, a halophilic archaeon, and Tp. acidophilum, a thermoacidophilic 
archaeon (Danson et al., 1984, Smith et al., 1987).  The activity detected in H. halobium 
was confirmed to be as a result of a dihydrolipoamide dehydrogenase, rather than a 
promiscuous glutathione reductase as the two activities could be separated by gel 
filtration (Smith et al., 1987).  The presence of dihydrolipoamide dehydrogenase activity 
and the detection of lipoic acid, an essential cofactor for OADHC activity, by GC-mass 
spectrometry, in H. halobium (Pratt et al., 1989) led to the hypothesis that some species 
of archaea may possess an OADHC in addition to the FORs.  E3 activity has since been 
detected in several species of aerobic archaea, but this has not been coupled with the 
detection of OADHC or E1 activity in any archaeal cell lysate. 
1.3.1.2 Identification OADHC genes archaea 
The E3 gene was identified in the halophile Haloferax volcanii; upstream sequencing of 
this gene identified the other three OADHC genes, E1α, E1β and E2, arranged in an 
operon-like structure.  H. volcanii messenger RNA was screened for a region containing 
the E3 sequence, and a single 5.2kb mRNA strand was identified (Al-Mailem et al., 2008); 
this size closely matches the 5.4kb expected if the putative OADHC genes are arranged as 
an operon and are translated as a single mRNA molecule (Jolley et al., 2000). 
The recent sequencing and annotation of the genomes of several species of archaea have 
identified the OADHC genes in aerobic organisms from mesophilic, halophilic and 











Figure 1.18 Putative OADHC gene arrangements in aerobic archaea.  The genes identified 
as encoding the components of a putative OADHC are shown by arrows indicating the 
direction of the open reading frame, and the distances in base pairs between the genes 
are shown above.  The -1* in the middle of the S. solfataricus E2 gene indicates that this 
gene contains a -1 base-pair frame-shift.  The AcoX gene located within the S. solfataricus 
operon encodes a protein that may be involved in acetoin metabolism. 
 
Transcriptomic studies of Pyrobaculum aerophilum have noted that the OADHC genes are 
transcribed, and that transcription appears to be regulated by the respiratory growth 
conditions of the organism (Cozen et al., 2009).  A proteomics study of large complexes 
(>1 MDa) in Tp. acidophilum identified the E1 and E2 proteins but not the E3, (Sun et al., 
2007), implying that the OADHC genes are transcribed and translated but under these 
conditions the E3 does not appear to associate with the E2 core. 
In conclusion, there is a mounting body of evidence implying that aerobic archaea utilise 
the OADHCs; this evidence includes the presence of genes encoding the OADHC proteins, 
E1α, E1β, E2, and E3, along with the proteins required for E2 lipoylation, and that these 
genes appear to be transcribed and translated, with E3 activity being detected in several 
cases.  The only result contradicting these findings, is that as yet no OADHC activity has 
been detected in cell lysates of the archaea. 
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1.3.2 Characterisation of the OADHC from Tp. acidophilum 
The four complex genes, E1α, E1β, E2 and E3, were identified in the Tp. acidophilum 
genome along with a possible LplA gene (Section 1.3.3), suggesting that this organism has 
the potential to produce a functional OADHC.  The OADHC genes were cloned and 
expressed by Heath (2006) and Aass (2003).  The E1α and E1β assembled into an α2β2 
tetramer which had activity with branched-chain 2-oxoacids and to a lesser extent, 
pyruvate (Heath et al., 2004).  The recombinantly expressed E2 was soluble and 
approximately 50% of the polypeptides were lipoylated by the E. coli cells when the 
medium was supplemented with lipoic acid; the E2 assembled into a large structure 
predicted to be a 24-mer by sedimentation velocity ultra-centrifugation.  The E3 gene was 
recombinantly expressed in E. coli, resulting in a dimeric protein with an equimolar 
concentration of FAD+ to E3 polypeptides (Aass, 2003).  The purified recombinant 
Tp. acidophilum OADHC enzymes were found to assemble into a large 5 MDa 
multienzyme complex, which was capable of catalysing the oxidatative decarboxylation of 
branched-chain 2-oxoacids and pyruvate (Heath et al., 2007).  These data prove that even 
though OADHC activity has not been detected in Tp. acidophilum cell extracts, the OADHC 
genes encode functional proteins that can assemble into a branched-chain OADHC. 
 
1.3.3 Identification of an E2 lipoylation pathway in Tp. acidophilum  
A search of the Tp. acidophilum genome for LplA or LipA/LipB genes, encoding the 
enzymes required to lipoylate the E2, identified a putative LlpA gene (Ta0514) (McManus 
et al., 2006); the LlpA protein was recombinantly expressed but lipoate protein ligase 
activity was not detected (PDB access code: 2C7I).  The Tp. acidophilum and E. coli LplA 
protein sequences align well with each other, except Tp. acidophilum LplA is 90 amino 
acids shorter than the E. coli LplA.  When the structure of the two LplAs were 
superimposed, the missing region equated to the E. coli C-terminal domain, a small 
domain that is separated from the rest of the protein by a flexible linker (McManus et al., 
2006).  A BLASTP search of the Tp. acidophilum genome for the missing 90 residues 
identified a short gene upstream of the putative LplA sequence (Ta0513m).  Thus, 
Tp. acidophilum appeared to possess genes for separate N- and C-terminal LplA domains 
that might constitute a novel bipartite LplA enzyme, (Posner, 2009).  The two proteins 
have been recombinantly expressed in E. coli and shown to associate with each other to 
give a catalytically-active LplA enzyme (Posner et al., 2009).  The Tp. acidophilum genome 
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therefore contains the proteins required to lipoylate the E2 enzyme in the presence of 
exogenous lipoic acid.  The presence of the bipartite LplA , E1, E2, and E3 genes suggests 
that even though OADHC activity has never been detected in cell lysate, it must have a 




1.4 Aims of the project 
To date studies of enzyme thermostability and thermoactivity have mainly been 
performed on individual isolated enzymes; however, this is not truly representative of the 
conditions within a cell, where a large number enzymes and proteins may be closely 
associated with one another.  This project aimed to extend these studies from small 
oligomeric enzymes to a multienzyme complex, namely the OADHC from the thermophilic 
and hyper-thermophilic archaea by characterising the thermostability and thermoactivity 
of the Tp. acidophilum individual OADHC components and the fully assembled OADHC.   
The E2 enzyme forms the structural core, around which the E1 and E3 enzymes associate; 
the thermostability of the E2 is fundamental to the stability of the whole multienzyme 
complex.  Due to the flexible multi-domain nature of the E2 protein's structure, the whole 
E2 is unlikely to crystallise; therefore, the second aim of this project was to clone and 
express the catalytic domain of the E2, in order to determine a high-resolution X-ray 
crystallographic structure. 
The final aim was to study other thermophilic and hyper-thermophilic OADHCs, in order 
to answer questions such as: what are the substrate specificities of the different 
complexes in the different species of archaea, how does this affect the possible 
physiological roles of the OADHCs and finally what is the evolutionary history of these 




Chapter 2: Material and Methods 
In all cases, unless otherwise stated, laboratory reagents were supplied by Sigma-Aldrich 
Company Ltd. (Poole, U.K.), Melford Laboratories Ltd. (Ipswich, U.K.), or Fisher Scientific 
(Loughborough, U.K.), and were of the highest grade commercially available. 
 
2.1  Microbiology techniques 
2.1.1 Escherichia coli strains  
Cloning experiments were carried out using E. coli JM109 cells, an endonuclease (endA) 
and recombinase (recA) deficient strain.  The following modified E. coli strains were used 
for protein expression: E. coli BL21, E. coli Rosetta (DE3) pLysS (both Novagen, Merck, 
U.K.) and Arctic Express™ (Stratagene, Agilent Technologies, U.K.); these strains utilise the 
IPTG-inducible lac promoter to drive the expression of the T7 RNA polymerase, and the 
consequent over-expression of the target protein.  The E. coli Rosetta strain contains an 
additional pRARE plasmid that supplies extra tRNAs, not commonly used by E. coli: AUA, 
AGG, AGA, CUA, CCC, and GGA.  The ArcticExpress™ strain was utilised when the target 
protein was consistently expressed in an insoluble form by the other two strains.  This 
strain contains the psychrophilic Cpn10 and Cpn60 chaperonins from Oleispira antarctica; 
these chaperonins are able to function between 4-12°C, assisting protein folding and thus 
increasing the overall yield of correctly-folded soluble protein. 
 
2.1.2 Growth of Escherichia coli 
Unless otherwise stated, all cultures were grown in 500ml Luria Bertani (LB) medium 
(1% (w/v) tryptone, 1% (w/v) NaCl, 0.5% (w/v) yeast extract and pH 7.0).  The LB medium 
was supplemented with antibiotics as recommended by the pET vector system, Promega 
and Stratagene manuals (carbenicillin 50μg/ml, kanamycin 30μg/ml, chloramphenicol 
34μg/ml, or 20µg/ml gentamycin). 
 
2.1.3 Production of electrocompetent E. coli cells 
To produce the electrocompetent E. coli JM109 and Rosetta cells, 5ml YENB medium 
(0.75% (w/v) yeast extract, 0.8% (w/v) nutrient broth, adjusted to pH7.5), supplemented 
with the required antibiotics, was inoculated with a single colony and incubated for 15 h 
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at 37°C; 2ml of this starter culture were then inoculated into 500ml YENB medium and 
incubated at 37°C, shaking at 200rpm, until the A600 reached 0.8-1.0.  The cells were then 
harvested by centrifugation at 13400 x g, at 4°C for 10 min.  The cell pellet was then 
gently resuspended in 25ml cold dH2O and centrifuged again; this wash step was repeated 
with another 25ml dH2O, and 30ml 10% (v/v) glycerol.  The final cell pellet was 
resuspended in 900μl 10% (v/v) glycerol, and then divided into 40μl aliquots, snap-frozen 
and stored at -80°C. 
 
2.2  Molecular biology techniques 
The following molecular biological instructions were followed to clone and express a 
target gene in E. coli: 
1. PCR amplify the required gene 
2. Determine PCR products size and purity by agarose gel electrophoresis 
3. Purify PCR product from agarose gel 
4. A-tail the PCR product and ligate into pGem-T Easy vector 
5. Transform the pGem-T Easy vector into E. coli JM109 for blue/white screening 
6. Select several white E. coli colonies, and extract the plasmid 
7. Confirm the presence and size of the insert in pGem-T Easy by restriction digestion 
using specific enzyme combinations 
8. Sequence the selected pGem-T Easy plasmids to confirm gene sequence 
9. Ligate the digested gene from pGem-T Easy into the required pET vector, that has 
been previously digested using the same restriction enzyme combination  
10. Transform the pET vector into E. coli JM109 
11. Select E. coli colonies to screen for the target gene using a colony PCR 
12. Extract the pET vector plasmid from positive colonies  
13. Confirm the positive colony PCR result by restriction digestion of the pET vector  
14.  Sequence the pET vector to ensure the correct gene is present without any 
mutations 




2.2.1 Polymerase chain reaction  
2.2.1.1 DNA amplification 
Unless otherwise stated, all PCR reactions were performed using Phusion® polymerase 
PCR kits (New England Biolabs) following the conditions recommended by the supplier; a 
standard PCR mixture contained: 1x High Fidelity buffer, 0.2-1.0μM primers, 6ng/50μl 
template DNA, 0.02U/μl Phusion DNA polymerase, and 200μM dNTPs (dATP, dCTP, dGTP, 
dTTP) (New England Biolabs, Ipswich).  The reactions were carried out in thin-walled 
Eppendorf PCR tubes in an Eppendorf Maser cycler (Eppendorf, Germany).  A standard 
cycle is shown in Table 2.1.  All primers were produced by Invitrogen (U.K.). 
 Temperature (°C) Time 
Initial denaturation 98 30 sec 
Denaturation 98 10 sec 
Annealing Y 30 sec 
Elongation 72 X min 
Final elongation 72 10 min 
 
Table 2.1 Temperatures and times of each stage of a standard PCR. The elongation time 
(X) is dependent on the length of each DNA sample (30 sec per 1Kb).  Temperature (Y) 
depends on annealing temperature of each pair of primers. 
 
2.2.1.2 Mutagenesis cycle 
Site-directed mutagenesis was utilised to mutate or delete short sequences of DNA in a 
plasmid.  The method described in the Stratagene Quickchange® Site-Directed 
mutagenesis kit manual was used to design the primers and Phusion polymerase-PCR 
conditions (Table 2.2). 
 Temperature (°C) Time 
Initial denaturation 98 30 sec 
Denaturation 98 30 sec 
Annealing 55 30 sec 
Elongation 72 X min 
Final elongation 72 10 min 
 
Table 2.2 The temperatures and times of each stage of a site-directed mutagenesis PCR.  
The elongation time (X) is dependent on total size of the plasmid and gene (30 sec per 







The methylated template DNA was removed, after the PCR, by a 60-minute incubation 
with Dpn I, leaving only the amplified plasmid containing the required mutation.  The PCR 
mixture, containing the Dpn I enzyme, was then incubated at 80°C for 20 min to inactivate 
the Dpn I.  The mutated plasmids were then purified, using the Wizard® SV Gel and PCR 
DNA Purification System (Promega) following the supplier’s instructions, and transformed 
into E. coli JM109 for propagation.  The plasmids were extracted from several E. coli 
colonies and sequenced by SourceBioscience plc (Oxford, U.K.) to ensure the correct 
mutation was present.  The mutated plasmid was then transformed into the required 
E. coli protein expression strain (Chapter 2.2.5). 
 
2.2.2 Agarose gel electrophoresis  
DNA was visualised on an agarose gel containing 1.0 - 2.5% (w/v) agarose (Lonza, 
Switzerland) dissolved in TAE buffer (40mM Tris-acetate, pH 8.0, and 1mM EDTA) with 
0.004% ethidium bromide.  DNA samples were prepared in x6 blue/orange loading buffer 
(Promega, U.K.).  To determine the size of the DNA bands, 1Kb and 100bp DNA markers 
(Promega, Southampton, U.K.) were run alongside any experimental samples.  The 
agarose gels were electrophoresed in TAE buffer at 80-100V until DNA were separated; 
the DNA bands were then visualised using a UV transilluminator.  The required DNA bands 
were excised and purified using the Wizard® SV Gel and PCR DNA Purification System 
(Promega) following the supplier’s instructions. 
 
2.2.3 A-tailing of the blunt-ended PCR products  
The PCR products generated by Phusion polymerase are blunt-ended; therefore, they 
require the addition of a 3' adenine before being ligated into pGem-T.  Taq polymerase 
(Genosys Ltd, U.K.) was used to A-tail the 3’ end of the DNA following the instructions 
detailed in the Promega pGem-T manual; each A-tailing reaction contained 7μl DNA, 1x 
standard Taq buffer, 0.2mM dATPs, and 0.5U Taq, this mixture was incubated at 70°C for 
30 min.  The A-tailed DNA was then purified using the Wizard® SV Gel and PCR DNA 




2.2.4 DNA plasmid ligation 
The A-tailed PCR products and restriction-digested gene fragments (Chapter 2.2.5) were 
ligated into either pGem-T or pET vectors, respectively.  A typical 10μl ligation reaction 
contained 0.5-1.5U T4 DNA ligase, 1x ligase buffer (both Promega), 7.5μl purified DNA 
fragment, and 1μl of either pGEM-T Easy (Promega) or digested pET vectors (Novagen, 
Merck, U.K.).  This mixture was incubated overnight at 16°C, along with a control ligation 
containing vector with no insert DNA. 
 
2.2.5 Restriction digest 
All restriction enzymes and buffers used were supplied by Promega or New England 
Biolabs (Ipswich, U.K.).  A typical restriction digest contained 0.25U enzyme, 2μl 
recommended buffer, 5-10μl DNA, and dH2O up to 20μl.  The reaction mixture was then 
incubated at 37°C for 2-4 h.  In the case of pET vector digestion, to prevent the vector 
undergoing self-ligation, the 5’phosphate was removed by the addition of 0.5U Shrimp 
alkaline phosphatase (Roche, U.K.) during the final hour of the digestion. 
 
2.2.6 Transformation of electrocompetent and chemically-competent E. coli cells 
The plasmid DNA was ethanol precipitated, to remove salts and concentrate the DNA, 
before being transformed into the required E. coli cells.  A typical ethanol precipitation 
mixture contained 10μl ligation mixture (Chapter 2.2.3), 66μl absolute ethanol, 0.1M 
sodium acetate, pH 5.2, and 1μl dextran blue.  The mixture was incubated at -20°C for 30 
min and then centrifuged at 13400 x g at 4°C to pellet the DNA.  The precipitated DNA was 
washed with 100µl of 70% ethanol and re-pelleted before being left to dry. The plasmid 
was then re-suspended in 5μl Milli-Q water. 
2.2.6.1 Transformation of electrocompetent cells 
0.5μl DNA was added to 40μl of electrocompetent cells and incubated on ice for 5 min.  
These cells were then transferred into a 10mm pathlength Genepuler™ electroporation 
cuvette (BioRad, U.K.) before being electroporated using the Micropulser™ electroporator 
set to Ec1, the E. coli setting of approximately 1.8kV for 3-5 milliseconds.  The cells were 
incubated for 1 h in 1ml SOC medium (LB medium supplemented with 20 mM glucose, 2.5 
mM KCl, 20 mM Mg2+ [from stock: 1M MgCl2.6H2O, 1M MgSO4.7H2O]) at 37°C.  The cells 
containing the pET vectors were spread onto LB agar plates supplemented with the 
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required antibiotic.  For blue/white selection of the JM109 cells containing the pGEM-T 
easy vector, the LB agar plates supplemented with 100μg/ml carbenicillin, with 100μl 
100mM IPTG and 20μl 50mg/ml X-Gal was spread on the surface. 
2.2.6.2 Transformation of chemically-competent cells 
The E. coli BL21 and ArcticExpress™ expression strains were chemically transformed with 
the required pET vector.  Approximately 50 ng (1-5 μl) of ethanol-precipitated DNA was 
added to 20µl of cells; this mixture was then incubated on ice for 30 min.  The cells were 
incubated at 42°C for 45 sec, and then immediately cooled on ice.  The cells were 
resuspended in 1ml SOC medium and incubated at 37°C for 1 h; the cells were then 
spread onto antibiotic-supplemented LB agar plates. 
 
2.2.7 Colony PCR screens 
Colony PCR reactions were performed when a large number of colonies were produced 
from transformations of newly-ligated pGEM-T easy or pET vector plasmids.  A typical 
reaction contained 10μl of Taq Master Mix (GeneSys Ltd, Surrey, U.K.) [Taq polymerase, 
Taq buffer, dNTPs and loading dye] diluted with 9μl water and 0.5μl of the forward and 
reverse gene specific primers.  The genomic DNA was introduced to the PCR mixture by 
the addition of a few cells from each colony; the cells were lysed and DNA released during 
the initial denaturation step shown in Table 2.3.  The PCR products were analysed by 
agarose gel electrophoresis, and any colonies that resulted in a PCR product of the 
expected gene size were subjected to a double restriction digest as described in Chapter 
2.2.5. 
 Temperature (°C) Time 
Initial denaturation 95 30 sec 
Denaturation 95 30 sec 
Annealing 55 30 sec 
Elongation 68 X min 
Final elongation 68 10 min 
 
Table 2.3 The temperatures and times of each stage of Taq polymerase PCR.  The 






2.2.8 DNA sequencing 
The genes inserted into the multiple cloning regions of both pGem-T Easy and pET vectors 
were sequenced, in the forward and reverse directions, using commercially available 
primers.  Inserts in pGem-T Easy were sequenced using the T7F and SP6 primers, and all 
pET vector inserts were sequenced using the T7F and T7R primers.  Internal gene-specific 
primers were designed for genes longer then 1.5Mbp.  The sequencing reactions were 
performed by SourceBioscience plc (Oxford, U.K.). 
 
2.3  Protein expression and purification 
2.3.1 Protein expression 
The pET vectors containing the genes of interest were transformed into E. coli 
Rosetta(DE3)pLysS, E. coli BL21 or Arctic Express™ for protein expression.  A 10ml LB 
medium starter culture, supplemented with the required antibiotics, was inoculated with 
a single colony and grown overnight; 2ml of this culture were used to inoculate 500ml of 
LB medium, in 2L flasks, supplemented with the required antibiotic.  All cultures were 
grown at 37°C until they reached an OD600 ≈0.6-1.0.  The conditions after this point varied 
depending on the protein being expressed and the E. coli expression strain.  The cultures 
containing the Tp. acidophilum genes were grown in conditions described in Table 2.4 for 
approximately 20 h, before the cells were harvested by centrifugation at 13400xg, 4°C for 
15 min. 
Protein Induction method Post induction temperature (°C) 
E1 1mM IPTG 25 
E2 1mM IPTG 25 
E2cat 1mM IPTG 37 
E3 Not induced (Aass, 2003) 37 
 
Table 2.4 The conditions used for the heterologous expressions of the Tp. acidophilum 
complex proteins in E. coli.  The mutated versions of the E2 and E2 catalytic domain 
(Chapters 7 and 8) were expressed in the same conditions as the non-mutated protein. 
 
2.3.2 Preparation of soluble cell extract 
The pelleted cells were resuspended in the required buffer (0.25-0.50 % (v/v) of the initial 
culture); E1, E2 and E3 samples were suspended in his-bind buffer (300mM NaCl, 50mM 
Tris-HCL, 20mM imidazole (Acros Organics, U.K.), pH8.0), and the E2cat samples in 50mM 
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Tris-HCl, pH8.8.  Complete protease inhibitor cocktail, EDTA-free, tablets (Roche) were 
added to all samples and 1mM EDTA was also added to the E2cat sample.  The cells were 
lysed by sonication, whilst remaining on ice, to release the cytoplasmic proteins and shear 
the genomic DNA. 
2.3.2.1 Heat treatment 
Heat treatments were used immediately after lysing the cells, to remove a large 
proportion of the contaminating E. coli proteins.  The Tp. acidophilum protein samples 
were incubated at 55°C for 10 min.  The cell lysate was then centrifuged at 13400 x g at 
4°C for 15-20 min.  The clear supernatant was then passed through a 0.45μm filter 
(Millipore, U.K.). 
2.3.2.2 Nickel-affinity chromatography 
Nickel-affinity chromatography was used to purify the N-terminal histidine-tagged E1, E2, 
and E3 proteins.  A PolyPrep chromatography column (BioRad, U.K.) was filled with 1ml 
chelating cellulose (Bioline, U.K.) and washed with 5ml of Milli-Q water, followed by 2ml 
0.4M NiSO4; the excess NiSO4 was removed with Milli-Q water and the column was finally 
equilibrated with his-bind buffer (50mM Tris-HCl, pH 8.0, 20mM imidazole (Acros 
organics, U.K.), and 300mM NaCl).  The filtered supernatant was loaded onto the column 
and allowed to flow through; the solution that passed through the column was collected 
and loaded again to ensure all his-tagged proteins had bound.  The unbound proteins that 
remained in the column were eluted with 5ml of his-bind buffer.  The bound proteins 
were then removed by increasing the concentration of imidazole in the elution buffer; the 
his-elute buffer (50mM Tris-HCl, pH 8.0, 1M imidazole, and 300mM NaCl,) and the his-
bind buffer were mixed together to produce an imidazole concentration gradient, usually 
5% and 10% (v/v) his-elute to his-bind solutions.  The undiluted 100% his-elute buffer was 
added and the eluent collected from the column in five 1ml aliquots. 
2.3.2.3 Analytical Gel filtration 
The Superdex 200, 10-300GL (GE Healthcare) was used to purify and determine the size of 
the recombinant proteins.  A maximum of 0.5ml of protein solution was loaded on to the 
Superdex 200 column, which had been equilibrated with the required buffer.  Gel 
filtration was used as the final E2cat protein purification step (Chapter 4); in this case the 
column was equilibrated in 50mM Tris-HCl, pH 8.8, and 100mM NaCl.  The molecular 
weights of the eluted protein peaks were determined by comparison with standard 
proteins of known molecular weight: Carbonic Anhydrase 29 kDa, Bovine Albumin 66 kDa, 
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Alcohol Dehydrogenase 150 kDa, β-Amylase 200 kDa, Apoferritin 443 kDa, and 
Thyroglobulin 669 kDa.  Dextran Blue (2000kDa; Sigma-Aldrich) was used to measure the 
void volume of the column. 
 
2.3.3 SDS-PAGE 
Proteins were visualised by SDS-PAGE using 10% or 12.5% acrylamide gels. 
10% Separating gel: 4ml Milli-Q water, 3.3ml 30% (v/v) acrylamide (BioRad), 2.5ml 1.5M 
Tris-HCl pH8.8, 100μl 10% SDS, 100μl 10% (w/v) ammonium persulphate and 10μl 
tetramethylethylenediamine (TEMED) (National diagnostics). 
Stacking gel - 1.5ml Milli-Q water, 0.3ml 30% (v/v) acrylamide , 0.5ml 0.5M Tris-HCl pH6.8, 
20μl 10% SDS, 20μl 10% (w/v) Ammonium persulphate, and 5μl TEMED.   
The protein samples were heated at 95°C for 3 min with loading buffer (4x loading dye 
contained 4ml 0.5M Tris-HCl, pH 6.8, 2ml 10% SDS, 4ml glycerol, 100μl β-mercapoethanol 
(Sigma-Aldrich), 8μg bromophenol blue); each sample was briefly centrifuged at 13400 x g 
before being loaded onto a gel.  The size of the protein bands were determined by 
comparison with the BioRad (U.K.) broad-range standard molecular markers: 200 kDa 
myosin, 116 kDa β-galactosidase, 97 kDa phosphorylase b, 66kDa serum albumin, 45 kDa 
ovalbumin, 31 kDa carbonic anhydrase, 21.5 kDa trypsin inhibitor, 14.4 kDa lysozyme, and 
7 kDa apoferitin. 
The electrophoresis tank was filled with Tris/glycine buffer containing 0.02M Tris-HCl, 
0.192M glycine, and 0.1% (w/v) SDS.  The gels were run at 200V until the marker dye had 
reached the bottom of the gel.  The gels were stained with Coomassie stain (50% (v/v) 
Methanol, 10% (v/v) Acetic acid, and 0.01% (w/v) Coomassie Brilliant Blue R 250 (Sigma-
Aldrich)), and then the excess stain was removed from the gel by incubation in destain 
solution containing 30% (v/v) Methanol and 10% (v/v) Acetic acid. 
 
2.4 Determination of protein concentration 
2.4.1 Bradford Assay 
The Bradford assay was used to determine the protein concentration of any impure 
protein samples.  A standard curve was produced by the addition of 200μl of Bio-Rad 
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reagent (Coomassie blue G 250) to 800μl of bovine serum albumin (Sigma-Aldrich) 
standards ranging between 2μg/ml and 10μg/ml.  The absorbance of the standards and 
protein samples were measured at 595nm, in a Cary UV spectrophotometer. 
 
2.4.2 Protein concentration determination by A280  
The concentration of pure protein samples were determined spectrophotometrically at 
280nm on a Cary UV spectrophotometer, using the absorption coefficient predicted by 
Expasy ProtParam, based on the amino acid sequence (Gasteiger et al., 2003).  Non-
specific light scattering was taken into account when measuring the E2 protein 
concentration.  That is, the apparent absorbance was measured at 280, 320 and 360nm, 
where that observed at 360 and 320nm is due to scattering of the beam rather than 
absorbance.  A linear extrapolation from 360-320 to 280nm then allowed a correction to 
be made to give the true A280nm.  In the case of E3 enzyme, the FAD concentration was 
determined by the absorbance at 455nm using the molar absorption coefficient 
11.3 x103 M-1cm-1. 
 
2.5 Enzyme assays 
Unless otherwise stated, all material was kept on ice, all buffers were pre-incubated to 
the required temperature before each experiment, and assays were carried out using a 
Cary 300 Bio or Cary 50 Bio spectrophotometer.  The total volume of all assays was 1ml. 
 
2.5.1 2-Oxoacid decarboxylase (E1) spectrophotometric assay 
The Tp. acidophilum E1 enzyme was first incubated at 55°C for 10 min in preheated E1 
buffer (20mM potassium phosphate, pH 7.0, 2mM MgCl2, and 0.2mM thiamine 
pyrophosphate).  The background rate was determined after the addition of 1μM 
2,6-dichlorophenolindophenol (DCPIP) (Sigma-Aldrich), an artificial electron acceptor that 
allows E1 activity in the absence of the E2 attached lipoic acid moiety.  The reaction was 
started by the addition of 0.4mM 2-oxoacid (Sigma-Aldrich).  The rate of DCPIP reduction 
was measured by the decrease in the absorbance at 595nm, using the absorption 




2.5.2 Dihydrolipoamide S-acetyltransferase (E2) spectrophotometric coupled assay 
E2 enzyme activity was measured by coupling the E2-transacylase activity with a 
phosphotransacetylase (PTA) from Geobacillus stearothermophilus (EC Number: 2.3.1.8) 
(Sigma-Aldrich), based on the assay described by Packman et al. (1984).  The production 
of thioester bonds were measured by the absorbance change at 233nm, using the 
absorption coefficient of 5.4x103 M-1cm-1 (Srere and Kosicki, 1961).  Each 1ml assay 
contained 0.1M Tris-HCl, pH 7.6, 4.0mM DL-dihydrolipoamide (DHlip), 0.1mM coenzyme 
A, 10mM acetyl phosphate, and 7.5U phosphotransacetylase; this reaction was allowed to 
reach equilibrium at 55°C before the E2 enzyme was added.  The E2 enzyme then 
converted the acetyl-CoA to acetyl-dihydrolipoamide, with the excess PTA replacing any 
acetyl-CoA used, resulting in an overall increase in total concentration of thioester bonds 
(an example assay is shown in Figure 2.1) (Packman et al., 1984). 
 
First reaction - catalysed by the phosphotransacetylase (PTA): 
CoA + acetyl phosphate  ↔  acetyl-CoA + Pi 
Second reaction - catalysed by E2 dihydrolipoamide transacetylase: 
acetyl-CoA + DHlip  ↔  Acetyl-dihydrolipoamide + CoA 
 
 
Figure 2.1 An example of the coupled E2-PTA assay 233nm trace.  Rate A is the 
background reaction with all substrates but no enzymes; rate B is as a result of the 
addition of excess PTA, resulting in an equilibrium of CoA + acetyl phosphate and acetyl-
CoA and Pi.  Rate C is due to the addition of E2 enzyme which converts acetyl-CoA into 
Acetyl-dihydrolipoamide.  
 
A  B   C 
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2.5.3 Dihydrolipoamide dehydrogenase (E3) spectrophotometric assay 
The rate DHlip oxidation was measured by the reduction of NAD+ to NADH at 340nm, 
using the absorption coefficient of 6.22x103 M-1cm-1.  The E3 assay buffer (50mM sodium 
phosphate, pH7.0) was preheated to 55°C. The background rate was measured after the 
addition of 0.4mM NAD+ and 0.4mM dihydrolipoamide (DHlip) to the cuvette, after which 
the reaction was started with the addition of E3 enzyme. 
2.5.3.1 Preparation of dihydrolipoamide 
DL-Lipoamide was reduced by NaBH4 to DL-dihydrolipoamide (DHlip) following the 
method described by Reed et al. (1958).  The DL-lipoamide (800mg) was dissolved in 40ml 
methanol:water (10:1) and mixed with 800mg NaBH4 dissolved in 4ml cold dH2O.  The 
solution was the stirred on ice for 2 h or until colour changed from yellow to white.  The 
solution was then acidified by the addition of 1M HCl until the effervescence stopped.  
The product was extracted three times with 50ml chloroform; the chloroform was 
removed from the dihydrolipoamide using a rotary evaporator.  The resulting crystals 
were dissolved in 40ml toluene and gentle warmed.  16ml hexane was added to this 
solution to precipitate dihydrolipoamide; the precipitated DHlip was collected and dried 
by vacuum filtration.(Reed et al., 1958) 
2.5.3.2 Determination of purity 
The purity of the DHlip was determined spectrophotometrically by reacting with 0.2mM 
5’,5’-dithiobis-2-nitrobenzoate (DTNB) with 0.05mM dihydrolipoamide (0.1mM thiol 
groups) in 1ml20mM Tris-HCl, pH 8.0.  A 100% pure sample of DHlip would be expected to 
have an absorbance at 412nm of 1.36 (Em = 13.6x10
3 M-1 cm-1) (Reed et al., 1958). 
 
2.5.4 Branched chain 2-oxoacid dehydrogenase complex assay 
The whole OADHC assay was performed in buffer containing 50mM potassium phosphate, 
pH 7.0, 2.5mM NAD+, 1mM MgCl2, and 0.2mM TPP.  The E1α2β2, E2 and E3α2 enzymes 
were added to the preheated buffer in the required molar ratio and incubated for 10 min 
at 55°C to allow the complex to assemble (Heath, 2006).  The reaction was started by the 
addition of 0.13mM CoA and the 2-oxoacid substrate, e.g. 2mM 3-methyl-2-oxopentanoic 
acid.  The rate of conversion of NAD+ to NADH+H+ was measured at 340nm, using the 




2.5.5 Determination of Michaelis-Menten kinetic parameters 
The Michaelis-Menten kinetic parameters, Michaelis constant (Km) and maximum velocity 
(Vmax), were determined by assaying the enzymes in saturating conditions for all but one 
substrate, which was varied each time.  The specific activity (U/mg) was calculated for 
each substrate concentration, where one Unit of enzyme activity (U) is defined as 1 μmol 
of substrate disappearance or product appearance per minute.  The Km and Vmax values 
were calculated by SigmaPlot 12 (Systat Software Inc) by fitting the data to the Michaelis-




   
          








    
    
  
    
 
Where v is the velocity of the reaction at a given substrate concentration [S], Km is the 




Chapter 3: Characterisation of the Tp. acidophilum 2-oxoacid 
dehydrogenase complex  
3.1 Introduction 
The Tp. acidophilum branched-chain 2-oxoacid dehydrogenase complex is composed of 
three enzymes: E1 (2-oxoacid decarboxylase), E2 (dihydrolipoamide transacetylase), and 
E3 (dihydrolipoamide dehydrogenase); consequently, the thermostability and 
thermoactivity of the assembled complex is dependent upon the stability of these 
individual subunits and the interactions between them.  This chapter studied the 
thermostability and thermoactivity of the individual recombinant enzymes and the 
assembled complex.  The in vitro study of the assembly of the Tp. acidophilum OADHC 
with varying stoichiometries of E1 and E3 compared to E2 subunits, and the effect on the 
relative activity of the complex was also investigated.  E3 activity has been detected in 
Tp. acidophilum cell lysates and the complex genes have been shown to be transcribed 
and translated, and E1 and E2 appear to assemble into a large complex (Sun et al., 2007, 
Sun et al., 2011).  However, OADHC activity has never been detected in any archaeal cell 
lysate, and therefore the aim of this chapter was to understand the thermostability, 
thermoactivity and assembly of this large multienzyme complex in an attempt to explain 





3.2.1 Cloning of E1β 
The E1β gene was released from the pGem-T Easy plasmid by digestion with Nhe I and 
Bam HI, and was then ligated into pET24a, resulting in a gene encoding the recombinant 
E1β enzyme without any additional tags.  The E1β-pET24a and E1α-pET19b plasmids were 
then co-transformed into E. coli Rosetta (DE3) pLysS for co-expression.  
 
3.2.2 Expression of E1, E2 and E3 
The individual enzymes were all expressed as described in Chapter 2.3.1 with the 
exception of the E2; when lipoylated protein was required in this case, the medium was 
supplemented with 0.2mM DL-lipoic acid.  
 
3.2.3 Mass spectrometric analysis 
Purified protein sample was buffer exchanged by dilution into 50ml 20mM acetic acid and 
then concentrated to 1ml followed by a second dilution into another 50ml of 20mM acetic 
acid.  The sample was then concentrated to less than 500μl, giving an E2 sample with a 
final concentration of 20 mg/ml.  The samples were then analysed by on a MicrOTOFTM, a 
time-of-flight mass spectrometer coupled with an electrospray source (ESI-TOF) (Bruker 
Daltonics Bremen, Germany).  Samples were injected into the machine via a syringe pump 
and data acquired for an average of 5 min.  The machine was calibrated after the samples 
were analysed using a sodium formate solution.  The results were analysed using the 
DataAnalysis program (Bruker Daltonics).  All samples were loaded and analysed by Dr A. 
Lubben (Department of Chemistry, University of Bath). 
 
3.2.4 Western blot analysis 
Western blot analysis was used to determine if the E2 protein had been lipoylated in vivo 
during recombinant expression.  Samples were first run on a 10% SDS-PAGE gel using 
loading dye without β-mercaptoethanol to ensure the lipoic acid was not in a reduced 
form.  The protein bands were then transferred to an Immobilon-P membrane (Millipore) 
by wet transfer in 20% (v/v) methanol, 192mM glycine, and 25mM Tris-HCl using the Mini 
Blot system (BioRad) at 100V for 1 h, at 4°C.  
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The membrane was then removed and incubated over night on a platform shaker (Stuart 
Scientific, U.K.), at 4°C, in phosphate buffered saline (PBS) solution pH 7.3 (160mM NaCl, 
3mM KCl, 8mM Na2HPO4, and 1mM KH2PO4)(Oxoid) with 0.1% Tween 20, and 5%(v/v) milk 
powder to block any nonspecific antibody binding sites.  The membrane was washed with 
PBS wash solution (PBS with 0.2% Tween 20) before incubation for 1 h with the rabbit 
anti-lipoic antibody (Calbiochem), which was diluted 5000 fold in blocking solution.  The 
membrane was washed with PBS wash solution and incubated with the secondary 
antibody, anti-rabbit IgG–peroxidise antibody (diluted the same as the primary antibody).  
After a final PBS wash, the membrane was incubated with Immobilon Western 
Chemiluminescent horseradish peroxidase (HRP) substrate at room temperature for 2 
min.  The western blot was then developed by exposing the membrane to X-ray film 
(Fujitsu) for between 5 s and 1 min. 
 
3.2.5 Heat precipitation assays 
Thermal precipitation experiments were carried out in a Mastercycler PCR machine 
(Eppendorf) using thin-walled 0.5ml Eppendorf tubes.  Protein samples were heated at 
various temperatures for a set time, usually 10 min; the soluble and insoluble proteins 
were then separated by centrifugation at 13 400 x g at 4°C for 10 min.  The insoluble 
protein was then re-suspended in an equal volume of 8M urea; both the soluble and 
insoluble fractions for each temperature were analysed by SDS-PAGE. 
 
3.2.6 Thermal inactivation assays 
The thermal inactivation assays were conducted in a Mastercycler PCR machine 
(Eppendorf) using thin-walled 0.5ml Eppendorf tubes.  The protein was heated in the PCR 
machine at various temperatures, the lid set to 105°C to prevent evaporation.  Sample 
tubes were removed periodically and cooled on ice.  Once fully cooled the tubes were 
centrifuged at 16000 x g for 5 min, 4°C.  The enzymes were assayed (see Chapter 2.5 for 
assay details), to determine the percentage activity of the heat-treated protein compared 
to the activity of the protein which had not been heated.  The E3 thermal inactivation 




3.2.7 Temperature optimum 
The E1 and OADHC enzymes were pre-heated in the E1 or complex assay buffer: 
containing phosphate buffer, TPP and MgCl2, respectively, for 10 min at 55°C prior to 
being assayed.  The reactions were started with the addition of enzyme rather than 
substrate as previously described for the E1 and complex assay and the temperature was 
recorded at the start and end of each assay. 
 
3.2.8 Determination of OADHC component concentrations and stoichiometry assays 
The concentrations of the purified enzymes were determined by measuring the 
absorbance at 280nm.  The A280 was then converted to a molar concentration of the active 
protein unit (E1α2β2, E2α, and E3α2) using the molar absorbance coefficients predicted 
from the sequence (Gasteiger et al., 2003). 
The required amounts of E1α2β2, E2α, and E3α2 were mixed in the cuvette containing 
complex assay buffer and incubated for 10 min at 55°C; whole complex 2-oxoacid 
dehydrogenase activity was assayed by measuring the conversion of NAD+ to NADH, after 
the addition of 0.13mM CoA and 2mM 3-methyl-2-oxopentaoic acid (Chapter 2.5.4). 
 
3.2.9 Gel filtration  
The required ratio of E1α2β2, E2α, and E3α2 were mixed and diluted 1:1 in 50mM 
potassium phosphate, pH 7.7, 1mM MgCl2, and 2mM 3-methyl-2-oxopentanoic acid.  The 
complex mixture was then heated at 55°C for 10 min to allow assembly and cofactor 
binding; any heat precipitated proteins were removed by centrifugation at 16 000 x g and 
filtration through a 0.45μm filter.  The soluble OADHC sample was then loaded onto a 
Superdex 200 column equilibrated with 50mM potassium phosphate, pH 7.7, 1mM MgCl2, 
and 2mM 3-methyl-2-oxopentanoic acid; 0.25-0.5ml fractions were collected.  The E1 and 
OADHC assays were modified for this experiment due to the presence of 3-methyl-2-
oxopentaonic acid in the gel filtration buffer: the E1 assay was started by the addition of 




3.3 Results and Discussion 
3.3.1. E1 2-oxoacid decarboxylase  
3.3.1.1 Cloning of Thermoplasma acidophilum E1β into pET24a 
The E1α and E1β genes were cloned by Dr. Heath into pET19b and pET28a, respectively 
(Heath et al., 2004), resulting in 4 N-terminal his-tags per E1α2β2 enzyme.  To reduce the 
number of his-tags in the assembled E1α2β2 protein, the E1β gene was cloned in to pET24a 
(Figure 3.1) using Nde I and Bam HI, instead of pET28a.  The pET19b (carbenicillin 
resistant) and pET24a (kanamycin resistant) vectors containing the his tagged E1α and 
non-tagged E1β genes were then co-transformed into E. coli Rosetta (DE3) pLysS cells for 
co-expression. 
 















3.3.1.2 Expression and purification of E1α2β2 
The untagged E1β protein was co-expressed with the E1α protein in E. coli 
Rosetta(DE3)pLysS.  Soluble E1α and E1β proteins were co-purified by nickel-affinity 
chromatography using the E1α N-terminal his-tag (Figure 3.2). 
 
Figure 3.2 SDS-PAGE of the co-purification of the E1α and β polypeptides.  Lane 1: flow 
through; lane 2: the his-bind buffer wash; lanes 3 and 4: the 5% and 10% his-elute 
washes; lanes 5 to 9: the 1ml fractions eluted with 100% his-elute buffer: lane 10 standard 
protein markers, with their Mw values. 
 
3.3.1.3 Characterisation of E1 2-oxoacid decarboxylase 
The removal of the his-tag from the E1β subunit may have altered the kinetic parameters 
of the E1 enzyme; therefore, the Km and Vmax values were determined for several 2-
oxoacid substrates except 2-oxoglutarate with which the enzyme demonstrated no 
activity (Table 3.1).  The assays were conducted as described in Chapter 2.5.1 with the 
exception of the 2-oxoacid substrate concentration which was varied each time.  The 
activity data were analysed using SigmaPlot 12 (Systat Software Inc) shown in figures 
3.3-3.8. 
Substrate Km (μM) Vmax (U/mg) 
3-methyl-2-oxopentanoic acid 88.8 ± 3.3 0.881 ± 0.010 
4-methyl-2-oxopentanoic acid 36.2 ± 1.2 0.345 ± 0.003 
Pyruvate 1732.3 ±31.9 0.249 ± 0.001 
 
Table 3.1 Kinetic parameters of the E1α2β2 enzyme.  1 Unit of enzyme activity is defined 
as 1μmol of DCPIP reduced per min. 
  























Figure 3.3 Michaelis-Menten plot of E1 activity with 3-methyl-2-oxopentanoic acid  
 
 





Figure 3.5 Michaelis-Menten plot of E1 activity with 4-methyl-2-oxopentanoic acid  
 
 







Figure 3.7 Michaelis-Menten plot of E1 activity with pyruvate 
 
 






The E1β subunit, without a his-tag, co-purified with the E1α, resulting in a functional 
E1α2β2 enzyme with half the number of his-tags of the previous recombinant E1.  The 
order of substrate preference remained unchanged but in all cases the Vmax increased; e.g. 
the Vmax with 3-methyl-2-oxopentanoic acid increased from 0.38U/mg protein to 
0.86U/mg protein.  The Km of the branched chain 2-oxoacids decreased slightly, whereas, 
the Km for pyruvate increased from 596μM (Heath, 2006) to 1380μM. 
 
3.3.1.5 E1: Temperature optimum  
The temperature optimum of the recombinant Tp. acidophilum E1 enzyme was 
determined to be 72°C. 
 
Figure 3.9 Temperature optimum of the E1 enzyme. Activity expressed as percentage of 




















3.3.1.4 E1: Thermostability  
The thermostability of the E1 enzyme was measured by assaying heat-treated protein 
under optimal conditions.  The reaction rate of enzyme that had not been heat-treated 
was taken to be 100%; the activity of the thermally-inactivated samples was compared to 
this value to determine the percentage activity of the sample after heating (Chapter 
3.2.6).  The E1 enzyme was diluted 3-fold in E1 assay buffer containing: 20mM potassium 
phosphate pH7.0, 2mM MgCl2, and 0.2mM TPP. 
 
Figure 3.10 Thermal inactivation plot of the E1 enzyme.  The E1 activity before heating is 
taken to be 100%.  Samples were heated at a various temperature then cooled before the 
























3.3.2 E2 Dihydrolipoamide transacetylase 
3.3.2.1 E2 expression, lipoylation and purification 
The E2 protein was purified to 85-95% purity by a heat-precipitation step followed by 
nickel-affinity chromatography, as shown by Figure 3.11. 
 
Figure 3.11 SDS-PAGE of E2 purification by nickel affinity chromatography.  Lane 1: flow 
through protein that did not bind to the column; lanes 2 to 4: the his-bind buffer, 5% and 
10% his-elute washes; lanes 5 to 9: his elute wash collected in 1ml fractions; lane 10: 
standard protein markers, with their molecular weight values. 
 
The recombinant E2 protein must be lipoylated, by the E. coli’s lipoylation system, to be 
catalytically active in the whole complex reaction.  To increase the yield of lipoylated E2, 
an expression trial was carried out to determine if the amount of lipoylated recombinant 
E2 could be increased (Figures 3.12 and 3.13).  




Figure 3.12 SDS-PAGE of recombinantly 
expressed E2 protein supplemented 
with lipoic acid.  Lane 1: the standard 
protein markers.  Lanes 2 and 3 contain 
the cell extract from medium 
supplemented with 0.2 and 0.4mM lipoic 
acid, respectively. 
Figure 3.13 Western blot of the 
recombinantly expressed E2 protein that 
has been lipoylated in vivo.  Lanes 1 and 
2 contain the cell extract from medium 
supplemented with 0.2 and 0.4mM lipoic 
acid, respectively, stained by rabbit anti-
lipoic acid and anti-rabbit antibodies. 
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Induction with 1mM IPTG increased the yield of lipoylated E2, this suggests that the E. coli 
lipoylation system is capable of dealing with the higher expression level.  Two 
concentrations of supplemented lipoic acid (0.2 and 0.4mM) were also compared by 
western blot analysis (Figure 3.13); it was found that changing the concentration of lipoic 
acid in the medium did not appear to significantly affect the relative amount of 
recombinant E2 lipoylation. 
To determine the percentage of recombinant E2 protein that has been lipoylated during 
expression, a purified sample was analysed by mass spectrometry.  Figure 3.14 shows two 
major peaks at 46460Da and 46278Da, these two values correspond to the predicted 
molecular weight of the lipoylated (46464 Da) and non-lipoylated (46276Da) E2 protein 
without the start methionine.  
 
 
Figure 3.14 Mass spectrometry analysis of recombinant E2 in vivo lipoylation.  The E2 
protein without the start methionine is predicted to be 46276Da, which corresponds to 
the 46278 peak.  The E2 with the additional 188Da lipoic acid (46460Da) is represented by 
other major 46460Da peak. 
 
Approximately 50% of the recombinant E2 polypeptides are lipoylated by the E. coli 
endogenous lipoylation pathway.  In comparison to previous work done by Dr. Heath 
(2006), it can be concluded that inducing E2 expression with 1mM IPTG does not affect 
the percentage of E2 polypeptides that are lipoylated in vivo during recombinant 




3.3.2.2 E2 Transacetylase coupled assay 
An assay for the E2 enzyme was developed based on the method described by Srere and 
Kosicki (1961).  A coupling phosphotransacetylase enzyme capable of functioning above 
50°C was identified from Geobacillus stearothermophilus (EC Number: 2.3.1.8) (Sigma-
Aldrich).  The temperature optimum of this enzyme was determined in order to identify 
an optimal temperature for the coupled assay (Figure 3.15).  The enzyme has 
approximately 90% activity at 55°C; so for consistency with all other OADHC assays, this 
temperature was used. 
 
Figure 3.15 Dependence of enzyme activity on assay temperature for the Geobacillus 
stearothermophilus phosphotransacetylase enzyme.  Phosphotransacetylase activity is 
expressed as a percentage of activity at 65°C 
 
The lipoylated and non-lipoylated purified E2 enzyme samples were assayed at 55°C 
(Chapter 2.5.2) to determine their specific activities and kcat values (Table 3.2). 
E2 Enzyme Specific activity (U/mg) kcat (min
-1) 
Lipoylated  0.29 ± 0.01 13.6 ± 0.5 
Non-lipoylated  1.05 ± 0.05 48.9 ± 2.2 
 
Table 3.2 Specific activity and kcat values for the recombinant E2 enzyme.  1 Unit of 
enzyme activity is defined as 1μmol of acetyl-dihydrolipoamide produced per min.  kcat 
was calculated using the concentrations E2 polypeptide chains. 
 
The lipoic acid modification reduces the specific activity and hence kcat values of the E2 
catalysed acetyl transfer reaction, this is possibly due to the presence of the endogenous 
lipoic acid, which may act as a competitive inhibitor of the exogenous DHlipoamide 

















direction with respect to its function in whole complex activity, converting 
dihydrolipoamide and acetyl-CoA into acetyl-dihydrolipoamide + CoA (Chapter 2.5.2).  
Therefore, the kcat and specific activity values determined for this enzyme cannot be 
directly compared to values of the E1 and E3 enzymes; rather, this assay can be used as a 
method for determining relative activities such as those in the thermostability assays. 
3.3.2.3 E2: Thermostability 
The thermostability of the E2 protein was measured by comparing the relative amounts of 
soluble protein, by SDS-PAGE, after incubation across a temperature gradient for 10 min 
(Figures 3.16 and 3.17).  The E2 protein begins to precipitate after 10 min at 85°C, with no 




Figure 3.16 Heat precipitation of the 
E2 protein - Soluble protein.  Lane 1: 
standard protein markers, with their 
Molecular weight values (kDa); lane 
2: untreated sample; lanes 3 to 8: 
soluble protein after 10 min at 70°C, 
75°C, 80°C, 85°C, 90°C, and 95°C. 
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Figure 3.17 Heat precipitation of the 
E2 protein - Insoluble protein.  Lane 1: 
standard protein markers, with their 
Molecular weight values (kDa); lane 2: 
untreated sample; Lanes 3 to 8: 
insoluble protein after 10 min at 70°C, 


































The thermostability of the E2 enzyme was also investigated by measuring the decrease in 
activity after the E2 protein was heated at various temperatures.  The thermal inactivation 
profile of the non-lipoylated E2 enzyme is shown in Figure 3.18.  After 10 min at 85°C, 20% 
activity had been lost, while at 90°C less than 10% activity remained after just 5 min.  This 
loss in activity agrees with the precipitation studies, after 10 min at 85°C a small amount 
of precipitation occurred, whilst at 90°C the protein had completely precipitated.  The E2 
protein was incubated in 50mM Tris-HCl, 100mM NaCl pH 6.8 at 90°C due to precipitation 
of most of the E2 protein during dialysis into phosphate buffers a buffer with a lower 
∆pKa/∆T than Tris-HCl. 
 
Figure 3.18 Thermal inactivation profile of the E2 enzyme.  Each sample was heated at a 
defined temperature and then cooled before the remaining activity was assayed under 
optimal conditions.  Samples were heated in 50mM Tris-HCl 100mM NaCl pH 8.8.  The E2 

























3.3.3 E3 Dihydrolipoamide dehydrogenase 
3.3.3.1 Expression and purification 
The E3 protein was purified to over 95% purity by a heat-precipitation step followed by 
nickel-affinity chromatography, as shown in Figure 3.19.  An additional 100 kDa band is 
often seen at higher E3 concentrations, a proportion of E3 polypeptides appears to form 
inter-subunit disulphide bonds. 
 
 
Figure 3.191 SDS-PAGE of the purification of the E3 protein.  E3 Lane 1: flow through; 
lane 2: his bind buffer wash; lanes 3 and 4: 5 and 10% his elute washes; lanes 5 – 9: 1ml 
fractions of 100% his elute buffer; and lane 10: standard protein markers, with their 
molecular weight values (kDa). 
 
3.3.3.2 E3: Temperature optimum 
The temperature optimum (Topt) of the E3 enzyme was determined by assaying the 
enzyme as described in Chapter 2.5.3.  In this experiment, the EPPS buffer was replaced 
with 50mM sodium phosphate, pH 7.0, to increase consistency between conditions used 
in the temperature optima experiments for the other OADHC enzymes, and to reduce any 
temperature-dependent variation in pH (the ∆pKa/∆T  of phosphate is -0.0028 compared 
to -0.015 for EPPS).  The E3 assay at pH 7.0 has a curved initial rate, so the assays were 
also repeated at pH 8.0 to ensure the pH was not affecting the temperature optimum of 
this enzyme.  The temperature optima curves in Figure 3.22 show that at pH 7.0 and 
pH 8.0 the E3 enzyme is optimally active between 45 and 50°C. 




















Figure 3.20 Temperature optimum of the E3 dihydrolipoamide dehydrogenase enzyme 
at pH7 and pH8.  E3 activity expressed as percentage of activity of optimal recorded 
activity at pH7.0 and pH8.0 
 
The E3 enzyme Topt curve is broader than expected, with activity only decreasing to 40% at 
15°C and 90°C.  The E3 enzyme has a Topt lower than the organism’s optimal growth 
temperature; however, as  E3 activity does not decrease rapidly after its Topt (65% 
remaining activity at 65°C) and E3 activity is not the rate limiting step of in the complex 
reaction (Danson et al., 1978), this lower optimal temperature may not be detrimental to 

























3.3.3.3 E3: Thermostability 
The thermostability of the E3 protein was determined in the presence and absence of the 
dihydrolipoamide substrate. 
 
Figure 3.21 Thermal inactivation profile of Tp acidophilum E3 enzyme.  Each E3 sample 
was heated at the specified temperature then cooled before the remaining activity was 




Figure 3.22 Thermal inactivation profile of the Tp. acidophilum E3 enzyme with 0.4mM 
dihydrolipoamide.  Each E3 sample was heated as described in Figure 3.23 with the 












































The presence of the DHlipoamide appears to decrease the stability of the E3 enzyme.  The 
thermal inactivation data shown in Figure 3.22 produce slightly curved lines at all 
temperatures which suggests that binding of the substrate influences the kinetics of the 
thermal inactivation of the protein.  The curves could be resolved into two straight lines, 
there is a faster initial decrease in activity followed by a slower decrease, this suggests 
that more than one inactivation process is occurring. 
 
Figure 3.23 Half life of the E3 enzyme with and without 0.4mM dihydrolipoamide at 
varying temperatures. 
 
The E3 enzyme is the most thermally stable enzyme of the all OADHC component 
enzymes, losing less than 10% activity after 20 min at 75°C; however the temperature 
optimum of the E3 enzyme is 20-25°C lower than that of the E1 enzyme.  The E3 DHlip 
dehydrogenase is an example of an enzyme, which although stable at high temperatures, 
is not optimally functional.  This could be due to the active site beginning to denature at a 
lower temperature than the rest of the protein, so that when the temperature is 
decreased the active site is pulled back into shape, resulting in an active protein (Daniel 
and Danson, 2010).  After a 20 min incubation at 85°C, without substrate, the enzyme 
retains 80% activity; when 0.4mM DHlip is present (approximately 70% saturation) the E3 
enzyme retains only 60% activity after 20 min at 65°C.  Reduction of the active-site 
disulphide bond by the initial reaction with DHlip (Mattevi et al., 1991b) may destabilises 
the active site reducing catalytic activity; therefore, the thermal inactivation assays in the 
presence of DHlip may be closer to the condition in the temperature optima assays, as the 
active site disulphide will temporarily be reduced whilst catalysing the transfer of the 






















3.3.4 Characterisation of the thermostability and temperature optimum of the 
branched-chain 2-oxoacid dehydrogenase multienzyme complex 
3.3.4.1 Tp. acidophilum OADHC assembly 
The molar concentration of each purified active enzyme assembly (E1α2β2, E2α, and E3α2) 
was determined by measuring the absorbance at 280nm.  The E1α2β2, E2 and E3α2 were 
mixed in a molar stoichiometry of 3:1:0.1 and preheated at 55°C for 10 min, to assemble 
an active OADHC (Heath, 2006). 
 
Figure 3.24 SDS-PAGE of the purified OADHC components.  Lane 1: E1; lane 2: standard 





















3.3.4.3 Comparison of the temperature optima of the individual components and 
OADHC  
The complex components were mixed in a molar ratio of 3:1:0.1 (Heath, 2006) and pre-
incubated to allow for cofactor binding and assembly.  The temperature optimum of the 
OADHC was determined to be 65°C (Figure 3.25). 
 
Figure 3.25 Temperature optimum of the Tp. acidophilum OADHC.  The OADHC activity is 
expressed as percentage of activity at 65°C 
 
 
Figure 3.26 Temperature optima profiles of the E1, E3 and the OADHC.  The E1 (red) 
temperature optimum is 72°C, and the E3 (blue) has a temperature optimum of 45°C.  The 
OADHC shown in black has a temperature of 65°C. Activity of each enzyme is expressed as 


































The temperature optimum (Topt) of the OADHC (65C) is similar to that of E1 (72C), 
whereas, the E3 temperature optimum is significantly lower at around 45-50°C.  The 
OADHC and E1 curves are very similar, suggesting that the Topt of the complex is 
dependent on the Topt of the E1 enzyme.  The lower temperature optimum of the E3 
enzyme does not appear to affect the Topt of the OADHC.  The activity of the E3 enzyme 
reduces slowly with increasing temperature and, even though functioning at below its 
optimal activity, this enzyme is capable of reoxidising the lipoic acids reduced by previous 
reactions.  To understand the effects that each individual enzyme Topt has on the overall 
complex Topt, the temperature optimum of the E2 enzyme should ideally be known; 




3.3.4.2 Comparison of the thermal inactivation of the individual enzymes and the 
assembled OADHC 
The OADHC was assembled in a stoichiometry of 3:1:0.5 (E1α2β2:E2:E3α2).  The complex 
components were mixed and diluted 2-fold in 200mM sodium phosphate, pH 7.0, 10% 
glycerol, 2mM MgCl2, and 0.2mM TPP, before a 10-min incubation at 55°C to permit the 
assembly to reach completion. 
 
Figure 3.27 Thermal inactivation profile of the OADHC.  The OADHC activity before 
heating is taken to be 100%.   
 
 















































The individual enzymes appear to be more stable than the assembled OADHC, suggesting 
that factors other than the thermostability of the individual enzymes are affecting the 
stability of the complex; this may point to the non-covalent interactions between the 
complex components being the bonds that are first disrupted by increased temperatures. 
 
Figure 3.29 Arrhenius plot of the thermal inactivation data of the individual enzymes 
and assembled OADHC.  
 
The Arrhenius equation can be rearranged into a straight line equation as shown below: 
Arrhenius Equation:        
  
     
and therefore:          
  
 
   
 
 
       
Where k = the rate of inactivation, Ea = activation energy of inactivation, R= universal gas 
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The activation energy of inactivation (Ea) and the Arrhenius constant (A) are compared 
below in Table 3.3 for the individual proteins and the OADHC. 
Enzyme -Ea/R Ea (KJ/mol)  LnA A (Units) 
E1 48400 402 136 1.2 x 1059 
E2 83200 692 224 1.9 x 1097 
E3 20900 174 50 5.2 x 1021 
Complex 76800 639 215 2.4 x 1093 
 
Table 3.3 Activation energy of inactivation and Arrhenius constant of the individual 
enzymes and the OADHC.  Values were calculated from the data shown in Figure 3.29. 
 
The Ea values calculated appear to suggest that the E3 enzyme is the least stable of the 
OADHC proteins assayed with the E2 and OADHC being the most stable; this contradicts 
the half-life data shown in Figure 3.27 in which E3 is the most stable and the OADHC the 
least. 
Transition state theory describes the rate of thermal inactivation energy by the following 
equation: 
  
   
 
   
    
     
 
and therefore:         





       
   
 
   
    
 
   
Where k = the rate of inactivation, R= universal gas constant, T = temperature (K), 
KB = Boltzmann’s constant, G°* = Standard Gibbs free energy of inactivation, H = enthalpy 
of inactivation, and S = entropy of inactivation.  
In this transition state theory equation the Arrhenius activation energy (Ea) now becomes 
a measure of the enthalpy of inactivation (ΔH), and the Arrhenius constant, a measure of 
the entropic contributions to inactivation (ΔS).  The rate of thermal inactivation of a 
protein is dependent on entropic and enthalpic contributions; the rate of inactivation can 
be reduced by either increasing ΔH or decreasing ΔS.  The entropic and enthalpic 
contributions determining the rate of inactivation of the E3 are different from the other 
enzyme with the rate influenced by smaller values of both the ∆S and ∆H.  The entropic 
and enthalpic contributions to the thermostability of the individual enzymes and the 
OADHC could be further investigated by isothermal titration calorimetry.  
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3.3.5 Stoichiometry of the multienzyme components 
3.3.5.1 Complex stoichiometry assays 
The affect on OADHC activity of different E1:E2:E3 stoichiometries were determined by 
mixing differing ratios of E1 and E3 to E2 and comparing the rate of whole complex 
activity (Figure 3.31). 
 
Figure 3.30 Graph showing the percentage activity of various stoichiometries of E1 and 
E3 to E2.  The ratio of E1α2β2 and E3α2 were varied independently with respect to the 
concentration of E2α with either the E1:E2 or the E3:E2 ratio set at 1:1.  The maximum 
activity of E1 and E3 is taken as 100% activity. 
 
Optimal OADHC activity was achieved at a stoichiometry of 1.75:1:0.5 E1α2β2:E2:E3α2.  
This is different from the value of 3:1:0.1 determined by Dr. C Heath (2006); the removal 
of the his-tags from the E1β may have affected interactions between the E1 and the 
peripheral subunit binding domain.  Optimal OADHC activity was achieved with three 
times more E1 compared to E3.  The E1 enzyme has previously been shown to be the rate 
limiting step in the E. coli PDHC by determining the rate of E2 acetylation in the absence 
of CoA and comparing it to the rate of whole complex activity (Danson et al., 1978).  The 
ratio of 3:1 E1:E3 allows maximal activity by balancing an increase in the amount of rate 
limiting E1, with a smaller amount of E3, an enzyme that is capable of reoxidising any 
























achieving optimal activity with three-fold more E1 than E3 is that the E2-PSBD may have a 
higher affinity for E3 than E1, in which case more E1 might be needed to out compete the 
E3 for PSDB binding sites.  In order to determine which explanation is correct OADHC 
activity would need to be compared with the ratio of E1 and E3 actually bound to the E2-
PSBD. 
3.3.5.2 Complex gel filtration 
The stability of the assembled complex was investigated by gel filtration.  The OADHC 
components were mixed in a molar stoichiometry of 1:1:1 (E1α2β2:E2:E3α2) and diluted 
1:1 in 50mM potassium phosphate, pH 7.7, 1mM MgCl2, and 2mM 3-methyl-2-
oxopentanoic acid, before being incubated at 55°C for 10 min to allow assembly and 
cofactor binding. The column was also equilibrated with the same buffer. 
 
Figure 3.31 Gel filtration trace of the OADHC.  The A280 readings are shown in blue, and 
the fraction numbers shown along the x-axis in red.  The column was equilibrated with 
50mM potassium phosphate, 1mM MgCl2, 2mM 3-methyl-2-oxopentanoic acid and pH7.7 
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Figure 3.32 SDS-polyacrylamide gels of the Superdex 200 gel filtration fractions.  Each 
lane is labelled with the corresponding fraction number.  The standard protein markers, 
with their molecular weight values (kDa), are shown in the lanes labelled M.  Lanes E1, E2 
and E3 are samples of the purified recombinant proteins used in the assembly process. 
 
 
Figure 3.33 A bar chart illustrating the specific activity of the E1, E3 and whole complex 
in each fraction after gel filtration.  The specific activity is shown in U/mg where 1Unit is 
equivalent to 1μmol of product per min, and the activity is shown per mg of total protein 
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The 1:1:1 (E1α2β2:E2α:E3α2) stoichiometry should saturate the E2, as there is twice the 
number of E1 and E3 enzymes compared to the E2, each E2 polypeptide binds can one E1 
or E3 in a mutually exclusive manner.  An excess of unbound E1 and E3 would be expected 
to elute from the gel filtration column as the E2 polypeptides would be able to bind only 
half the E1 or E3 enzymes; however, 92.4% of the E1 and 98.9% of the E3 activity is found 
in the unbound fractions, with only 7.6% and 1.1% E1 and E3 activities present in the 
complex fractions.  The OADHC formed by mixing the components in a stoichiometry of 
1:1:1 has a higher specific activity than any lower ratio, but it would appear, that this 
mixture contains a large amount of E1 and E3 enzymes that either do not bind to the E2 
or only bind weakly. 
Key residues involved in the interaction between Geobacillus stearothermophilus E3 and 
the E2-PSBD have been well characterised by Mande et al. (1996); a sequence alignment 
of the G. stearothermophilus and Tp. acidophilum: E2-PSBD and E3, identifies any 
differences between these key amino acids.  Table 3.3 summarises the results of the 
alignment; the majority of the key residues are conserved or similar, therefore this 
alignment does not indicate why the Tp. acidophilum E2-PSBD and E3 binding appears to 
be weak.  This alignment only compares sequence similarity, so does not take into 
account any structural changes which may affect the positions of the side chains involved 




 G. stearothermophilus Tp. acidophilum 
 E2-PSBD E3  E2-PSBD E3  
Polar Ser 133 Oγ Glu A437 Oε1  - Ala  -Met 
 Ser 133 N Asp A438 Oδ1  - Ala  
 Arg 135 Nε Asp B344 Oδ2   - Glu 
 Arg 135 Nη1 Glu B431 O   
 Arg 135 Nη2 Glu B431 Oε2   
 Lys 136 Nζ Glu A437 O ε2  - Arg  
 Arg 139 Nη2 Asp B344 Oδ1   - Glu 
 Arg 139 Nη2 Ala B432 O   
Non-Polar Met 131 Cβ Asp A438 Cγ  - Ser  
 Pro 132 Cδ Leu A441 Cδ1   
 Pro 132 Cβ Leu A441 Cβ   
 Pro 132 Cγ Glu B431 Cγ   
 Ser122 Cγ Asp A438 Cγ  - Ala  
 Arg 139 Cβ Ala A342 Cβ   
 Arg 139 Cβ Ala B342 Cβ   
 Glu 140 Cγ Pro B334 Cγ   - Asp 
 
Table 3.3 Comparison of the residues involved in polar and non-polar interactions 
between the G. stearothermophilus E3 and peripheral subunits binding domain (Mande 
et al., 1996) compared to Tp. acidophilum E3 sequence.  A sequence alignment has been 
used to determine if the amino acids involved in the interaction between the 
G. stearothermophilus E3 and PSBD are found in Tp. acidophilum.  The presence of a 
conserved residue is indicated by a tick; crosses have been used to indicated when the 





The results in this chapter demonstrate that the recombinant E1, E2 and E3 enzymes form 
a complex that catalyses the conversion of branched chain 2-oxoacids to their 
corresponding acyl-CoAs at temperatures within the growth range of Tp. acidophilum.  
This result, along with the identification of the Tp. acidophilum E2 lipoylation mechanism 
(LplA-CTD) (Posner et al., 2009), indicates that the native E1, E2 and E3 enzymes could be 
functional, if their genes were transcribed and translated by the organism.  E3 enzyme 
activity has been detected in Tp. acidophilum cell lysates but no whole complex activity 
has been detected in this, or any other archaeon (Danson et al., 1984).  The lack of whole 
complex activity could be explained by the apparent weak interaction between the E1 and 
E3 enzymes with the E2 core.  A proteomics studies by Sun et al. (2007) that identified 
large complex proteins from Tp. acidophilum cell lysates found that the E2 and E1 proteins 
formed a large protein complex no E3 was present.  The results described in this chapter 
along with the study by Sun et al. (2007) suggest that the OADHC genes are transcribed 
and translated in Tp. acidophilum resulting in functional individual enzymes, but this 
enzymes do not strongly associate in cell lysates so no active OADHC is formed.   
It has also been shown that there is no change in the expression of the Tp. acidophilum 
OADHC genes under aerobic and anaerobic conditions, but under anaerobic conditions 
there is up-regulation of the ferredoxin oxidoreductase genes (Sun et al., 2011).  The 
OADHC in Tp. acidophilum may be regulated by other conditions that have not yet been 
determined, such as changes to growth substrate, or in response to different respiratory 
terminal electron acceptors.  The presence of nitrate, a respiratory electron acceptor, 
resulted in a 16-fold up-regulation of the OADHC genes in Pyrobaculum aerophilum 
compared to anoxic conditions, although the up-regulation was significantly less 
compared to aerobic conditions (Cozen et al., 2009).  It would be interesting to compare 
the expression levels of the central metabolism genes after growth of Tp. acidophilum on 




Chapter 4: Cloning, expression and characterisation of the E2 
catalytic domain 
4.1 Introduction 
The E2 dihydrolipoamide transacetylase enzyme is composed of three functional domains 




Figure 4.1 The Tp. acidophilum E2 protein domain structure.  The N-terminal 8.5 kDa 
lipoyl domain is shown in yellow, the 6 kDa peripheral subunit (E1 and E3) binding domain 
is shown in green, and the C-terminal 25 kDa catalytic domain in blue. 
 
The thermostability of the catalytic domain is crucial to the stability of the 2-oxoacid 
dehydrogenase multienzyme complex (OADHC).  A high-resolution structure of the fully-
assembled E2 protein may provide insights into the thermostability of this protein 
complex.  Ideally, an X-ray crystallographic structure would provide these details; 
however, due to the flexible nature of this multi-domain protein, the whole E2 protein is 
unlikely to crystallise.  The experiments detailed in this chapter, aimed to clone and 
express the E2 catalytic domain (E2cat) by removing the flexible regions, the peripheral 
subunit binding domain (PSBD) and the lipoyl domain.  The E2cat protein was then 
compared to the full-length E2, to determine the affects this truncation had on enzymatic 
activity and thermostability. 
  







4.2.1 Cloning of the E2 catalytic domain gene 
The location of the forward primer was chosen based on sequence alignments with other 
E2 sequences, for which crystal structures were available.  Figure 4.2 shows the known 
sequences of three E2 catalytic domain structures along with the whole Tp. acidophilum 
E2 sequence. 
 
Figure 4.2 A protein sequence alignment of the E2 catalytic domains with known 
structures and the Tp. acidophilum E2.  The sequences are labelled by their PDB access 
code: 1B5S, Geobacillus stearothermophilus PDHC; 1E2O, Escherichia coli 2-oxoglutarate 
dehydrogenase complex; and 1EAF, Azotobacter vinelandii PDHC. TPE2 is whole 
Tp. acidophilum E2 protein sequence.  The region highlighted in yellow is the 





The E2cat primers are shown below; the sequence complementary to the E2 gene is in 
bold, the restriction sites (XhoI and NdeI) are in italics and any additional bases added in 
grey. 
E2 Cat Forward   5’CAT ATG GCA CCT GGG AGA GAA GAG ATC CTG G3’ 
E2 Reverse   5’CCG CTC GAG TCA GAT CTC GTA GAT TAT AGC GTT CGG3’ 
The E2cat gene was PCR amplified and ligated via the cloning vector pGem-T Easy 
(Promega, U.K.), into the expression vectors pET24a and pET28a (Novagen, Merck, U.K.) 
as described in Chapter 2.2. 
 
4.2.2 Expression and purification of E2cat protein 
4.2.2.1 E2cat protein expression  
The E2cat protein was expressed without a his-tag, from pET24a, following the method 
described in Chapter 3.2.1.  The cell lysate was incubated at 55°C for 10 min and 
centrifuged to remove the heat-precipitated proteins. 
4.2.2.2 Polyethylenimine DNA precipitation 
The E. coli genomic DNA was precipitated before anion exchange chromatography, by the 
titration of the cell lysate with polyethylenimine (PEI) (BDH Ltd.).  A range of 
concentrations (0.1-0.6% (v/v)) were tried to determine the amount required to 
precipitate the DNA whilst not affecting the solubility of the E2cat protein.  The cell lysate 
containing PEI was incubated on ice for 1 h, and then centrifuged at 16000 x g for 15 min, 
to remove all precipitated DNA.  The supernatant was dialysed overnight into 50mM Tris-
HCl, pH8.8. 
4.2.2.3 Anion exchange chromatography 
Anion exchange chromatography was carried out using the Äkta FPLC system (Amersham 
Biosciences, U.K.), using two 5ml Q-Sepharose Hi-Trap column equilibrated in 50mM Tris-
HCl, pH 8.8.  The E2cat protein was eluted from the column using a 0-1M NaCl gradient in 
the same buffer. 
4.2.2.4 Gel filtration purification and size determination 
The final purification step was carried out as described in Chapter 2.3.3.3. 
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4.3.3 Characterisation of E2cat 
4.3.3.1 Mass spectrometric analysis 
The mass spectrometry experiments in this chapter were performed and analysed by 
Trevor M. Gibson, at The BioCentre Facility, University of Reading.  A sample of purified 
E2cat protein at 2mg/ml was dialysed against Milli-Q water overnight at 4°C.  Acetic acid 
was added to a final concentration of 0.1% (v/v) before samples were loaded onto the 
MicrOTOFTM mass spectrometer coupled with an electrospray source (ESI-TOF) (Bruker 
Daltonics Bremen, Germany.). 
4.3.3.2 E2 dihydrolipoamide transacetylase assays and thermal inactivation 
The E2 assay and thermal inactivation experiments are described in Chapters 2.5.2 and 
3.2.6, respectively.  The purified E2cat protein in 50mM Tris-HCl, pH 8.8, and 100mM 
NaCl, was diluted in 50mM Na phosphate, pH 7.0, in a ratio of 1μl:4μl (protein:buffer) 
before each thermal inactivation incubation. 
4.3.3.3 Dynamic light scattering  
Dynamic light scattering (DLS) was used to determine the hydrodynamic diameter of the 
E2cat protein; all measurements were performed using a Zetasiser Nano S from Malvern 
Instruments Ltd. (Malvern, U.K.).  50μl of purified sample was loaded into a low volume 
quartz cuvette and heated to 25°C or 55°C.  The thermostability was studied by 
performing measurements at various temperatures; the protein was heated to the 
required temperature and held for 2-5 min before each measurement was taken.  The 
relative molecular mass of the protein was predicted based on the known hydrodynamic 
diameter of other globular proteins, using the Protein utilities tools within the Zetasiser 




4.3 Results and discussion 
4.3.1 Cloning and expression 
The E2cat gene was PCR amplified from Tp. acidophilum genomic DNA; the gene was 
cloned using Nde I and Xho I into pET28a and pET24a, resulting in recombinant proteins 
with and without an N-terminal his-tag.  The presence of the correct gene was confirmed 
by a restriction digest of the pET vectors (Figure 4.3) and DNA sequencing by Source 
Bioscience (U.K.). 
 
Figure 4.3 Restriction digest of pET28a (lanes 3-7) and pET24a (lane 8) with Nde I and 
Xho I to release the 678bp E2cat gene. The markers shown in lanes 1 and 2 are 1Kb 
ladders and 100bp ladder (Promega, U.K.). 
 
The E2cat protein was completely insoluble with an N-terminal his-tag; whereas, the non-
tagged protein was partially soluble.  The pET24a E2cat protein without his-tag was used 
for all further experiments. 
 
Figure 4.4 SDS-PAGE of E2cat expression trial.  Lanes 1 and 2 are the soluble and 
insoluble un-tagged E2cat protein expressed from pET24a.  Lanes 3 and 4 show the 
soluble and insoluble his-tagged E2cat protein expressed from pET28a.  The standard 
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4.3.2 Purification of the E2 catalytic domain 
4.3.2.1 Polyethyleneimine DNA precipitation  
Initial purification attempts using anion exchange chromatography and gel filtration 
resulted in E2cat protein which was contaminated with DNA/RNA; therefore a 
polyethylenimine (PEI) DNA/RNA precipitation step was added between the heat 
precipitation and anion exchange steps.  In each purification, the cell lysate was titrated 
with PEI to determine the optimal volume required to precipitate the DNA without 
precipitating the E2cat protein (Figures 4.5 and 4.6), usually between 0.2-0.3% (v/v) PEI 
was used. 






 1       2       3       4       5       6       7       8 
Figure 4.5 SDS-PAGE of the PEI DNA 
precipitation step during the purification 
of the recombinant E2cat protein. 
Lane 1: the cell lysate after heat 
treatment; lane 2: standard protein 
markers, with their molecular weights 
(kDa); lanes 3 -8: cell lysate incubated 
with 0.1-0.6% (v/v) PEI. 
Figure 4.6 Agarose DNA gel of the PEI 
DNA precipitation step during the 
purification of the recombinant E2cat 
protein. The lanes are labelled with the 















4.3.2.2 Anion exchange Chromatography 
Following the PEI precipitation, the E2cat protein was further purifed by anion exchange 
chromatography (Figures 4.7 and 4.8). 
 
Figure 4.7 An E2cat purification anion exchange trace.  The A280 readings are shown in 
blue; the concentration gradient of NaCl from 0-1M is shown in green; and the 2ml 
fraction numbers are shown along the x-axis. 
 
 
Figure 4.8 SDS-PAGE of the E2cat anion exchange fractions. Lanes are labelled by the 
fraction number shown in Figure 4.6.  The load sample is shown in the lane labelled L and 
the standard protein markers, with their molecular weights (kDa), are shown in the lanes 
labelled M. 
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4.3.2.3 Gel filtration 
The anion exchange fractions containing the E2cat protein were concentrated, before a 
final gel filtration purification step (Figures 4.9 and 4.10).  This 4 step purification method 
produced a pure E2cat protein sample containing no DNA/RNA in 50mM Tris-HCl, pH 8.8, 
and 100mM NaCl. 
 
4.9 Gel filtration trace of the E2 cat protein purifcation.  The A280 readings are shown in 
blue, and the fraction numbers are shown along the x-axis. 
 
 
4.10 SDS-PAGE of gel filtration fractions.  The lanes are labelled by fraction number 
corresponding to the fractions shown in Figure 4.8; the standard protein markers are 
shown with their molecular weights (kDa) in the lane labelled M. 
 Manual run 5:10_UV  Manual run 5:10_Fractions  Manual run 5:10_Inject  Manual run 5:10_UV@01,BASEM
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4.3.3 1 Mass spectrometric analysis of the E2cat 
Mass spectrometric analysis was performed to ensure the purified protein was the 
Tp. acidophilum E2cat.  Figure 4.11 shows 2 peaks that correspond to the predicted 
molecular weight of the E2cat protein with and without the start methionine: 25.455 kDa 
and 25.323 kDa, respectively. 
 
Figure 4.11 Mass spectrometry analysis of recombinant E2cat.  The molecular weight 
values of the E2cat protein, with and without the start Met, are predicted to be 
25.455 kDa and 25.323 kDa, respectively. 
 
4.3.3 E2 catalytic domain assays 
The E2cat protein was assayed to determine if the truncation altered the enzymatic 
activity of the protein.  The E2cat, and full length non-lipoylated E2 proteins were assayed 
under standard conditions, the specific activity and kcat values of the two proteins are 
shown in Table 4.1. 
Enzyme Specific activity (U/mg) kcat (min
-1) 
E2 Catalytic domain 1.63 ±0.13 42.8 ± 3.4 
Whole E2 Non-lipoylated  1.06 ± 0.05 48.9 ±2.3 
 
Table 4.1 E2cat and full-length E2 specific activity and kcat values.  The specific activity is 
shown in U/mg of E2, where 1 Unit is described as the conversion of 1 μmol of acetyl-CoA 
to 1 μmol of acetyl-dihydrolipoamide.  The kcat value is the turnover number per min per 
E2 monomer. 
 
The kcat values determined for the non-lipoylated full-length E2 and the E2cat proteins are 
almost identical.  The removal of the flexible regions of the E2 protein has not affected 
enzyme activity; therefore, it would appear that this modification has not affected the 
structure of the E2 active site. 
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4.3.4 E2 catalytic domain thermostability 
The thermostability of the E2cat protein was measured by several methods, in order to 
determine both the structural and functional thermostability of the protein. 
4.3.4.1 Dynamic light scattering  
DLS was used to assess the thermostability of the E2cat protein, by measuring the 
changes in the hydrodynamic diameter of the protein at increasing temperatures.  The 
E2cat protein forms a single structure with an average diameter of ≈21nm between 25°C 
and 78°C.  Above 80°C there is an increase in the average diameter (Figure 4.12), due to 
the emergence of a large protein aggregate seen by the secondary peak in Figure 4.13; 
however, the majority (95%) of the soluble protein remains in the smaller peak.  This 
aggregation appears to be irreversible as, after cooling on ice and then warming back to 
55°C, there is no decrease in the large aggregate peak. 
 




Figure 4.13 DLS volume distribution graph at 85°C.  The majority of the signal is in the 
peak with a z-average ≈21nm but there is a second peak starting at 1000nm due to the 






















4.3.4.2 Heat precipitation of the E2 catalytic domain  
The thermostability of the E2cat structure was measured by comparing the ratio of 




Figure 4.14 SDS-PAGE of the soluble 
protein after a 10 min incubation.  Lane 
1: standard protein markers, labelled 
with their Mw (kDa); lane 2: non-heated 
sample; lanes 3-7: the soluble protein 
after 10 min at 75, 80, 85, 90 and 95°C, 
respectively 
 Figure 4.15 SDS-PAGE of the insoluble 
protein after a 10 min incubation.  Lane 
1: standard protein markers, labelled with 
their Mw (kDa); lanes 2-6: the insoluble 
protein after 10 min at 75, 80, 85, 90 and 
95°C, respectively. 
The E2cat protein is more stable to higher temperatures than the full-length E2.  Only a 
small quantity of E2cat begins to precipitate after 10 min at 95°C; whereas the full-length 
E2 begins to precipitate after 10 min at 85°C and is completely insoluble at 90°C (Figures 
3.16 and 3.17).  This experiment measures the temperature at which the protein 
precipitates, but it does not provide any information about the enzyme's ability to 
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4.3.5.3 E2cat thermal inactivation profile  
The thermal inactivation profile of the E2cat enzymatic activity was determined at 99°C 
(Figure 4.16).  The E2cat protein is a highly thermostable enzyme that retains 
approximately 75% of its initial activity after a 90-minute incubation at 99°C.  This is 
significantly more stable than the full-length E2 protein, which lost over 90% of its activity 
after 5 min at 90°C.  The thermoactivity E2cat protein of the enzyme remains 
uncharacterised due to the coupled nature of the continuous E2-PTA assay. 
 
Figure 4.16 Thermal inactivation profile of E2 catalytic domain at 99°C.  The E2cat 





















The C-terminal catalytic domain of the Tp. acidophilum E2 enzyme has been successfully 
cloned and expressed.  The E2cat protein assembles into a large structure which retains 
acetyl-transferase activity with a similar kcat value to the full-length E2 protein; this 
suggests that the structure and assembly of the E2cat domain has not been affected by 
the removal of the flexible linker regions.  The E2cat protein is significantly more 
thermostable than the full-length E2, and this result raises the question as to why this 
domain is hyper-thermostable whereas the whole E2 protein is not.  One possible 
explanation stems from the observation that thermostable enzymes tend to have shorter 
loops, and reduced N- and C-terminal extensions, as these flexible structures can be sites 
of thermal denaturation (Thompson and Eisenberg, 1999).  In the case of the E2 protein, 
the lipoyl domain must be able to move freely between the active sites of the E1 and E3 
enzymes; consequently, the E2 catalytic domain may be required to be hyper-
thermostable, to resist the thermal denaturation forces resulting from the movement of 




Chapter 5: The structure of the Tp. acidophilum dihydrolipoamide 
transacetylase  
5.1 Introduction 
5.1.1 Determining the structure of the Tp. acidophilum E2 catalytic domain 
The previous chapter described the cloning and expression of the Tp. acidophilum E2 
catalytic domain; the aim of this chapter was to determine the structure of this 
hyperthermostable protein, in order to begin to understand the structural basis of the 
thermostability of the OADHC.  The E2 catalytic domain was cloned and expressed, 
without its flexible regions, with the aim of crystallising the protein and generating a high-
resolution X-ray crystallographic structure.  This chapter also covers other biophysical 
techniques including small-angle X-ray scattering, sedimentation equilibrium analytical 
ultracentrifugation, and transmission electron microscopy; these techniques were used to 
validate the E2cat crystal structure, and to compare it with the whole E2, to establish if 
removing the flexible regions alters its structure and/or assembly. 
 
The E2 structures currently available are either cubic 24-mers or dodecahedral 60-mers; in 
all cases, the E2 polypeptide chains form trimers that then assemble into a large hollow 
cage, composed of either square or pentagonal faces, with a large opening in the centre 
of each face (Figure 5.1).  The E2 transacylase active site is located in a channel between 
the monomers of each trimer; this channel extends from the outside to the inside of the 
assembled E2 structure.  The lipoic acid moiety with the acyl group attached enters the 
active site from the outside and the CoA enters from the inside; once the acyl-groups has 
been transferred, the acyl-CoA leaves the active site and diffuses through the windows in 
each face, and the lipoyl domain then visits an E3 in order to be re-oxidised and thus 




       
 
Figure 5.1 Surface representations of A) the cubic 24-mer and B) the dodecahedral 60-
mer.  The cubic 24-mer is the pyruvate dehydrogenase complex from Azotobacter 
vinelandii (PDB code: 1EAF) (Mattevi et al., 1992) and the 60-mer is from the pyruvate 
dehydrogenase complex from Geobacillus stearothermophilus (PDB code: 1B5S) (Izard et 
al., 1999).  The maximum diameter is shown below each structure. 
 
5.1.2 X-ray crystallography 
X-ray crystallography is a powerful technique capable of determining high-resolution 
protein structures.  The first hurdle to overcome is growing a good quality crystal from the 
required protein, which involves producing an ordered, three dimensional arrangement of 
the protein molecules held together by non-covalent interactions.  Each protein crystal 
comprises a lattice of unit cells in which several protein molecules may be packed.  Slow, 
controlled precipitation of a protein is required to produce a good quality protein crystal 
containing identical unit cells, which are packed into a regular lattice.  The exact 
conditions (buffer, pH, precipitant type and concentration, presence of additional ions or 
sugars and protein concentration) required to produce a crystal rather than an 
amorphous precipitate vary depending on each protein (Rhodes, 1993). 
Structural information about the protein is determined by mounting the crystal in an X-ray 
beam and recording the pattern of diffracted X-rays.  Each exposure of the crystal to the 
X-ray beam produces a scattering pattern containing two-dimensional information about 
the crystal; the crystal is rotated in the beam to provide multiple images that are 
compiled to construct a three-dimensional image.  The quality of packing within the 
crystal affects the resolution of the data recorded - the more ordered and similar each of 
the unit cells, the higher the resolution (Rhodes, 1993). 




An electron density map can be created from the diffraction pattern using the Fourier 
equation; this process is simplified if another similar structure is available, as molecular 
replacement can solve the phase problem by predicting the X-ray diffraction pattern 
created by another similar protein, and comparing it with the experimental data (Rhodes, 
1993).  The level of detail contained within the electron density map depends on the 
quality of data collected - the higher the resolution the more accurately each atom can be 
positioned.  The protein structure is modelled into the electron density map and the 
positioning of each atom improved with iterative rounds of refinement. 
Determination of a high-resolution protein structure by X-ray crystallography requires the 
protein to be packed into a crystalline state, a process that is not possible for all proteins 
or protein regions.  Flexible proteins can adopt multiple conformations, and therefore do 
not pack into ordered crystals; the full length E2 protein is an example of a flexible protein 
which to date has not been crystallised.  Another limitation that should be considered is 
the distortion of protein structures or alteration of interaction caused as a result of crystal 
packing; the structures determined by X-ray crystallography may, in some cases, differ 
from the protein structure or arrangement in solution (Rhodes, 1993). 
 
5.1.3 Small-angle X-ray scattering 
Small-angle X-ray scattering (SAXS) is a method used to determine the molecular weight, 
oligomeric state, and shape of a protein in solution.  The X-ray radiation is scattered as it 
passes through the solution containing protein and/or buffer (Figure 5.2).  The scattering 
pattern produced is a rotational average, as the protein will be in multiple orientations 
within the solution at any one time, unlike the ordered crystal packing seen in X-ray 
crystallography; this pattern is recorded on a detector up to an angle typically of 3°.  The 
scattering pattern of a protein is measured at several different concentrations, to 
establish if there are any concentration-dependent changes in the structure or assembly.  
Each sample is also subjected to multiple exposures to detect any radiation damage.  The 
‘buffer-only’ scattering pattern is deducted from the protein pattern and the data are 
normalised by comparison with BSA standards (Figure 5.3). The normalised scattering 
intensity of the protein can then be plotted versus the scattering vector (Figure 5.3B), the 
shape of this plot supplies information about the protein’s size and overall shape.  
Examples of the characteristic scattering patterns produced by a variety of shapes are 






Figure 5.2 Experimental arrangement to collect small-angle X-ray scattering data.  The 
synchrotron X-ray radiation passes through the solution containing protein and buffer.  
The protein and buffer molecules scatter the X-rays, producing a rotation averaged 
scattering pattern that is collected usually up to an angle of 3°.  The scattering intensity 
versus the scattering vector (S) is recorded and analysed to provide low-resolution 
structural information about the protein. 
 
A)       B) 
 
 
Figure 5.3 Examples of scattering intensity graphs of the logarithm of the intensity (Log 
I(s)) versus the scattering vector (s, nm). Graph A shows the scattering pattern of a 
protein sample in blue and a ‘buffer-only’ control in red.  Graph B is the normalised 





Figure 5.4 Examples of characteristic scattering patterns produced by a range of 
theoretical shapes.  The coloured lines represent typical scattering patterns produced by 
following shape molecules: a rod (yellow), dumbbell (grey), flat disk (brown), hollow 
sphere (cyan) and solid sphere (dark blue). 
 
The scattering pattern can then be transformed to produce a series of graphs that provide 
the various parameters used to determine the size and shape of the protein, the presence 
of any aggregation, and the quality of the data (Jacques and Trewhella, 2010).  The 
secondary plots and the information provided are detailed below: 
• Guinier plot – radius of gyration (Rg), molecular weight and assessment of the 
data quality 
• Porod plot – particle volume 
• P(r) plot – maximum linear dimension (Dmax), and identification of elongated 
protein structures 
 
An ab initio bead model can then be created by predicting the scattering pattern 
produced by a hollow sphere and comparing this to the experimental data; the hollow 
sphere is then modified and the scattering pattern determined again.  After multiple 
iterations of this process, the aim is to produce a final model that generates a predicted 
scattering pattern that is the same as the experimental scattering data.  A higher-
resolution crystallographic structure of the protein, if available, can be modelled into the 
ab initio bead model to confirm statistically if the crystallographic and SAXS structures are 
consistent with one another.  
s, nm
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5.2.1. Protein Expression and purification 
5.2.1.1 E2 and E2cat expression 
The E2 and E2cat proteins were expressed following the method described in Chapter 
3.2.1. 
5.2.1.2 E2 and E2cat protein purification 
The E2 and E2cat proteins were both purified by the method described in Chapter 4.2.2, 
resulting in protein samples which were >95% pure in 50mM Tris-HCl, pH 8.8, and 100mM 
NaCl 
 
5.2.2 Transmission electron microscopy 
Purified E2cat protein (25μg/ml) was attached to Formvar carbon-coated grids, 
negatively-stained and visualised by Ursula Potter (University of Bath).  The carbon-coated 
grids were prepared by overnight exposure to UV-light.  The E2cat protein (25μg/ml in 
50mM Tris-HCl, pH 8.8, 100mM NaCl) was attached to the carbon-coated grids by adding 
30μl of protein and incubating for 1 min, any unattached protein was then removed by 
two washes with 50µl of dH2O.  The protein coated grids were blotted dry and stained 
with 50μl of either 2% (w/v) uranyl acetate pH 4, or 2% (w/v) phosphotungstic acid pH 8; 
after 30 sec any excess stain was removed and the grids air-dried before visualisation on a 
Jeol JEM1200EXII (Tokyo, Japan). 
 
5.2.3 Determination of the X-ray crystallographic structure of the E2 catalytic domain 
5.2.3.1 Crystal condition screens 
An Art Robbins Nano dispenser robot was used to set up PACT and JCSG 96-well screens 
(Molecular Dimension, Suffolk, U.K.).  Each condition had 3 sitting drops with a differing 
volume ratio of protein (~10mg/ml) to well solution: 1:2 1:1 and 2:1, totalling 300nl.  The 
plates were sealed with a plastic sheet and stored at 16°C.  The screens were checked 
every two days for two weeks, and then weekly for several months. 
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5.2.3.2 Optimisation  
Conditions from the 96-well plates that resulted in protein crystals or granular 
precipitation were selected for optimisation in a 24-well hanging-drop plate.  The 
conditions identified from the 96-well screens were initially replicated in hanging drops 
containing 1.5μl:1.5μl well solution to protein.  The conditions were then varied to 
improve the size and quality of the crystals, including changing the buffer composition 
and pH, precipitant and its concentration, protein concentration and the addition of other 
metal ions and sugars. 
5.2.3.3 X-ray diffraction data collection  
The crystals were removed from the drops with a cyroloop and soaked in 0.1M Na 
acetate, pH 5.5, 15% (v/v) 2-methyl-2,4-pentanediol (MPD), 0.20M NaCl and 10% (v/v) 
ethylene glycol, before flash-freezing in liquid nitrogen.  X-ray diffraction data were 
collected at the Diamond LightSource (Oxfordshire, U.K.) on an ADSC Q315 3x3 CCD 
detector on station I04 (at wavelength =0.9702 Å) by Dr Jean van den Elsen and Dr. 
Susan Crennell (University of Bath, U.K.).  The data were then processed by Dr Susan 
Crennell using the HKL2000 package.  
5.2.3.4 Model building and refinement 
Molecular replacement was carried out by Dr. Susan Crennell with BALBES (Long et al., 
2007) using the Azotobacter vinelandii dihydrolipoamide acyltransferase structure (PDB 
access code 1EAF).  The model was built and refined using COOT (Emsley and Cowtan, 
2004) and REFMAC5 - CCP4i software (Bailey, 1994).  The protein structure was deposited 
in the Protein Data Bank (PDB access code: 3RQC).  Images were created using PyMOL. 
 
5.2.4 Small-angle X-ray scattering 
The E2cat protein was purified as described in Chapter 4.3.2.  The E2cat sample was 
analysed in two buffers: (1) 50mM sodium phosphate, pH 7.0, and 100mM NaCl; 
(2) 50mM Tris-HCl, pH 8.8, and 100mM NaCl.  The SAXS data were collected at the X33 
beam line, EMBL Hamburg Outstation, (DORIS-III storage ring at Deutsches Elektronen-
Synchrotron (Roessle et al., 2007)) at 10°C using an automatic sample changer (Round et 
al., 2008); data were collected for four protein concentrations: 1.0, 1.5, 2.0 and 2.5mg/ml.  
Two successive two-minute exposures of the 1.0 mg/ml sample detected no radiation 
damage.  The data were processed and analysed by Dr. Dmitri Svergun (EMBL Germany), 
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Dr. Peter Konarev (EMBL, Germany) and Dr Jean van den Elsen (University of Bath, U.K.).  
The results were analysed using standard procedures; the data were extrapolated to zero 
solute concentration using PRIMUS (Konarev et al., 2003), GNOM was used to determine 
forward scattering and the radius of gyration, that were used to calculate the proteins 
maximum dimensions and intraparticle distance (Svergun, 1992).  Ten low-resolution ab 
initio bead models of the E2 catalytic domain were produced by the DAMMIFF 
programme (Franke and Svergun, 2009, Svergun, 1999) and averaged using the DAMAVER 
programme (Volkov and Svergun, 2003).  The high-resolution scattering models were 
calculated with the program CRYSOL (Svergun et al., 1995), and the rigid-body modelling 
of the E2cat was performed using the program SASREF without symmetry restrictions 
(Petoukhov and Svergun, 2005).  The 4Å X-ray crystallographic structure previously 
determined was then modelled into the ab initio bead model. 
 
5.2.5 Sedimentation equilibrium analytical ultracentrifugation 
All experiments were performed and results analysed by Dr. Jacqui Marshall (University of 
Bristol), using an An60Ti rotor in a Beckman XL-A ultracentrifuge at 20°C.  A 6-sector 
centrepiece centrifuge cell was loaded with 120μl of three different protein 
concentrations, along with three buffer-only controls, to give absorbance values in each 
1.2 cm cell of approximately 0.8, 0.5 and 0.3.  The different concentrations were analysed 
to detect any concentration-dependent changes in the protein.  
The samples were centrifuged at various speeds, and the absorbance values were 
measured every 6 h until equilibrium was reached.  The buffer background was measured 
at the end of the experiment after a 6 h clearing run at 40,000 rpm. 
The data were fitted using ORIGIN to the model for a single ideal protein species, based 
on the Svedberg equation (shown below).  The partial specific volume ( ) of the protein 
and buffer density (ρo) were estimated from the protein sequence and the buffer 
composition, respectively, using SEDNTERP: 
   [http://www.jphilo.mailway.com/download.htm] 
The predicted molecular weight (Mw) and absorbance coefficient of each protein was 






    
   
        
 
 
Where Mw = molecular weight (Da) of the protein assembly, R = universal gas constant 
(8.314 x 103 J/K/Kg mol mass), T = temperature (K), s = sedimentation coefficient (sec), 
D = diffusion coefficient (m2/sec),   = partially specific volume of the protein (ml/g), and 




5.3 Results and discussion 
5.3.1 Transmission electron microscopy 
Transmission electron microscopy was used as an initial low-resolution method to 
determine if the E2cat protein assembled into a large hollow structure.  Figure 5.5 shows 
a hollow protein structure approximately 17nm in diameter; however, it is not possible to 
determine the structure from this image as the symmetry is not clear. 
 
Figure 5.5 Transmission electron microscopy image of the E2cat protein.  E2cat protein 
visualised by negative staining with 2% (w/v) phosphotungstic acid, pH 8.0 
 
5.3.2 E2catalytic domain crystal trials  
5.3.2.1 Initial 96 well plate crystal screen  
PACT and JCSG 96-well screens (Molecular Dimensions, Suffolk, U.K.) were used to 
identify conditions that resulted in crystals or granular precipitate.  The PACT screen 
resulted in precipitate in all 96 conditions and all concentrations.  The JCSG screen 






0.1M Tris-HCl, pH 8.5 
1.26M Ammonium sulphate  
0.2M lithium sulphate 
 
0.1M Caps, pH 10.5 
40% MPD 
 
0.1M Hepes, pH 7.5 





Table 5.1 Examples of the crystals that grew in three different conditions within the 
JCSG 96-well crystal screen.  The images show the crystal forms that grew in each 
condition within 1 month. 
 
5.3.2.1 Crystal optimisation  
The 0.1M Caps, pH 10.5, 40% MPD condition was optimised for protein concentration, pH, 
buffer, precipitation and additional salts.  The final condition that produced crystals 
suitable for X-ray diffraction contained 1.5µl of 10mg/ml protein, mixed with 1.5µl of well 
solution containing 0.1M Na acetate, pH 5.5, 12% MPD, and 0.2M NaCl, and storing at 
16°C for approximately 2 weeks (Figure 5.6).  All attempts to reproduce and optimise the 




Figure 5.6 E2cat crystal in 0.1M Na Acetate, pH 5.5, 12% MPD, 0.20M NaCl.  Crystals 
grew over two weeks at 16°C. 
 
5.3.3 The structure of the Thermoplasma acidophilum E2 catalytic domain 
5.3.3.1 X-ray diffraction data collection 
Diffraction to 4Å was achieved with a diamond-shaped crystal that was flash frozen in 
0.1 M Na acetate, pH 5.5, 15% MPD, 0.20 M NaCl, with an additional 10% ethylene glycol.  
A variety of crystal sizes, morphologies and cryoprotectants were tried but no further 
improvements were made to the diffraction data. 
5.3.3.2 E2cat model building and refinement 
The X-ray diffraction data were collected at the Diamond Light Source and processed to 
4.0 Å (Table 5.2); the refinement statistics are given in Table 5.3. 
Space Group R32 (H32) 
Cell parameters  a=b, c  206.3Å, 438.4Å 
α=β, γ  90.00°, 120° 
Resolution (Å) (last shell)   4.00 (4.14 - 4.00) 
Number of observations 670508 
Number of unique reflections 29696 
Completeness (last shell) 98.0 (99.3) 
R merge (%)(last shell) 12.7 (48.5) 
Average I/σI (last shell) 7.9 (1.58) 
Redundancy 3.7 (3.5) 
 






Resolution range  44.95 - 4.00Å 
Number of protein atoms  12157 
Number of solvent atoms None 
Average B value  97.108Å2 
R-crystal  25.3% 
R-free  32.8% 
Rms deviations 
 
Bonds  0.015Å 
Angles  1.806° 
 
Table 5.3 E2cat structure refinement statistics 
 
The structure of the Tp. acidophilum E2cat protein was solved by molecular replacement 
using the A. vinelandii dihydrolipoamide acyltransferase structure (PDB access code 
1EAF).  This produced a model comprising 6 monomers arranged as two adjacent trimers, 
with clear electron density for a seventh monomer.  An additional single monomer was 
modelled into this density resulting in a 7 chain asymmetric unit (Figure 5.9).  The 
polypeptide backbone of this seven-chain model (Figures 5.7 - 5.9) was refined to give 
final values of Rwork 25.3% and Rfree 32.8% (Table 5.3). 
 








Figure 5.9 Ribbon diagram of the seven chains comprising the E2cat asymmetric unit.  
The seventh chain (black) sits on a three-fold axis of symmetry; the other 2 monomers in 
the trimer are created by symmetry. 
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5.3.3.1 The 42-mer structure of the Thermoplasma acidophilum E2  
The 7-chain asymmetric unit comprises two trimers and one monomer; the seventh 
monomer creates a third trimer as it is located on a three-fold symmetry axis; the 
complete E2cat structure was created by positioning the other symmetry related trimers 
(Figure 5.10).  The resulting structure was neither the expected cubic 24-mer (432-
symmetry) nor the dodecahedral 60-mer (532-symmetry); instead, the Tp. acidophilum 
E2cat assembled into a novel 42-mer, with 32-symmetry (Figure 5.10) (Marrott et al., 
2012).  The 1.08 MDa, 42-mer structure is an oblate sphere, comprising three square and 
six pentagonal faces, with a maximum diameter of 220 Å and a minimum of 190 Å.  The 
large openings located in the centre of the square and pentagonal faces have a diameter 
of 40 Å and 52 Å respectively.  The cubic A. vinelandii E2cat has an overall diameter of 
120Å, with 30 Å wide windows (Mattevi et al., 1991b); and the dodecahedral 
G. stearothermophilus E2cat measures 237 Å in diameter, with 52 Å windows (Izard et al., 
1999).  The Tp. acidophilum 42-mer dimensions fit between these two previously 
described structures.  The windows in the pentagonal faces are similar to those of the 
dodecahedral structure; however, the windows in the Tp. acidophilum square faces are 
larger than those in the cubic 24-mer structure.  The Tp. acidophilum structure has a high 
solvent to protein ratio of 76%, which may have been responsible for limiting the data 
collection resolution to 4Å; this is similar to the 4.4Å resolution achieved by Izard et al 





       
 
Figure 5.10 The assembled 42-mer Tp. acidophilum E2cat structure.  The ribbon diagrams 
shown in figures A and C illustrate the backbone structure of the E2cat from 2 different 
angles, showing two pentagonal and one square face.  B and C show a space-filling 
representation of A and C respectively.  The three polypeptide chains within each trimer 
are coloured the same.  PDB accession code: 3RQC. 
  
A             B 









5.3.4 Analysis of the E2 catalytic domain structure 
5.3.4.1 Sequence and structural alignments with other E2 catalytic domain structures 
The polypeptide backbone structure can be determined utilising the 4Å resolution data 
but not the position of the side chains.  In order to analyse the structure further, 
comparisons were performed with other higher-resolution E2cat structures in which the 
side-chain positions have be determined, including: the A. vinelandii PDHC (2.6Å) (Mattevi 
et al., 1991b), the bovine branched-chain OADHC (2.7Å) (Kato et al., 2006), the E. coli 2-
oxoglutarate dehydrogenase complex (OGDHC) (3.0Å) (Knapp et al., 1998) and also the 
lower resolution G. stearothermophilus PDHC (1B5S) (4.4Å).  The alignment of the 
Tp. acidophilum E2cat sequence with the sequences from known E2cat crystal structures 
are shown in Figure 5.11 with the key residues involved in trimer-trimer interaction and 
catalytic activity highlighted. 
 
Figure 5.11 Thermoplasma acidophilum E2cat sequence alignment with sequences from 
other known E2cat structures. Tp.acid is the Tp. acidophilum sequence E2 catalytic 
domain.  The other E2cat sequences are labelled with their PDB codes: 1B5S: 
G. stearothermophilus PDHC; 1E2O: E. coli OGDHC, 1EAF: A. vinelandii, PDHC; 2IHW: 
bovine branched-chain OADHC.  The three key active site residues are in red, the anchor 




5.3.4.2 Active site residues 
The active site residues of the E2 transacylase are positioned within a tunnel which allows 
entry of the lipoic acid from the outside and the CoA from the inside of the hollow E2 core 
(Mattevi et al., 1992).  The key active site residues in the Tp. acidophilum E2cat protein 
can be predicted based on alignments with other E2cat sequences; the active site is found 
between 2 monomers with one chain contributing a threonine (Thr 151) residue and the 
other providing the histidine (His 195) and aspartic acid (Asp 199) (Figure. 5.12).  The 
active site side chains appear to be in the correct position in the Tp. acidophilum E2cat 
structure, suggesting that the polypeptide backbone has been positioned correctly, as 
although the exact side chain position is not known they are orientated correctly on the α-




Figure 5.12 The E2cat active site shown in channel between 2 monomers (cyan and 
blue).  The blue monomer contributes the Asp (199) and His (195), and the Thr (151) is 




5.3.4.4 Predicting the anchor residue key to inter-trimer interactions 
An anchor residue is predicted to be important in the formation of inter-trimer 
interactions, in both the 24- and 60-mer structures; it is a branched side-chain residue 
that extends from one trimer into a hydrophobic pocket on the second trimer and vice 
versa (Izard et al., 1999).  Based on the sequence alignments of the Tp. acidophilum 
sequence along with other known structure sequences (Figure 5.11), two possible 
isoleucine anchor residues (E2cat Ile 220 and Ile 221) have been identified.  Comparing 
the locations of these two residues on the crystal structure, isoleucine 221 appears the 
more likely candidate, as it is positioned in the correct orientation on the 310 helix (Figure 
5.14).  There is electron density for the Ile 221 side chain extending from one trimer 
towards the adjacent trimer; however, due to the 4Å resolution the precise position of 
the side chain cannot be confirmed (Figure 5.13).  The consequences of mutating and 
removing this anchor residue are detailed in Chapter 6.  The trimers located on both the 
square and pentagonal faces interact via the same putative Ile 221 anchor residue; this 
ball and socket-like interaction may allow the flexibility required for the trimer to form 




Figure 5.13 The E2cat backbone structure with the side-chain of the possible anchor 
residue (isoleucine 221) with the electron density superimposed.  The isoleucine 221 





Figure 5.14 Crystal structure highlighting the possible anchor residues involved in inter-
trimer interactions.  The ribbon diagram backbones of the two adjacent trimers are 
shown in red and blue.  The Ile 221 side-chains are shown in black, extending from each 
















5.3.4.5 Formation of square and pentagonal faces within the 42-mer  
All current E2 structures comprise trimers that associate into a hollow cage with either 
square or pentagonal faces.  The 24-, 42-, and 60-mer arrangements are not as a result of 
differences in the trimer structure (Figure 5.15), rather the angle at which the trimers 
interact (Figure 5.16).  Unlike the other known structures, the Tp. acidophilum trimers 
appear to be capable of interacting differently with one another in order to form both 
square and pentagonal faces (Figure 5.17). 
 
Figure 5.15 Overlaid E2 trimer structures of Tp. acidophilum 42-mer, a cubic 24-mer and 
a dodecahedral 60-mer.  The Tp. acidophilum ribbon diagram is shown in black, the 
A. vinelandii is shown in orange and the G. stearothermophilus in blue. 
 
 
Figure 5.16 Overlaid structures of 2 adjacent trimers from a cubic 24-mer and a 
dodecahedral 60-mer.  The trimers on the left have been superimposed over each other, 








Figure 5.17 The square and pentagonal faces of the Tp. acidophilum 42-mer.  A) The top 
left trimer of the square ribbon diagram (blue) and pentagonal (red) faces have been 
aligned with one another.  B) Illustrates the different angles at which the trimers interact 





The Tp. acidophilum E2 trimers located on the square and pentagonal faces of the 42-mer 
interact at differing angles (Figure 5.17).  Figure 5.18 illustrates how the differing angles of 
the two trimers relative to each other may influence the number of possible inter-trimer 
interactions.  The trimers located on a pentagonal faces are arranged so that there is a 
possibility of an ionic bond forming between the arginine of one trimer and an aspartic 
acid on the second (approximately 4.5Å apart), and vice versa (Figure 5.18A).  The same 
interaction appears unlikely between two adjacent trimers located on a square face, as 






Figure 5.18 Trimer-trimer interfaces on A) a pentagonal and B) a square face of the 
Tp. acidophilum E2 42-mer.  The pentagonal-face trimers are shown in shades of blue and 
green and the square-face trimers in shades of purple and orange. The side chains of key 
residues have been included on these images but it should be noted that the exact 
location of these residues is unclear.  Measurements are shown between the polypeptide 
backbone bones.  The line diagram next to each image indicates the location of the two 











The 4Å resolution of this structure and the 60-mer prevents the exact identification of the 
residues that are responsible for determining the angle at which the trimers interact.  
Interactions between the anchor residue and the hydrophobic pocket, or surface regions 
at the inter-trimer interface may influence the angle at which the trimers interact with 
one another, and ultimately govern the overall structure of the E2.  A higher resolution 
structure of the 42-mer and 60-mer might confirm which residues and interactions are 
important; however, this may not be feasible, so a second option is to mutate the amino 
acids predicted to contribute side chains to the inter-trimer interactions and determine 
the effect on the overall structure. 
The E2 trimers within the 42-mer are all identical, but the individual monomers occupy 
differing environments depending upon their location within a square or pentagonal face; 
this variation may go beyond the quasi-equivalence principles previously suggested, by 
Izard et al. (1999), to govern the assembly of the OADHC E2 proteins.  Quasi-equivalence 
suggests that all protein subunits are linked by the same type and number of bonds, but 
these bonds may be deformed slightly (Caspar and Klug, 1962).  The interactions between 
the trimer of the 24-mer and 60-mer structures are described as quasi-equivalent; 
however the interaction between the non-Euclidean 42-mer trimers cannot be described 
as quasi-equivalent.  The bonds between the 42-mer trimers are not merely distorted, in 
some cases they are completely different, some interactions are only possible between 
monomers located within pentagonal faces and not between monomers located on a 
square face. 
The Tp. acidophilum 42-mer structure cannot be predicted based on quasi-equivalence 
and the rules of Euclidean symmetry; but it can, however, be explained by another 
argument that subunits are not obliged to occupy identical environments and form 
identical interactions, rather they assemble into the lowest energy structure possible 
(Caspar and Klug, 1962, Caspar, 1980).  
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5.3.4.6 Thermostability of the E2cat protein 
Evidence suggests that protein thermostability is not achieved by one method, but rather 
through a number of small changes.  A range of structural features have been proposed to 
contribute to protein thermostability, although their contribution and usage varies 
depending on the organism and protein, these adaptations include: 
 Decreased conformational flexibility  
 Decreasing fraying by reduced terminal extensions and additional terminal 
interactions 
 Increased packing efficiency 
 Increase in salt bridge networks  
 Increased hydrogen bonding 
 Extra disulphide bonds 
 Amino acid substitutions  
o  More hydrophobic and helix stabilising residues  
o Fewer exposed thermolabile amino acids 
(Radestock and Gohlke, 2010, Daniel et al., 2008, Li et al., 2005) 
 
The E2cat is a hyperthermostable protein but the structural basis of this thermostability is 
not clear from this 4Å model.  Reducing the flexibility of the full length E2 is not a feasible 
option for this protein as the flexible linker regions are key to enzyme functionality; 
instead one possibility is that the E2 catalytic domain has evolved to become hyper-
thermostable and therefore capable of resisting the denaturing forces exerted on it 
(Chapter 4.4).  It is not currently possible to prove this hypothesis as thermostability data 
from mesophilic and thermophilic E2cat and full length E2 protein are not available. 
 
Despite the variety of potential stabilising interactions referred to above, one prevalent 
feature of thermophilic and hyper-thermophilic proteins is that they tend to have more 
charged residues, resulting in the possibility of forming extra ionic bonds.  These 
interactions increase in strength at higher temperatures as the energy required to 
desolvate a charge residue is lower, due to increased water entropy, but the Coulombic 
interaction between opposite charges within an ionic bond remains the same; therefore, 
the formation of ionic interactions becomes increasingly favourable as temperatures 
increase.  Hyper-thermophilic enzymes also utilise a network of ionic bonds.  The 
formation of an ionic bond requires the desolvation of two charged residues in order to 
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create one bond, but the addition to the interaction of a third charge to form a network 
requires the desolvation of only one charged residue; given that a full Coulombic 
interaction is gained, ionic networks are highly favourable with respect to thermostability. 
The number of ionic interaction in the Tp. acidophilum E2cat cannot be accurately 
determined, and a higher resolution structure would be required to determine the 
positions of the side chains and thus to identify ionic interactions.  The percentage of 
charged residues in full-length E2 sequences from mesophilic through to hyper-
thermophilic organisms can, however, be compared; there is a positive correlation 
between the percentage of charged residues and the optimal growth temperature of the 
source organism (Figure 5.19).  The Tp. acidophilum E2 protein contains a higher 
percentage of charged residues than the mesophilic E. coli PHD E2 but less than the 
hyper-thermophilic E2 from Pyrobaculum aerophilum. 
 
Figure 5.19 The percentage of charged residues per full-length E2 as a function of the 
growth temperature of the source organism.  The total number of positive and negative 
residues was calculated as a percentage of the total number of resides in each E2.  The 
temperature corresponds to the optimal growth temperature of the organism.  The E2 
proteins sequences are taken for the following mesophilic to hyper-thermophilic 
organisms: human, cow, E. coli, Ferroplasma acidarmanus, G. stearothermophilus, 
Tp. acidophilum (shown as a triangle), Picrophilus torridus, Sulfolobus islandicus, 











































5.3.5 Small-angle X-ray scattering 
SAXS was used to determine the E2cat structure in solution, and hopefully to verify that 
the novel 42-mer X-ray crystallographic structure was not an artefact of crystallisation.  
The SAXS data indicated that the E2cat protein, in 50mM Tris-HCl pH 8.8 and 100mM 
NaCl, was monodisperse, with pronounced subsidiary maxima, characteristic of a hollow 
globular protein structure.  The Guinier plot determined the radius of gyration (Rg) to be 
85 ±3 Å, and the P(r) (distance distribution) plot determined the maximum linear 
dimension (Dmax) value to be 220 ± 10 Å; these values imply that the E2cat is a distorted 
sphere structure, as the Dmax value is not double the Rg value, as would be expected for a 
perfect sphere.  The molecular weight determined from these experiments was 
950 ± 90 kDa, equivalent to 37.3 ± 3.5 monomers. 
Figure 5.20 shows the experimental scattering pattern compared to the predicted 
scattering pattern produced by the 24, 42 and 60-mer structures (PDB codes: 1EAF, 3RQC, 
and 1B5S respectively); only the predicted 42-mer pattern fitted the experimental data (χ 
= 0.95).  A hollow spherical ab initio bead model was produced from the SAXS data that 
superimposed well with the X-ray crystal structure (χ = 1.6) (Figure 5.20D); this indicates 
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Figure 5.20 Small-angle X-ray scattering data and analysis.  A-C) illustrates the X-ray 
scattering data in blue along with predicted scattering pattern in red for a 24-mer, 60-mer 
and 42-mer structure respectively; the chi values for fit of the model to the experimental 
data are shown above the graph.  Image D shows the low resolution 42-mer ab initio bead 
model (cyan) superimposed over the crystal structure. 
  
Log I 




χ = 0.95 
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5.3.6 Sedimentation equilibrium analytical ultracentrifugation 
The sedimentation equilibrium analytical ultracentrifugation experiments were performed 
and analysed by Dr. Jacqui Marshall (University of Bristol).  The molecular weights of the 
purified E2 and E2cat proteins (Figure 5.21) in 50mM Tris-HCl, pH 8.8, and 100mM NaCl, 
were determined by fitting the equilibrium data from two speeds and three protein 
concentrations (when possible) to a single ideal species model (example shown in Figure 
5.22). 
 
Figure 5.21 The E2 and E2cat protein samples used for centrifugation.  E2cat protein is 
shown in lane 1 and the full-length E2 protein in lane 2. The standard protein markers, 
with their molecular weights (kDa) are shown in lane M. 
  


















Figure 5.22 Sedimentation equilibrium analytical ultracentrifugation of the E2cat 
protein.  A) The blue dots are the recorded A280 values with radial distance across the cell 
after 48 h at 5000 r.p.m.  The red line is the fitted model for a single ideal species with the 
residuals from fitting the data to this model shown in B. 
 
 
Table 5.4 The molecular weights of the E2 and E2cat protein determined by 
sedimentation equilibrium ultracentrifugation.  The molecular weights of the E2 and 
E2cat proteins are shown for 3000 and 5000 r.p.m, at three concentrations listed from 
highest to lowest along with the average Mw for each speed.  The E2 5000 r.p.m result 
does not have an average due to the non-random residual produced during the fitting of 
the data to the single ideal species model. 
 
Protein Expected Mw 
 42-mer (MDa) 
Calculated Mw (MDa) 
3k r.p.m.  5k r.p.m.  
E2cat 1.07 1.20, 1.18, 1.25 
Average = 1.21 
1.02, 1.07, 1.08  
Average = 1.08 
Full-length E2 1.95 1.93, 1.89, 2.10 
Average = 1.94 
1.58, 1.52, 1.74  










The E2cat 3k r.p.m and 5k r.p.m results and the full-length E2 3k r.p.m result fit the single 
ideal species model; therefore, an accurate molecular weight can be determined.  The 
E2cat 3k r.p.m and 5k r.p.m results were combined resulting in a molecular weight of 
1.08 MDa ±0.02, equivalent to 42.2 (±0.8) subunits.  The 3k r.p.m results was used to 
determine the molecular weight of the E2 protein to be 1.94 (±0.05) MDa, this equates to 
41.8 (±1.1) subunits (Table 5.4); the 5k r.p.m results for the E2 have not been included as 
they do not fit the model; this may be due to the steepness of the curve at this speed 
making it difficult to fit the model accurately to the data points. 
Sedimentation equilibrium analytical ultracentrifugation is a method that determines the 
molecular weight of a protein independently of its structure; this result therefore strongly 
supports the previous conclusion that the Tp. acidophilum E2cat protein assembles into a 
novel structure composed of 42 monomers.  This method also confirms that the removal 
of the flexible linker region does not affect how the E2 trimers interact, as both the full-





In this chapter, several complementary techniques have been used to determine the 
structure of the Tp. acidophilum E2cat protein.  X-ray crystallography, small-angle X-ray 
scattering, and sedimentation equilibrium analytical ultracentrifugation all confirm that 
the Tp. acidophilum E2cat protein assembles into a 42-mer structure; analytical 
ultracentrifugation also proves that the full-length E2 protein assembles into a single 
structure with a molecular weight consistent with that of a 42-mer.  All currently known 
E2 structures are Euclidean shapes, either cubic 24-mers with square faces or 
dodecahedral 60-mers with pentagonal faces.  The Tp. acidophilum E2 structure is an 
intermediate between the 24-and 60-mer structures, comprising 42 monomers with both 
square and pentagonal faces; despite this apparent intermediate structure only a 42-mer 
is formed, rather than any other shape.  The data presented in this chapter contradict the 
previous sedimentation-velocity analytical ultracentrifugation experiments conducted by 
Heath et al. (2007) that determined that the E2 was a 24-mer.  The discrepancy between 
the two results may be due to proteolysis of the E2; if the flexible linker region between 
the PSBD and the catalytic domain were cleaved, the resulting protein would have a 
monomer Mw = 26.8 kDa, and a 42-mer Mw = 1.13 MDa, this is close to the 1.11 MDa 
expected for an intact E2 24-mer.  The E2 protein samples were not analysed by SDS-PAGE 
after the experiments of Heath et al. (2007), so it is not possible to confirm this theory. 
The structural adaptations that cause the Tp. acidophilum E2 to form a 42-mer rather than 
24-or 60-mer are not understood; currently there are not enough structures available 
from differing organisms, temperatures and assemblies, to be able to predict which 




Chapter 6: The effects of mutating and removing the putative E2 
anchor residue on the assembly of the 42-mer 
 
6.1 Introduction 
The amino acid side-chains involved in the Thermoplasma acidophilum E2 catalytic 
domain trimer-trimer interactions are of interest, due to the hyper-thermostability of this 
protein and its ability to form a novel 42-mer.  The C-terminus of the E2 catalytic domain 
has been shown to be important in the formation of trimer-trimer interactions; the 
addition of a C-terminal his-tag to the E. coli succinyltransferase disrupted inter-trimer 
interactions, resulting in E2 trimers that no longer associated with one another (Knapp et 
al., 2000).  One residue in particular, an "anchor residue", is thought not only to be 
important in the formation of trimer-trimer interactions, but also affect the angle at 
which the trimers interact, and this in turn  influences the multimeric structure of the E2 
assembly (Izard et al., 1999).  The E2 anchor residue is a hydrophobic amino acid, usually a 
valine or leucine, located a few amino acids from the E2cat C-terminus; the hydrophobic 
anchor residue side-chain extends from one trimer into a hydrophobic pocket on the 
adjacent trimer, and vice versa, tethering neighbouring trimers to each other.  Unusually, 
the Tp. acidophilum E2cat appears to have an isoleucine as its anchor residue; the aim of 
this chapter was to determine how either mutating or removing this putative anchor 
residue affected the 42-mer assembly. 
 
Figure 6.1 A ribbon diagram displaying the location of the putative anchor residue (E2-




6.2.1 Identification of a putative anchor residue 
The Tp. acidophilum E2cat sequence was aligned and the structure compared with the 
following 24-mer and 60-mer E2s: G. stearothermophilus PDHC, E. coli OGDHC, 
A. vinelandii PDHC, and bovine branched-chain OADHC.  Two possible Ile anchor residues 
were identified from the E2 sequence (whole E2: Ile396 and 397; E2cat: Ile 220 and 221,); 
the two residues were mapped onto the Tp. acidophilum E2cat structure to determine 
which was the more likely candidate.  The sequence below shows the location of the two 
possible Ile anchor residues. 








6.2.2 Site-directed mutagenesis and truncation of the E2 and E2 catalytic domain 
Site-directed mutagenesis was used to mutate the putative E2cat anchor residue 
(E2cat-Ile 221) to either a valine or leucine, following the method described in Chapter 
2.2.1 (primers shown in Table 6.1).  In addition, the C-terminal anchor residue was 
removed from both the E2 and E2cat protein by the insertion of a premature stop codon 
before the final 5 amino acids (IIYEI); the stop codon (TGA) was inserted by site-directed 
mutagenesis using the primers shown in Table 6.1.  The presence of the correct mutations 
was determined by sequencing the E2 gene in pET28a and E2cat in pET24a, using the 
vector specific T7F and T7R primers by Source BioScience Plc (Oxford, U.K.). 
Original  5’GAGGATCCGAACGCTATAATCTACGAGATCTGACTC3’ 
Valine Forward 5’GAGGATCCGAACGCTATAGTCTACGAGATCTGACTC3’ 
Reverse  5’GAGTCAGATCTCGTAGACTATAGCGTTCGGATCCTC3’ 
Leucine Forward 5’GAGGATCCGAACGCTATACTCTACGAGATCTGACTC3’ 
Reverse  5’GAGTCAGATCTCGTAGAGTATAGCGTTCGGATCCTC3’ 
Truncation Forward 5’GAGGATCCGAACGCTTGAATAATCTACGAGATCTGAC3’ 
Reverse  5’GTCAGATCTCGTAGATTATTCAAGCGTTCGGATCCTC3’ 
 
Table 6.1 E2 and E2cat mutagenesis primers. Primers designed to mutate the E2/E2cat 
anchor residue isoleucine 397/221, or to truncate the sequence before isoleucine 
396/220. Stop codon sequence in red, Ile anchor residue in green, mutation in blue and 
early stop codon in purple. 
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6.2.3 Expression of the mutated and truncated E2 and E2 catalytic domain proteins  
The truncated E2 and E2cat proteins were expressed following the same method as the 
non-truncated E2 and E2cat proteins, described in Chapters 2.3.1 and 3.2.2, respectively.  
A range of different expression conditions were tried in order to express the 
conservatively mutated E2cat protein in a soluble form, including using Overnight 
Express™ Instant TB medium (Novagen, Merck, U.K.), and altering the temperature 
(between 20-37°C) and length of growth (between 4-20h) after induction in LB medium. 
 
6.2.4 Purification of the truncated E2 and E2 catalytic domain proteins  
The truncated E2 (E2-trunc) was purified by heat precipitation followed by nickel affinity 
chromatography (Chapter 2.3.3).  The truncated E2cat (E2cat-trunc) was purified by the 4 
step purification method established for the E2cat protein in Chapter 4.2.2: 10 min heat 
precipitation at 55°C, DNA precipitation by titration of the cell lysate with PEI, followed by 
anion exchange and gel filtration chromatography.  The E2-trunc was also purified by this 
method, instead of nickel affinity chromatography, when higher purity was required for 
structural studies. 
 
6.2.5 Determining the size and multimeric nature of the E2-trunc and E2cat-trunc 
proteins 
6.2.5.1 Purification and size determination by gel filtration 
The final purification step and size determination experiments were carried out as 
described in Chapter 2.3.3.3 using a Superdex 200, 10-300GL column equilibrated with 
50mM Tris-HCl, pH 8.8, and 100mM NaCl. 
6.2.5.2 Sedimentation equilibrium analytical ultracentrifugation analysis of the E2-trunc 
and E2cat-trunc proteins 
All experiments were performed and results analysed by Dr. Jacqui Marshall (University of 
Bristol) using an An60Ti rotor in a Beckman XL-A ultracentrifuge at 20°C, as described in 
Chapter 5.2.5.  The experiments were performed using the same buffer as the previous E2 




6.2.6 Determination of the structure of the truncated E2 catalytic domain  
6.2.6.1 Small-angle X-ray scattering 
The SAXS data were collected at the X33 beam-line, EMBL Hamburg Outstation, (DORIS-III 
storage ring at Deutsches Elektronen-Synchrotron (Roessle et al., 2007)) using an 
automatic sample changer (Round et al., 2008); the SAXS data were processed and 
analysed by Dr. Dmitri Svergun, Dr. Peter Konarev and Dr. Gundolf Schenk (EMBL, 
Hamburg, Germany) and Dr Jean van den Elsen (University of Bath, U.K.).  The results 
were analysed by the method described in Chapter 5.2.4. 
6.2.6.2 E2cat-trunc X-ray crystallography  
An Art Robbins Nano dispenser robot was used to set up the following 96 well condition 
screens: PGA-LM, Crystal Screen 1 and 2, Morpheus, PACT and JCSG (Molecular 
dimensions, Suffolk, U.K.); each of the 96 conditions had 3 sitting drops with a differing 
ratio of protein to well solution: 1:2, 1:1 and 2:1 protein (~10mg/ml) to well solution, 
totalling 300nl.  The plates were sealed with a plastic sheet and stored at 16°C.  The 
screens were checked every two days for two weeks, and then weekly for several months. 
The crystals were optimised following the method detailed in Chapter 5.2.3.2.  A crystal 
grown in 8% (w/v) polyethylene glycol (PEG) 4k (Fluka, Sigma-Aldrich), 3% (w/v) Poly-
glutamic acid (PGA-LM) (Molecular dimensions, U.K.), 0.1M Na cacodylate and pH 6.5 was 
soaked in the following cryoprotectant before being flash frozen: 8% (w/v) PEG 4k, 3% 
(w/v) PGA, 0.1M Na cacodylate, pH 6.5 and 30% glycerol.  The resultant crystal was used 
to collect X-ray diffraction data at the Diamond Light Source (Oxfordshire, U.K.) on an 
ADSC Q315 3x3 CCD detector on station I04 (at wavelength =0.9702 Å).  The data were 
collected and processed using the HKL2000 package by Dr Susan Crennell (University of 
Bath). 
The E2cat-trunc model was built and refined by Dr. Jean van den Elsen (University of 
Bath).  The E2cat and E2cat-trunc monomer crystal structures were compared using the 




6.3 Results and discussion 
6.3.1 Mutation of the E2cat anchor residue 
The putative E2cat anchor residue (E2cat-Ile 221) was mutated into a valine and a leucine 
by quick-change site-directed mutagenesis.  Recombinant expression of the 
E2cat (Val 221) and E2cat (Leu 221) resulted in insoluble protein in all conditions tried 
(Figure 6.2). 
 
Figure 6.2 SDS-PAGE of the soluble and insoluble cell lysate expressing the wild-type 
and mutated E2cat proteins.  Lane 1: standard protein markers, with their molecular 
weights (kDa).  Lanes 2 and 5 contain the soluble and insoluble non-mutated E2cat cell 
extract proteins.  Lanes 3 and 6, and 4 and 7, contain the soluble and insoluble 
E2cat (Ile 221 Val) and E2cat (Ile 221 Leu) cell lysate respectively.  
  


















6.3.2 Removal of the anchor residue by truncating the E2 and E2cat proteins 
The putative anchor residue (E2-Ile 397/ E2cat-Ile221) was removed by the insertion of a 
stop codon (TGA), before the final five C-terminal amino acids (IIYEI); the insertion of the 
stop codon was confirmed by sequencing.  The sequence of the E2 protein's N-terminal 
lipoyl domain and PSBD are unaffected by this truncation. 
 
6.3.3 Expression and purification of the truncated E2 and E2cat proteins 
6.3.3.1 Expression of the truncated E2 and E2cat proteins 
The E2-trunc was expressed solubly with an N-terminal his-tag from pET28a.  TheE2cat-
trunc protein was expressed in a partially soluble form without a his-tag from pET24a 
when the cells were induced with IPTG (Figure 6.3). 
 
Figure 6.3 SDS-PAGE comparing the soluble and insoluble cell lysate proteins when the 
E. coli cells containing the E2cat-trunc-pET24a vector were induced and not induced 
with IPTG.  Lane 1: standard protein markers, with their molecular weight values (kDa); 
lanes 2 and 3: Insoluble protein from induced and non-induced cell cultures respectively.  
Lanes 4 and 5: soluble protein from induced and non induced cell cultures. 
  














6.3.3.2 Nickel affinity chromatography purification of truncated E2 
The E2-trunc protein was purified to between 85 and 95% purity, by heat-precipitation, 
and nickel-affinity chromatography (Figure 6.4); although some of the E2-trunc protein 
eluted during the low concentration imidazole wash steps, the majority eluted in the first 
two His-elute buffer 1ml washes. 
 
Figure 6.4 SDS-PAGE of E2-trunc purification by nickel affinity chromatography.  
Lane 1: flow through protein that did not bind to the column; lanes 2: the his-bind buffer 
wash, lanes 3 and 4: the 5% and 10% (v/v) His-elute fractions, respectively; and lanes 5 to 
9: his elute wash collected in 5 separate 1ml fractions.  The standard protein markers are 
in lane M and are labelled with their molecular weight values.  
 
6.3.3.3 Anion exchange chromatography purification of the E2cat-trunc 
An example E2cat-trunc anion exchange chromatography trace is shown in Figure 6.5.  
Cell lysate was loaded onto the column in 50mM Tris-HCl, pH 8.8, in this buffer the E2cat-
trunc protein did not bind to the anion exchange column, but the majority of 
contaminating E. coli proteins did.  The flow through fractions (A3- A6 in Figure 6.6) were 














Figure 6.5 Anion exchange trace of the E2cat-trunc protein purifcation.  The A280 readings 
are shown in blue, the fraction numbers are shown along the x-axis, and the 
concentration of NaCl is shown in green, increasing from 0 to 1M. 
 
 
Figure 6.6 SDS-PAGE of anion exchange fractions.  The lanes are labelled by the fraction 
number corresponding to the fractions shown in Figure 6.4; the standard protein markers, 
with their molecular weight values (kDa) are shown in the lanes labelled M and the lane 
labelled L is the load fraction. 
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6.3.3.4 Gel filtration chromatography of the truncated E2 and E2cat 
Size exclusion gel filtration chromatography was used as a final purification step, and also 
used to determine the molecular weight of the E2-trunc and E2cat-trunc proteins (both in 
50mM Tris, pH 8.8, and 100mM NaCl). 
The E2-trunc protein eluted from the column in a single peak at 11.23 ml (Figure 6.7), this 
elution volume equates to an approximate molecular weight of 340 kDa, the equivalent to 
7 E2-trunc subunits. 
 
Figure 6.7 E2-trunc Gel filtration trace.  The A280 readings are shown in blue, and the 




Figure 6.8 SDS-PAGE of the E2-trunc gel filtrations fractions. The lanes are labelled with 
the fraction number corresponding to Figure 6.7 The lane labelled L contains the load 
sample and the lane labelled M contains broad range molecular weight markers along 
with their molecular weights (kDa). 
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The E2cat-trunc protein eluted from the gel filtration column at 15.25ml (Figure 6.9); the 
molecular weight of the protein in this peak was determined to be approximately 61 kDa, 
the equivalent to 2.45 E2cat-trunc monomers. 
 
Figure 6.9 E2cat-trunc gel filtration trace.  The A280 readings are shown in blue, and the 
fraction numbers are shown along the x-axis. 
 
 
Figure 6.10 SDS-PAGE of E2cat-trunc gel filtration fractions.  The lanes are labelled by 
fraction number corresponding to the fractions shown in Figure 6.9.  The lane labelled M 
contains the standard protein markers, with their molecular weight values (kDa) and the 
lane labelled L contains the proteins loaded onto the column 
 
The E2-trunc and E2cat-trunc proteins did not elute from the column in the void volume 
like the non-truncated versions of these proteins.  The E2-trunc gel filtration results imply 
that this protein assembles into a structure comprising 7 monomers; however, this is 
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unlikely to be an accurate molecular weight, as the flexible linker regions of the E2 protein 
extend out from the catalytic domain, creating a larger hydrodynamic radius than would 
be expected for a protein of equal molecular weight.  The E2cat-trunc data suggests that 
this protein is forming either dimers or trimers.  The conclusion drawn from the gel 
filtration data is that the truncation of the C-terminal 310 helix results in E2 and E2cat 
proteins that no longer form 42-mers. 
 
6.3.4 Sedimentation equilibrium analytical ultracentrifugation of the truncated E2 and 
E2cat proteins 
The E2-trunc and E2cat-trunc proteins do not appear to form 42-mers.  The molecular 
weights of these proteins determined by gel filtration are unlikely to be accurate, as this 
technique can be influenced by the shape of a protein.  Therefore, equilibrium analytical 
ultracentrifugation (AUC) was used to accurately determine the molecular weights of the 
two proteins and thus elucidate the multimeric nature.  These experiments were 
performed on E2-trunc and E2cat-trunc protein in 50mM Tris-HCl, pH 8.8, and 100mM 
NaCl, the same buffer as was used for the non-truncated E2 and E2cat protein AUC 
experiments. 
6.3.4.1 Determination of the molecular weight of the truncated E2 protein 
The molecular weight of the E2-trunc was determined at two speeds (7.5k and 9.5k 
r.p.m.) and at 3 protein concentrations (1.3, 0.8, 0.4mg/ml) (Table 6.2).  The samples were 
run on an SDS-PAGE after centrifugation to ensure proteolysis of the flexible linker regions 
had not occurred during the experiment (Figure 6.12).  
 
Table 6.2 Sedimentation equilibrium analytical ultracentrifugation results for the 
truncated E2 protein.  The molecular weight in kDa is shown for the three concentrations 
and two speeds along with the combined and global fits for all results. 
 
 Mw (kDa; data fitted to a single ideal species model) 
Channel A  Channel B Channel C  Global fit 
Protein concentration (mg/ml)  1.3 0.8 0.4  
7k r.p.m. 24 h 118.9 129.1 135.7 123.5 
9.5k r.p.m. 30 h 122.1 134.4 125.2 127.5 




6.11 Sedimentation equilibrium analytical ultracentrifugation of the E2-trunc protein. 
The blue dots are the A280 recorded with radial distance across the cell after 24 h at 7k 
r.p.m (B). The red line is the fitted model for a single ideal species with the residuals from 
fitting the data to this model shown above (A). 
 
 
Figure 6.12 SDS-PAGE of the E2 protein after centrifugation.  The lanes are labelled with 
the letter that refers to the channel labelled (Table 6.2).  The lane labelled M contains the 






















The E2-trunc protein molecular weight was determined by fitting the experimental data to 
a single ideal species model; channel C, the lowest concentration data, fitted the model 
well (Figure 6.11), and channel B fitted reasonably well.  The absorbance in channel A was 
above 1.5, this is above the linear absorbance range which can lead to the molecular 
weight being underestimated, and in fact in all cases the molecular weights calculated 
from channel A data were the lowest.  The molecular weight of the E2-trunc protein was 
calculated to be 127.2 (± 3.0) kDa, the equivalent of 2.8 (± 0.1) monomers.  This result 
strongly suggests that the E2-trunc protein assembles into trimers and that the molecular 
weight determined by gel filtration was artificially increased by the protein's flexible 
linkers. 
 
6.3.4.2 Determination of the molecular weight of the truncated E2 catalytic domain  
The data recorded for all three concentrations and speeds fit well to the single ideal 
species model (Figure 6.13), and therefore all results were used to determine the 
molecular weight of this protein.  The E2cat-trunc protein was calculated to have a 
molecular weight of 70.2 (± 3.2) kDa, which equates to 2.8 (± 0.1) E2cat-trunc monomers 
(Table 6.3). 
 Mw (kDa; data fitted to a single ideal species 
model) 
Channel A Channel B Channel C Global fit 
Protein concentration (mg/ml) 0.88 0.56 0.23  
12k r.p.m 34 h 77.4 71.2 71 75.1 
15k r.p.m 30 h 73.7 69.8 65.1 71.6 
18k r.p.m. 28 h 69.6 69.1 64.1 68.7 
Combination 71.8 69.5 64.6 70.2 
 
Table 6.3 Sedimentation equilibrium analytical ultracentrifugation results for the E2cat-
trunc protein.  The molecular weight in kDa is shown for the three concentrations and 





Figure 6.13 Sedimentation equilibrium analytical ultracentrifugation of the E2cat-trunc 
protein.  The blue dots are the A280 recorded with radial distance across the cell after 30 h 
at 15k r.p.m (B). The red line is the fitted model for a single ideal species with the 
residuals from fitting the data to this model shown above (A). 
 
The E2cat-trunc data are more reliable than the E2-trunc, as more of the concentration 
and speed data sets fitted well to the ideal species model.  The molecular weight and 
multimeric nature of the E2-trunc and E2cat-trunc assemblies, determined by analytical 
ultracentrifugation, are consistent with one another, indicating that the truncated E2 and 
E2cat both form trimers. 
 
6.3.5 Small-angle X-ray scattering of E2cat-trunc 
SAXS was used to determine a low-resolution structure of the E2cat-trunc protein in 
solution.  All experiments were performed on a pure sample of E2cat-trunc (5.8, 4.9, 4.3, 
4.0, 3.2, and 0.9 mg/ml) in 50mM Tris, pH 8.8, and 100mM NaCl, the same buffer as was 
used for the 42-mer E2cat SAXS and all analytical ultracentrifugation experiments.   
SAXS confirmed that the E2cat-trunc protein does not form a 42-mer; however, unlike the 
monodispered E2-trunc and E2cat-trunc trimers detected by analytical 







by SAXS.  A trimer from the non-truncated E2cat 42-mer has been modelled into part of 
the SAXS ab initio bead model (Figure 6.14); the E2cat trimer fits well into this part of the 
model, and the similarities in size and shape indicate that the E2cat and E2cat-trunc 
trimers have the same overall structure.  Whilst the majority of the E2cat-trunc forms 
trimers, 20% is hexameric, which may be the result of two trimers interacting with one 
another.  A second trimer cannot be fitted with any certainty into the elongated part of 
the SAXS model, indicating that this trimer may not have a fixed position relative to the 
first. 
 
Figure 6.14 Low resolution ab initio bead model of the truncated E2cat protein.  A 
ribbon diagram of a trimer (red) derived from the Tp. acidophilum E2cat 42-mer has been 
superimposed over the SAXS ab initio bead model (cyan). 
 
The SAXS and AUC experiments were performed on pure E2cat-trunc protein in the same 
buffer conditions; however, higher protein concentrations were used for the SAXS 
experiments (5.8 - 0.9 mg/ml) compared to the AUC experiments (1.3 - 0.6 mg/ml).  The 
difference in protein concentrations may be the reason why a small proportion of 
hexamers were detected by SAXS and not AUC.  It is not feasible to repeat both sets of 
experiments using the same concentration range, due to the limitations of each detection 
method; that is, the AUC centrifuge spectrophotometer is only capable of measuring 
absorbance <1.2, whereas SAXS requires higher protein concentration as scattering is 




6.3.6 Truncated E2 catalytic domain crystal trials 
Truncating the C-terminus of the E2cat and removing the putative Ile anchor residue 
produces a polypeptide that assembles into trimers but not a 42-mer.  A 42-mer E2cat 
trimer can be superimposed over the E2cat-trunc SAXS ab initio bead model; this indicates 
that the inability of the E2cat-trunc trimers to form a 42-mer, is not due to a large change 
in the overall structure of the E2cat trimer.  Two possible explanations why the truncated 
E2 trimers no longer interact are: 
1. Shortening the C-terminal helix may disrupt the tertiary structure of the trimer at 
the trimer interface. 
2.  The trimer structure may be completely unaffected, but without the essential 
anchor residue they are unable to interact. 
X-ray crystallography has been used to determine the structure of the E2cat-trunc 
protein, with the aim of elucidating the reason why the truncated trimers do not interact 
with one another.  A secondary aim was to obtain a high-resolution crystal structure of 
the E2cat trimer, in order to improve the current 4 Å 42-mer model; the E2cat-trunc 
trimer is smaller (75 kDa) than the 42-mer and therefore may crystallise in a more 
compact lattice.   
6.3.6.1 Initial 96 well plate crystal screen  
The PGA-LM screen (Molecular dimensions, Suffolk, U.K.) resulted in E2cat-trunc crystals 
in several related conditions containing 5% (w/v) PGA-LM, 0.1M Na cacodylate, pH 6.5, 
and various molecular weight polyethylene glycols including PEG 400, 550 MME, 2k MME, 
4k, 8k and 20k; an example of the crystals that grew in these conditions are shown in 
Figure 6.15. 
 
Figure 6.15 E2cat-trunc crystals in 
the PGA-LM 96 well crystal screen 
condition. The 9mg/ml E2cat-trunc 
protein was mixed with well solution 
containing 0.1M Na cacodylate, 
pH 6.5, 5% (w/v) PGA-LM, and 15% 




6.3.6.2 E2cat-trunc crystal optimisation 
The conditions identified from the PGA-LM screen were reproduced in 24-well hanging-
drop trays, and the following components were optimised: storage temperature, PEG 
molecular weight, the concentration of: PGA, PEG, and protein, and buffer pH.  Figure 
6.16 shows an example of the crystal morphologies that grew in the optimised condition 
(8% (w/v) PEG 4k, 3% (w/v) PGA, and 0.1M Na cacodylate, pH 6.5). 
 
Figure 6.16 Example of the E2cat-trunc crystals.  The crystals grew in 8% (w/v) PEG 4k, 3% 
(w/v) PGA, and 0.1M Na cacodylate, pH 6.5, at 16°C. 
 
6.3.7 The structure of the truncated Tp. acidophilum E2 catalytic domain 
6.3.7.1 X-ray diffraction data collection  
Diffraction to 4.1 Å was achieved at the Diamond Light Source (Oxfordshire) with E2cat-
trunc crystals (8% (w/v) PEG 4k, 3% (w/v) PGA-LM, and 0.1M Na cacodylate, pH 6.5) that 
were soaked for 20 s in cryoprotectant (8% (w/v) PEG 4k, 3% (w/v) PGA-LM, 0.1M 
Na cacodylate, pH 6.5, plus an additional 30% (v/v) glycerol) before being flash frozen.  All 
attempts to improve diffraction resolution by optimising the crystals, freezing conditions 
and data collections at room temperature, were unsuccessful the crystals either 
diffracting poorly or showing high levels of mosaicity. 
6.3.7.2 Model building and refinement 
The structure of the Tp. acidophilum E2cat-trunc protein was determined to a resolution 
of 4.1Å by molecular replacement using a monomer from the Tp. acidophilum E2cat 




The asymmetric unit of the E2cat-trunc contains 6 monomers arranged as 2 adjacent 
trimers (Figure 6.17); the two trimers are, however, in different orientations relative to 
each other compared to the non-truncated 42-mer E2cat trimers.  The polypeptide 
backbone of the two trimers model was refined to give a final Rwork of 21.5% and Rfree of 
28.4%. 
Space Group P32 2 1 
Cell parameters  a=b, c  107.2Å, 238.6 Å 
α=β, γ  90°, 120° 
Resolution (Å) (last shell)   4.1 (4.17-4.10) 
Number of observations 12274 
Number of unique reflections 12902 
Completeness (last shell) 99.2% (97.4) 
R merge (%)(last shell) 0.122 (0.551) 
Average I/σI (last shell) 13.06 (2.48) 
Redundancy 5.3 (5.1) 
 
Table 6.4 X-ray data collection statistics from the E2cat-trunc crystal  
 
 
Resolution range  92.80- 4.10 Å 
Number of protein atoms  10296 
Number of solvent atoms None 
Average B value  74.61 Å2 
R-crystal  21.5% 
R-free  28.4% 
Rms deviations 
 
Bonds  0.01Å 
Angles  1.63° 
 






Figure 6.17 Crystal structure of the truncated E2cat protein to 4.1Å.  Images A and B 
show a ribbon diagram of the polypeptide backbone structure and space filling 
model/surface representation, respectively, of the two trimers contained within the 
asymmetric unit.  The image is orientated looking down the three-fold axis of symmetry of 














6.3.8 Analysis of the truncated E2cat crystal structure and comparisons with the 42-mer 
structure.  
6.3.8.1 Comparison of the trimer structure of the truncated and non-truncated E2cat 
The removal of the putative Ile anchor residue, by truncating the C-terminal 310 helix, 
does not affect the overall structure of either the E2 monomer or trimer (Figure 6.18).  
Monomer A from the trimeric E2cat-trunc and from the E2cat 42-mer have a Cα RMSD 
value of 0.86Å (214/219 residues); furthermore, two intra-trimer monomers (monomer A 
and B) taken from an E2cat-trunc trimer, and E2cat trimer have a Cα RMSD value of 0.71Å 
(214/219) and 0.77Å (217/222), respectively.  The E2cat and E2cat-trunc trimers appear to 
be essentially identical; truncating the C-terminal helix does not change the tertiary 
structure of the protein.  Therefore, it can be concluded that the C-terminal anchor 
residue is crucial in the formation of the inter-trimer interactions. 
 
Figure 6.18 E2-trunc trimer superimposed over an E2 trimer from the 42-mer crystal 
structure.  The E2-trunc trimer structure is shown in blue and the 42-mer trimer is shown 




6.3.8.2 Orientation of the two trimers within the asymmetric unit 
The asymmetric unit of the E2cat-trunc crystal structure contains two trimers, but these 
are orientated differently relative to each other, compared to the position of two 42-mer 
E2cat trimers (Figure 6.19).  The C-terminal anchor residue appears to be crucial in the 
formation of the 42-mer trimer-trimer interactions; without this region, the trimers do 





Figure 6.19 The relative orientations of two trimers in the 42mer E2cat structure (A), 
and the trimeric E2cat-trunc (B).  Space filling diagrams of two E2cat trimers shown in 














The E2 anchor residue has been predicted to play a key role in the formation of trimer-
trimer interactions.  Two possible Tp. acidophilum E2 anchor residues were identified by 
sequence alignments with other E2 sequences with known structures, they were E2-
Ile 396 and E2-Ile 397; based on the Tp. acidophilum E2cat structure, Ile 397 would seem 
the more likely candidate, however this has not been unequivocally confirmed. 
The conservative mutation of the E2cat Ile 397, to a valine or a leucine, resulted in 
insoluble protein; whereas, removal of both isoleucines, by the insertion of a premature 
stop codon before the final 5 C-terminal residues (IIYEI), resulted in soluble recombinant 
E2 and E2cat proteins.  The molecular weights of the E2-trunc and E2cat-trunc protein 
determined by equilibrium analytical ultracentrifugation (AUC) equated to a trimeric 
assembly, rather than a 42-mer.  Unlike the monodisperse E2cat-trunc assembly seen by 
AUC a mixture of trimers (80%) and hexamers (20%) were seen by small-angle X-ray 
scattering (SAXS).  The variation between the two methods could be explained by 
different protein concentrations: SAXS requires a much higher concentration than AUC, 
and therefore any weak interactions that result in trimer-dimers are only seen at the high 
protein concentrations used in the SAXS experiments. 
The structure of the E2cat-trunc trimer was determined by X-ray crystallography to 4.1 Å 
resolution.  The structure of the trimeric E2cat-trunc trimer and the 42-mer E2cat trimer 
are the same; removing the C-terminal anchor residue has no effect on the structure of 
the trimer, but it completely disrupts the 42-mer trimer-trimer interactions.  The results 
discussed in this chapter are consistent with work by Peng et al. (2012) on the 
dodecahedral G. stearothermophilus E2; in this case, the whole C-terminal helix 
(DPELLLMEA) was removed, resulting in a trimeric E2 catalytic domain protein. 
The C-terminal anchor residue region has been shown to be crucial in the formation of a 
42-mer; the angle at which the trimers interact with one another may be influenced by 
how the anchor residue fits into the hydrophobic pocket on the adjacent trimer.  As site-
directed mutagenesis of the putative anchor residue was unsuccessful, in that the protein 
was expressed in an insoluble form, the hydrophobic pocket residues could be mutated to 
investigate how the anchor residue interactions affect the angle at which the trimers 
interact.  Further experiments are also needed to confirm if E2-Ile 397 rather than Ile 396 
is the Tp. acidophilum E2 anchor residue.  
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Chapter 7: Characterisation of the trimeric E2 and OADHC 
7.1 Introduction 
A trimeric version of the Thermoplasma acidophilum E2 catalytic domain, and full length 
E2, along with its N-terminal PSBD and lipoyl domain, have been produced by removing 
the inter-trimer anchor residue, a C-terminal Ile that extends from one trimer into a 
hydrophobic pocket on the adjacent trimer and vice versa.  The removal of this key 
residue, by truncating the C-terminus of the catalytic domain, prevents the E2 trimers 
associating into a 42-mer.  There are three acyltransferase active sites per trimer, situated 
in a tunnel at each of the monomer-monomer interfaces; the key active site residues are 
provided by both monomers: one monomer provides a His and an Asp, and the other a 
Thr (Figure 7.1). 
 
Figure 7.1 Crystal structure of the trimeric E2 catalytic domain.  The three monomers are 
coloured in three shades of blue, and the active site residues (Thr, His, and Asp) are 
highlighted in red.  There are three active sites per trimer, with one monomer 
contributing the His and Asp and a second monomer contributing a Thr. 
 
The structure of the trimeric E2cat, determined in Chapter 6, superimposes over the 42-
mer E2cat trimer, this suggests that removing the E2cat's C-terminal anchor residue does 
not alter the structure of the trimer, only its ability to interact with other trimers and 
assemble into a 42-mer.  If the structure of the trimer remains identical, then it can be 
hypothesised that it may retain acyltransferase activity.  The N-terminal region remains 
unaltered by this mutation, and therefore the full-length E2 has the PSBD and lipoyl 
domain required for OADHC assembly and activity.  The aim of this chapter was to 
characterise the trimeric Tp. acidophilum E2cat and the trimeric full-length E2, and to 




7.2.1 Expression and purification of truncated E2 and E2 catalytic domain proteins  
The truncated E2cat (E2cat-trunc) was expressed as described in Chapter 2.3.1.  The 
truncated E2 (E2-trunc) was expressed and lipoylated as described in Chapter 3.2.2. 
The E2-trunc was purified by the method described in Chapter 2.3.3, and resulted in 
protein that was approximately 90% pure.  The E2cat-trunc protein was purified by the 4-
step purification method established for the purification of the E2cat protein in Chapter 
4.2.2; this method was also used when the E2-trunc protein was required to be >95% pure 
and in a buffer not containing imidazole. 
 
7.2.2 E2 dihydrolipoamide transacetylase assay  
The E2 assay is described in Chapter 2.5.2.  Unless otherwise stated, the non-lipoylated 
E2-trunc was utilised for all E2 activity assays, rather than the lipoylated form of the 
enzyme, as previous results suggest that the enzyme-bound lipoic acid competes with the 
exogenous DHlip (Chapter 3.3.2.2). 
 
7.2.3 Assembly and OADHC activity of a trimeric complex  
7.2.3.1 Expression and purification of the E1 and E3 enzyme 
The E1 and E3 enzymes were expressed as described in Chapter 2.3.1 and purified 
following the method in Chapter 2.3.3.  The E1, E2-trunc, and E3 enzymes were dialysed 
overnight, at 4°C, into 50mM Tris, pH 8.5, 100mM NaCl and 50mM imidazole. 
 
7.2.3.2 2-oxoacid dehydrogenase complex assembly and activity assay  
The OADHC assays were performed as described in Chapter 2.5.4.  The concentrations of 
the purified enzymes were determined by measuring the absorbance at 280nm or using 
the Bradford assay, depending on the purity of the enzyme (Chapter 2.4).  The protein 
concentration was then converted to a molar concentration of the active protein units: 
E1α2β2, E2α, and E3α2, using the molar absorbance coefficient predicted from the protein 
sequences (Gasteiger et al., 2003).  The required molar ratio of E1α2β2, E2α, and E3α2 
were mixed in assay buffer in the cuvette (50mM potassium phosphate pH7.0, 2.5mM 
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NAD+, 1mM MgCl2, and 0.2mM TPP) and incubated at 55°C for 10 min before the reaction 
was started with the addition of 0.13mM CoA, 2.6mM cysteine/HCl and the 2-oxoacid 
substrate (e.g. 2mM 3-methyl-2-oxopentanoic acid). 
The Km and Vmax values of the E2 or E2-trunc OADHC with respect to 3-methyl-2-
oxopentanoic acid were determined under comparable conditions by mixing the 
E1α2β2:E2α:E3α2 in a stoichiometry of 1:1:0.5. 
 
7.2.3.3 Gel filtration of the assembled trimeric OADHC 
The E1α2β2, E2α-trunc, and E3α2 were mixed in a ratio of 1:1:1 and heated at 55°C for 10 
min without dilution; any precipitate was removed by centrifugation at 16 000 x g and 
filtration through a 0.45μm filter.  The soluble OADHC sample was then loaded onto a 
Superdex 200, 10-300GL (GE Healthcare) column equilibrated with 25mM Tris-HCl, pH 8.5, 
100mM NaCl and 25mM imidazole.  The column eluent was collected in 0.5ml fractions; 
E1, E3 and OADHC activities were measured for each fraction, along with the 
determination of the protein concentration by the Bradford assay (Chapter 2.4.1). 
 
7.2.4 Characterisation of the temperature optima and thermal inactivation profiles of 
the truncated E2 and OADHC 
7.2.4.1 Thermal inactivation assays 
The thermal inactivation assays were performed as described in Chapter 3.2.6.  The 
E2-trunc was incubated in 50mM Tris-HCl, pH 8.8, and 100mM NaCl, and the E2cat-trunc 
was incubated in 50mM Tris-HCl, pH8.8.  The OADHC components were mixed in the 
required stoichiometry to produce a stock solution; all aliquots to be heated were taken 
from this solution to ensure a constant stoichiometry. 
7.2.4.2 Temperature optima 
The temperature optima assays were performed as described in Chapter 3.2.7.  A stock of 
assembled OADHC was made by mixing the component enzymes in a stoichiometry of 
1:1:0.5 (E1α2β2:E2:E3α2) and incubated in complex assay buffer at 55°C for 10 min, the 
OADHC stock was then cooled on ice and stored at 4°C.  The reactions were started with 
the addition of enzyme rather than substrate.  
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7.3 Results and discussion 
7.3.1 Characterisation of the truncated E2 and E2cat dihydrolipoamide transacetylase 
activity  
7.3.1.1 The dihydrolipoamide transacetylase activity of the E2-trunc and E2cat-trunc 
proteins 
The enzymatic activities of the truncated E2 and E2cat were compared to that of the non-
truncated versions, to determine if the truncation and prevention of 42-mer assembly 
influenced the enzymes’ catalytic ability.  The recorded specific activities (Table 6.1) show 
that both the E2-trunc and E2cat-trunc are capable of catalysing the acyltransferase 
reaction, albeit at reduced rate; compared to the non-truncated versions, the specific 
activity of the E2-trunc had been reduced to 78% and the E2cat-trunc to 36%.  Thus, 
truncating the E2 and preventing assembly does not abolish activity but does reduce the 
enzymes’ efficiency. 
Enzyme Specific activity (U/mg) kcat (min
-1) 
E2 1.06 ± 0.05 48.9 ±2.3 
E2-trunc 0.83± 0.01 37.8 ± 0.2 
E2cat 1.63 ±0.13 42.8 ± 3.4 
E2cat-trunc 0.58 ± 0.08 14.5 ± 2.0 
 
Table 7.1 Specific activity and kcat values for the truncated and non-truncated E2 and 
E2cat.  The specific activity is shown in U/mg of E2, where 1 Unit is described as the 
conversion of 1 μmol of acetyl-CoA to 1 μmol of acetyl-dihydrolipoamide per minute. 
 
7.3.1.2 Thermal inactivation of the truncated E2 catalytic domain  
The thermostability of the truncated proteins can be measured as both the E2-trunc and 
E2cat-trunc are catalytically active.  The thermostability assays of the truncated and the 
non-truncated 42-mer E2 and E2cat proteins (Chapters 3.3.2 and 4.3.5) were conducted 
under the same conditions; therefore, the half-lives can be directly compared to 
determine if preventing the trimers associating into a 42-mer affects the proteins’ 





Figure 7.2 Thermal inactivation profile of the truncated E2.  The truncated E2 protein 
was incubated in 50mM Tris-HCl, pH 8.8, 100mM NaCl 
 
 
Figure 7.3 Thermal inactivation profile of the truncated E2cat.  The truncated E2cat 



















































Figure 7.4 Bar chart comparing the half-lives of the trimeric E2-trunc, and E2cat-trunc 
with the non-truncated42-mer E2 and E2cat 
 
The trimeric E2cat-trunc is significantly less thermostable than the non-truncated 42-mer 
E2cat; the E2cat has a half-life of 215 min at 99°C, whereas, the E2cat-trunc has a half-life 
of just 3 min at 95°C (Figure 7.4).  There is less of a difference between the 
thermostability of the E2 trimer and 42-mer; at 85°C both versions have a similar half-life 
of 56 and 39 min, respectively (Figure 7.4).  This data set implies that the trimeric E2-trunc 
is slightly more thermostable than the 42-mer E2; however, further replicates of these 
results would be required to determine if there is a statistically significant difference 
between the thermostabilities. 
Truncating the E2cat protein reduces its thermostability to a greater extent than 
truncating the E2 protein.  Interestingly, the presence or absence of the flexible linker 
regions has more of an effect on the thermostability of the E2, than preventing the 
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7.3.2 Truncated E2 and OADHC activity 
The trimeric E2 is capable of catalysing the dihydrolipoamide acyltransferase reaction, 
albeit at a reduced rate compared to the fully-assembled 42-mer E2.  The removal of the 
C-terminal anchor residue is unlikely to influence the peripheral subunit binding domain 
or lipoyl domain; therefore, the E2-trunc should be capable of binding the E1 and E3 
enzymes, and forming an OADHC. 
7.3.2.1 Trimeric and functional OADHC detection 
The specific activity values shown in Table 7.2 demonstrate that when lipoylated E2-trunc 
is mixed with E1 and E3, it is capable of catalysing the OADHC reaction.  The order of 
substrate preference is the same as the pattern seen for the E1 (Chapter 3.3.1.3), with the 
highest activity seen with 3-methyl-2-oxopentanoic acid, low activity with pyruvate and 
no activity with 2-oxoglutarate. 
 Specific activity 
Substrate U/mg complex U/mg E2 
3-methyl-2-oxopentanoic acid 0.013 ± 0.001 0.068 ± 0.003 
4-methyl-2-oxopentanoic acid 0.010 ± 0.001 0.050 ± 0.005 
Pyruvate 0.006 ± 0.002 0.030 ± 0.009 
 
Table 7.2 Specific activity of the trimeric OADHC with a variety of 2-oxoacid substrates.  
The components were mixed in a stoichiometry of 1:1:0.5 (E1α2β2:E2α:E3α2) and assayed 
with 1mM 2-oxoacid.  The specific activity is shown in U/mg of E2 and U/mg of complex, 
where 1 Unit is described as the conversion of 1 μmol NAD+ to NADH per minute. 
 
7.3.2.2 Comparison of kinetic parameters of the trimer and 42-mer complexes 
The Km and Vmax values were determined under comparable conditions for the 42-mer and 
trimeric OADHCs; the component enzymes were mixed in a stoichiometry of 1:1:0.5 
(E1α2β2:E2α:E3α2) (Table 7.3 and Figures 7.5-7.8). 
Complex 
structure 
Km Vmax Vmax/Km 
mM U/mg Complex U/mg of E2 U/mg of E2 / mM 
42-mer 0.306 ± 0.011 0.173 ± 0.002 0.922 ± 0.009 3.02 ± 0.11 
Trimer 0.122 ± 0.002 0.080 ± 0.001 0.430 ± 0.002 3.51 ±0.07 
 
Table 7.3 Comparison of the Km and Vmax values for the trimeric complex (E2-trunc) and 
the 42-mer complex (non-truncated E2) when utilising 3-methyl-2-oxopentaonic acid.  
The component enzymes were mixed in the cuvette in a stoichiometry of 1:1:0.5 
(E1α2β2:E2α:E3α2). The specific activity is shown in U/mg of E2 and U/mg of complex, 




The Vmax and Km values determined for the trimeric OADHC are 54% and 60% lower than 
that of the 42-mer OADHC, respectively.  The Vmax/Km values for the two complexes are 
similar, therefore implying, but not explicitly stating, that the catalytic efficiencies of the 
two complexes are similar (Eisenthal et al., 2007).  From these experiments it is not 
known why the kinetic parameters of the 42-mer and trimeric complexes are different.  
The E1 enzyme is usually the rate limiting step in the OADHC catalysed reaction.  
Therefore, the Vmax and Km of the complex will depend upon the amount of E1 bound to 
the E2; preventing the trimers from assembling into a 42-mer may influence the amount 




Figure 7.5 Michaelis-Menten plot of 42-mer OADHC activity with 3-methyl-2-




Figure 7.6 Hanes-Woolf plot of 42-mer OADHC activity with 3-methyl-2-oxopentanoic 




Figure 7.7 Michaelis-Menten plot of trimeric OADHC activity with 3-methyl-2-





Figure 7.8 Hanes-Woolf plot of trimeric OADHC activity with 3-methyl-2-oxopentanoic 




7.3.3 Assembly of the trimeric OADHC 
7.3.3.1 Stoichiometry of the trimeric E2 complex 
The OADHC activity was measured with different stoichiometries of E1 and E3, in order to 
determine if varying the ratio of the E1 and E3 to the trimeric and 42-mer E2 cores affects 
OADHC activity in a similar pattern.  Optimal activity for the trimeric OADHC was achieved 
with the stoichiometry of 1:1:1 (E1α2β2:E2-truncα:E3α2) (Figure 7.9), compared to the 
optimal stoichiometry for the 42-mer OADHC of 1.75:1:0.5 (E1α2β2:E2α:E3α2) 
(Chapter3.3.5).   
Figure 7.9 Specific activity of the trimeric complex as a function of the ratios of E1 and 
E3 to E2.  The ratio of E1α2β2 and E3α2 were varied independently with respect to the 
concentration of E2α.  The E1:E2 ratio was fixed at 1:1 when the amount of E3 was varied, 


































Figures 7.10 and 7.11 compare the relative OADHC activities when the ratios of E1 and E3 
were varied with respect to 42-mer E2 and trimeric E2-trunc. 
 
Figure 7.10 A comparison of the effect of changing the E1:E2 stoichiometry on the 
OADHC activity of the 42-mer and trimeric complexes. The amount of E1α2β2 was varied 
with respected to the amount of 42-mer E2 or the trimeric E2-trunc; the ratio of 42-mer 
E2α: E3α2 was fixed at 1:1, and the ratio of trimeric E2-trunc:E3α2 was fixed at 1:0.5 
 
The ratio of the 42-mer E2:E3 was fixed at 1:1, whereas the trimeric E2-trunc:E3 ratio was 
fixed at 1:0.5.  There appears to be less competition for E1 to bind to the E2-trunc PSBD 
from E3, than in the non-truncated E2 experiments; this variation may explain why 






















Figure 7.11 A comparison of the effect of changing the stoichiometry of E3:E2 on the 
OADHC activity of the 42-mer and trimeric complexes. The amount of E3 was varied with 
respect to 42-mer E2 and trimeric E2-trunc; the ratio of E1α2β2:E2/E2-trunc was fixed at 
1:1. 
 
To achieve optimal activity, a higher ratio of E3:E2 was required for the trimeric complex 
than for the 42-mer complex.  In the case of the 42-mer OADHC, optimal activity was 
achieved with an excess of E1:E3.  The E1 enzyme is probably the rate limiting step in the 
reaction catalysed by the 42-mer OADHC, which may be capable of channelling acyl 
groups around the complex faster than the E1 can catalyse the decarboxylation reaction 
(Danson et al., 1978).  The reduction in the number of E3 enzymes per complex does not 
compromise overall activity, as the E3 enzyme is the fastest of the three component 
enzymes, and therefore is capable of regenerating the lipoic moiety as quickly as the E1 
acylates it.  The trimeric OADHC requires a higher ratio of E3:E1 than the 42-mer complex; 
this complex is most likely not capable of channelling substrates between trimers, and so 
consequently each trimer must have at least one E1 and one E3 bound.  The E3 binds less 
tightly to the PSBD than the E1 (gel filtration experiments in Figures 7.13 and 7.14); 
therefore, a greater concentration of E3 is required to displace an E1 and occupy at least 






















7.3.3.2 Gel filtration of the trimeric complex  
Size exclusion gel filtration chromatography was performed to examine the stability of the 
assembled trimeric complex.  The purified complex components in 25mM Tris-HCl, pH 8.5, 
100mM NaCl, and 25mM imidazole were mixed in a molar stoichiometry of 1:1:1 
(E1α2β2:E2:E3α2) and incubated at 55°C for 10 min to allow assembly.  The gel filtration 
column was equilibrated with 25mM Tris-HCl, pH8.5, 100mM NaCl, and 25mM imidazole.  
 
Figure 7.12 Gel filtration trace of the trimeric OADHC.  The A280 readings are shown in 
blue, and the fraction numbers are shown along the X-axis in red.  
 
 
Figure 7.13 SDS-PAGE of the gel filtration fractions.  The lanes are labelled with the 
fraction number corresponding to the trace shown in Figure 7.12.  The standard protein 
markers are shown with their molecule weights (kDa) in the lane labelled M. 
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Figure 7.14 A bar chart illustrating the specific activities of the E1, E3, and OADHC in 
each gel filtration fraction.  The specific activities are shown as U/mg of total protein 
where 1Unit is equivalent to 1μmol of product per min. 
 
The two peaks shown in Figure 7.12 correspond to protein assemblies with an 
approximate molecular weight of 920 kDa and 88 kDa.  The E2-trunc alone eluted from 
the gel filtration after 11.2ml, the approximate molecular weight of this protein peak is 
340 kDa (Figure 6.9).  When the E2-trunc was mixed with E1 and E3 there is no longer a 
peak at 11.2ml; instead the E2-trunc eluted after 8.95ml, a peak that contained branched-
chain OADHC activity.  This indicates that all the E2 trimers have bound E1 and E3 
enzymes producing a trimeric OADHC (Figure 7.14).  The second peak, which eluted 
between 13 and 15.5ml, contained the unbound E1α2β2 and E3α2.  More of the E1 than 
the E3 enzyme remains bound to the E2, this is the same pattern as was seen for the 42-
mer complex, again suggesting that the E3 binds less tightly to the E2 than the E1 
(Chapter 3.3.5). 
It is difficult to predict the stoichiometries of the E1:E2:E3 from the SDS-PAGE, as the E2 
and E3 monomers have similar molecular weights; however, it can be concluded that 
under these conditions the E2-trunc binds more E1 than E3.  This gel filtration result 
cannot be directly compared with the gel filtration of the 42-mer complex as the previous 
experiment was carried out in a different buffer due to the stability of the E2-trunc 
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The specific activity of the trimeric OADHC is higher after gel filtration (fractions 11 and 
12) as the excess unbound and thus non-functional E1 and E3 has been removed.  The 
specific activity seen in this experiment is higher than the values previously achieved; this 
may be due to the assembly conditions in that the complex components were at a much 
higher concentration than that used for the preceding experiments and therefore more 
functional OADHC is likely to form. 
 
7.3.4 Thermostability and temperature optimum of the trimeric OADHC 
7.3.4.1 Temperature optimum of the trimeric OADHC 
The temperature optima (Topt) of the trimeric OADHC (E2-trunc) and the 42-mer OADHC 
(E2) (Chapter 3.3.4) are both 65°C (Figure 7.15).  Preventing the trimers from assembling 
into a 42-mer has no affect on the thermoactivity of the OADHC. 
 
Figure 7.15 Temperature optima of the trimeric and 42-mer OADHC.  The trimeric 
complex is composed of E1α2β2:E2-trunc:E3α2 in stoichiometry of 1:1:0.5 and the 42-mer 
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7.3.4.2 Thermal inactivation of the trimeric OADHC 
The trimeric OADHC was assembled in a stoichiometry of 1:1:0.5 (E1α2β2:E2-trunc:E3α2).  
There is very little difference between the thermostability of the non-truncated 42-mer E2 
and the truncated trimeric E2 (Figure 7.4); however, the trimeric OADHC appears to be 
less thermostable than the 42-mer OADHC (Figure 7.17).  The stoichiometry of the 42-mer 
complex was 3:1:0.5 (E1:E2:E3), whereas 1:1:0.5 was used for the trimeric complex; the 
affect that the stoichiometry of the OADHC has on thermostability is not known, and 
therefore the difference in stability between the two complexes may be due to the 
stoichiometry.  The decrease in stability of the trimeric complex compared to the 42-mer 
may also be influenced by a change in interactions between the E2-trunc and the E1/E3 
enzymes, or the binding of these enzymes to the E2 trimer may affect the strength of the 
interaction between the E2-trunc trimers.  Any changes to the E2 stability could be 
investigated by repeating the E2-trunc thermal inactivation assays in the presence and 
absence of the E1 and/or E3 enzymes. 
 
Figure 7.16 Thermal inactivation profile of the trimeric OADHC.  The non-heated samples 
at time zero were taken to be 100% active.  The (E1α2β2:E2-trunc:E3α2) were mixed in a 

























Figure 7.17 Bar chart comparing the half-lives of the trimeric and wild type 42mer 
OADHCs.  The trimeric and 42-mer complexes were formed by mixing the following 
stoichiometries: trimeric complex (E1α2β2:E2-trunc:E3α2) 1:1:0.5, and the 42-mer complex 




























The removal of the C-terminal anchor residue of the E2 protein does not alter the trimer 
structure, only its ability to form inter-trimer interactions.  The trimeric E2-trunc and 
E2cat-trunc are capable of catalysing the dihydrolipoamide-dependent transacylase 
reaction, albeit at a reduced rate compared to the 42-mer E2.  The trimeric E2 is also 
capable of binding E1 and E3, producing a functional trimeric OADHC; optimal activity was 
achieved when mixing the E1:E2-trunc:E3 enzymes in a stoichiometry of 1:1:1. 
It would appear that it is not essential for the Tp. acidophilum branched-chain OADHC to 
assemble into a large 42-mer, but that assembly does increase the Vmax of the complex.  
The Tp. acidophilum trimeric branched-chain OADHC is currently the only example of a 
functional trimeric OADHC.  Removal of the final C-terminal five residues (LLLDL) from the 
porcine E2, prevented 24-mer assembly but also abolished all E2 activity (Koike et al., 
2000); although a trimeric G. stearothermophilus E2 has been reported (Peng et al., 2012), 
the effects on E2 and OADHC activity have not, to date, been published. 
Direct comparisons between the trimeric and 42-mer OADHCs have been limited in this 
chapter due to variations in the experimental conditions used.  Preferably all experiments 
would be performed in identical conditions utilising the same E1 and E3 preparations, so 
that any changes to the activity and stability are due only to the 42-mer and trimer 




Chapter 8: The role of the 2-oxoacid dehydrogenase multienzyme 
complexes in Tp. acidophilum and other Archaeal OADHCs 
8.1 Introduction 
8.1.1 The role of the Thermoplasma acidophilum branched-chain OADHC  
It was previously thought, that all archaea utilise ferredoxin oxidoreductases to catalyse 
the conversion of the various 2-oxoacids to their corresponding acyl-CoAs; however, 
genome sequencing has identified the putative genes encoding the proteins required to 
produce a fully-assembled and functional OADHC in numerous species of aerobic archaea.  
The Tp. acidophilum OADHC genes have been recombinantly expressed and the 
component enzymes assembled, resulting in a functional branched-chain OADHC (Heath 
et al., 2007).  Dihydrolipoamide dehydrogenase (E3) activity has been detected in 
Tp. acidophilum cell lysates (Smith et al., 1987), but OADHC activity has not been 
detected.  One of the aims of this chapter was to investigate a possible role of the 
Tp. acidophilum branched-chain OADHC within central metabolism; a genome search was 
performed in order identify genes encoding putative enzymes involved in the metabolism 
of branched-chain amino acids, details of this pathway can be found in Chapter 1.2.3 
(Figure 1.4).  The Tp. acidophilum OADHC has activity with both the branched-chain 2-
oxoacids and pyruvate; as yet, it is unclear which substrate is the physiological substrate 
and under what conditions the OADHC replaces or complements the corresponding 
ferredoxin oxidoreductase enzyme. 
 
8.1.2 The putative Sulfolobus solfataricus OADHC 
The second aim of this chapter was to recombinantly express a hyper-thermostable 
OADHC from S. solfataricus, a hyper-thermophilic Crenarchaeota that grows at 
temperatures up to 85°C and between pH 2-3 (Brock et al., 1972).  The E1 enzyme from 
this putative OADHC has been recombinantly expressed and been shown to possess a 
substrate specificity for acetoin, suggesting that S. solfataricus may possess an acetoin 




8.1.3 A putative Picrophilus torridus OADHC 
The Tp. acidophilum E2 forms a 42-mer structure comprising both square and pentagonal 
faces, unlike the other previously described 24-and 60-mer structures.  The final aim of 
this chapter was to identify, clone and express the OADHC genes from P. torridus; this 
organism grows optimally at 60°C and at pH 0.7, and along with Tp. acidophilum is of the 
order Thermoplasmatales (Futterer et al., 2004).  The substrate specificity and E2 
structure of the P. torridus putative OADHC may provide an insight into the evolutionary 
origins of the OADHC in Thermoplasmatales and the novel 42-mer E2 structure seen in 




8.2.1 Identification of archaeal OADHCs and other genes  
The Protein Basic Local Alignment Search Tool (PBLAST) programme was initially used to 
identify OADHC genes in other archaeal species, using the Tp. acidophilum OADHC genes 
as a reference sequence.  Once one of the complex genes, usually E2, had been identified 
the Kyoto Encyclopaedia of Genes and Genomes (KEGG) (Ogata et al., 1999) was used to 
identify and position the other OADHC component genes.  KEGG was also used to identify 
other OADHC genes distal from any putative complex operon.   
The putative enzymes involved in branched-chain amino acid metabolism were identified 
based on gene annotations and PBLAST searches using the Bos tauraus and Pseudomonas 
putida GB1 protein sequences as a reference.  Genes encoding putative S. solfataricus 
enzymes involved in acetoin anabolism were identified using the sequences from 
Klebsiella terrigena (Blomqvist et al., 1993). 
 
8.2.2 Cloning of the OADHC genes for heterologous expression in E. coli 
The cloning of the OADHC genes from S. solfataricus into various pET vectors along with 
the protein expression trials were performed by Dr. K. Payne (University of Bath).  The 
P. torridus E1, E2 and E3 genes were cloned from P. torridus DSM 9790 (DSMZ, Germany) 
genomic DNA, which was extracted by Nicholas Morant (GeneSys Ltd., Surrey); the PCR 
primers used to amplify the genes are shown in Table 8.1.  The P. torridus OADHC genes 
were ligated into pGem-T Easy and pET28a using Nhe I/Nco I and Xho I, following the 




Primer name Restriction 
Site 
Primer Sequence 5'- 3' 
E1α Forward NheI CGGCTAGCATGATTGAGGAAGATATTAGTAAAGAGG 
E1α Reverse XhoI CCCTCGAGTCATTCTATCTCACCCCTTTCC 
E1β Forward NcoI CCCATGGGCACCGAGATGAACATGGTAAAGG 
E1β Reverse XhoI CCCTCGAGCTAATAATTTATAACCTTATTTATAGCATTCATAATTC 
E2 Forward NheI AGCTAGCTAGCATGTACACGTTGAAGGTTCCACCAATAGG 
E2 Reverse XhoI CCGCTCGAGTTAATCACCAATGTAAAGCATTGGC 
E3 Forward NheI CGGCTAGCATGGATTACGATGTCATTATCCTTGG 
E3 Reverse XhoI CCCTCGAGTTAATTTTCGAAGTCATCATGTATCCC 
 
Table 8.1 The primers used to PCR amplify the P. torridus OADHC genes.  The sequence 
complementary to the gene is shown in black, the restriction site in red and any extra 
bases in blue.  An additional G, shown in green, was added after the NcoI site and before 
the E1β gene to keep the gene in-frame with the ATG start codon found in the restriction 
site. 
 
8.2.3 Expression of the OADHC proteins 
The OADHC genes from P. torridus and E2 proteins from S. solfataricus, were expressed in 
E. coli Rosetta(DE3)pLysS following the method described in Chapter 2.3.1.  Expression 
trials were conducted to attempt to increase expression of soluble P. torridus OADHC 
proteins using the following expression strains: E. coli BL21(DE3) grown in Overnight 
Express™ Instant TB medium (Novagen, Merck, U.K.) and ArcticExpress™ (Stratagene, 
Agilent Technologies, U.K.) grown in LB medium (Chapter 5.2.1.1). 
 
8.2.4 Purification of the E2 dihydrolipoamide transacetylase  
The E. coli cell pellets were resuspended in His-bind buffer and lysed by sonication as 
described in Chapter 2.3.2; the proteins were then purified by a heat precipitation at 70°C 
for 10 min, except those expressing the P. torridus E2 enzyme which was not heat treated, 




8.2.5 Characterisation of the E2 dihydrolipoamide transacetylase protein 
8.2.5.1 Dihydrolipoamide S-acetyltransferase spectrophotometric coupled assay  
The E2 activity assays were performed as described in Chapter 2.5.2.  
8.2.5.2 Determining the molecular weight of the assembled E2 protein  
The molecular weight of the assembled E2 protein was determined by gel filtration and 
dynamic light scattering (DLS); for details see Chapters 2.3.2.3 and 4.3.4.3, respectively. 
8.2.5.3 Thermostability of the E2 protein from Picrophilus torridus 
The thermostability of the P. torridus E2 was measured by heating aliquots of the protein 
and comparing the relative amounts of soluble, insoluble and aggregated protein by SDS-
PAGE and DLS, following the methods described in Chapters 3.2.5, and 4.3.4.3, 
respectively. 
 
8.2.6 Homologous expression of S. solfataricus putative E3 dihydrolipoamide 
dehydrogenase 
The S. solfataricus E3 was expressed recombinantly following the method developed by 
Albers et al. (2006). 
8.2.6.1 Creation of the E3 expression plasmid for homologous expression  
The N-terminal his-tagged putative E3 (SSO1524) gene (Payne et al., 2010) was cloned by 
Dr. Karl Payne into the modified viral vector pMJ0503 (kindly provided by Dr. Sonja-
Verena Albers, Max-Planck-Institute for Terrestrial Microbiology, Marburg, Germany) 
following the method developed by Albers et al. (2006).  The E3 gene was cloned via 
pET28a via pGem-T.  The E3 gene was then excised from pET28a along with the N-
terminal his-tag and ligated into the pMZ1 vector; this vector added the arabinose 
promoter (AraS) region upstream of the his-tagged E3 gene.  The E3 gene and AraS 
sequence were then excised and ligated into pMJ0503 to create the final homologous 






Figure 8.1 S. solfataricus pMJ0503-E3 construct.  The pMJ0503 viral vector is shown in 
orange and contains the S. solfataricus E3 gene (black), the N-terminal his-tag (His) 
originally from pET28a (green), the arabinose promoter (AraS) (blue), and the marker 
gene PyrEF (red).  The restriction enzymes used to clone each part are shown above and 
the arrow indicates the direction of transcription of the his-tagged E3 gene.  
 
The pMJ0503-E3 viral vector was transformed into the S. solfataricus uracil auxotroph 
strain (ΔpyrEF/lacS double mutant) by Dr. Sonja-Verena Albers.  The transformants were 
then grown under selective conditions using basal salt medium without uracil (Brock et 
al., 1972), containing (per litre): 0.28g KH2PO4, 1.3g (NH4)2SO4, 0.25g MgSO4.7H2O, 0.25g 
CaCl2.7H2O and adjusted to pH3.5.  The medium was supplemented with 1% trace 
elements solution (20.0g FeCl2.6H2O, 4.5mg Na2B4O7.10H2O, 1.8g MnCl2.4H2O, 0.22mg 
ZnSO4.7H2O, 0.05mg CuCl2, 0.03mg Na2MoO4.4H2O, 0.03mg VOSO4.2H2O, 0.01mg 
CoSO4.7H2O), 0.05% (w/v) Yeast extract and 0.2 % D-arabinose (Albers et al., 2006).  
Selection of transformants was by growing cells on medium lacking uracil, the pMJ0503 
plasmid contains the pyrEF gene which rescues the uracil auxoptroph mutation.  
8.2.6.2 Homologous expression of the S. solfataricus E3 
The transformed S. solfataricus cultures were grown in increasing volumes of medium 
until two 500ml cultures were inoculated and grown at 75°C; gene expression was 
induced by presence of D-arabinose in the medium during this time.  The cultures were 
harvested after 2-4 days by centrifugation at 13400 x g, for 10 min at 4°C.  The cells were 
resuspended in His-bind buffer and lysed by sonication; the his-tagged E3 was then 
purified from cell lysates following the method described in Chapter 2.3.2, except in this 
case, the heat purification step was omitted.  
8.2.6.2 E3 dihydrolipoamide dehydrogenase assay 
E3 dihydrolipoamide dehydrogenase activity was measured following the method 
described in Chapter 2.5.3, except the assay temperature was increased to 70°C.  
174 
 
8.3 Results and discussion 
8.3.1 Tp. acidophilum branched-chain amino acid metabolism 
The protein sequences from B. taurus and P. putida GB-1 were used to search the 
Tp. acidophilum genome for putative genes encoding enzymes involved in the metabolism 
of the branched-chain amino acids, Leu, Ile and Val into acetyl-CoA, acetoacetate, or 
succinyl-CoA (Chapter 1.2.2); these organisms were chosen as the branched-chain OADHC 
from each has been characterised (Kato et al., 2006, Ævarsson et al., 1999).  Any 
hypothesis regarding the metabolism of the branched-chain amino acids in 
Tp. acidophilum is cautiously proposed, as the proteins have not been characterised and 
therefore catalytic activity and substrate specificity is not certain. 
The branched-chain amino acids are initially converted into 2-oxoacids by a branched-
chain aminotransferase (EC 2.6.1.42 and 2.6.1.6); the Tp. acidophilum genome does not 
contain any genes with homology to either the B. taurus or P. putida branched-chain 
aminotransferase enzymes.  There are, however, nine genes in the Tp. acidophilum 
genome annotated as aminotransferases or aminotransferase-related proteins; the 
substrate specificity of these enzymes has not been determined, and it is therefore 
possible that one may possess branched-chain aminotransferase activity. 
The Tp. acidophilum genes identified as possibly encoding enzymes involved in the 
metabolism of branched-chain acyl-CoAs are shown in Table 8.2.  These results suggest 
that the Tp. acidophilum possesses several of the necessary enzymes but not all.  From 
the data available, it is not possible to conclude if Tp. acidophilum utilises the branched-
chain OADHC as part of the metabolism of Val, Leu and Ile, or if pyruvate is the OADHCs 
physiological substrate.  There are two sets of ferredoxin oxidoreductase subunits genes 
annotated as having putative activity with pyruvate and 2-oxoglutarate, although 
interestingly there is not a set of genes annotated as a branched-chain FOR.  The 
branched-chain 2-oxoacid degradation pathway can produce various molecules required 
for the biosynthesis of polyketides and branched chain fatty acids; however, 
Tp. acidophilum is unlikely to utilise these precursors as archaea do not synthesise 
polyketides and their cell membranes comprise isoprenoid lipids, rather than fatty acid 
lipids (Boucher et al., 2004). 
Confirmation of the ability of Tp. acidophilum to metabolise branched-chain amino acids 
as a carbon source could be analysed by gene knock-outs and growth studies, as in the 
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case of Haloferax volcanii, in this case it has been suggested it utilises its branched-chain 
OADHC when grown on isoleucine but not valine or leucine (Sisignano et al., 2010). 
 
Required enzyme Thermoplasma acidophilum gene(s)  
Gene 
number 
Putative enzyme function 
Isoleucine   
Acyl-CoA dehydrogenase 
(1.3.8.1) 
Ta0230 Isovaleryl-CoA dehydrogenase 
Ta0974 acyl-CoA dehydrogenase 
Ta0295m Acyl-CoA dehydrogenase 
3-Hydroxyacyl-CoA dehydrogenase  
(4.2.1.17) 
Ta0121 3-hydroxybutyryl-CoA dehydratase-like 
protein  
Ta0291 L-3-hydroxyacyl-CoA dehydrogenase 
precursor 















Ta0462 Methylmalonyl-CoA mutase, alpha 
subunit, N-terminus 
Valine   
Butyryl-CoA dehydrogenase 
(1.3.8.1) 
Ta0230 Isovaleryl-CoA dehydrogenase 
Ta0974 acyl-CoA dehydrogenase 
3-Hydroxyacyl-CoA dehydrogenase 
(4.2.1.17) 
Ta0121 3-hydroxybutyryl-CoA dehydratase-like 
protein  











Ta0809 Aldehyde dehydrogenase 
Propionyl-CoA carboxylase (See 
isoleucine) 
(6.4.1.3) 
- Valine pathway merges with isoleucine 
pathway at this step 
 
Table 8.2 The enzymes required to metabolise the branched-chain acyl-CoAs produced 





Table 8.2 The enzymes required to metabolise the branched-chain acyl-CoAs produced 
by the branched-chain OADHC.  The required enzymes, along with their EC numbers, 
were identified from B. taurus or P. putida GB-1; the Tp. acidophilum gene number and 
putative enzyme function are shown in each case.  The coloured Tp. acidophilum genes 
indicate where the same gene has been identified in more than one pathway.  The valine 
pathway merges with the isoleucine pathway at the propionyl-CoA carboxylase step. 
  
Required enzyme Thermoplasma acidophilum gene(s) 
Gene 
number 
Putative enzyme function 
Leucine   
Isovaleryl-CoA dehydrogenase 
(1.3.8.4) 
Ta0230 Isovaleryl-CoA dehydrogenase 













8.3.2 S. solfataricus acetoin dehydrogenase multienzyme complex 
Please note that some results in this section include experiments completed by Dr. Karl 
Payne (University of Bath). 
8.3.2.1 Possible Acetoin Dehydrogenase multienzyme complex operon 
The genes required to produce a putative OADHC have been identified in S. solfataricus, 
Figure 8.2 shows the location of 4 of these genes  The E2 gene contains a -1 frame-shift 
that results in a premature stop codon; this frame-shift is probably corrected in 
S. solfataricus during transcription by a process called programmed ribosomal frame-shift 
(Cobucci-Ponzano et al., 2006).  The E2 gene used to express the recombinant E2 enzyme 
was mutated, by site directed mutagenesis, to remove this frame-shift, based on a 
sequence alignment with the Sulfolobus islandicus E2 gene which does not have the -1 
mutation (experiments completed by Dr. Karl Payne). 
 
Figure 8.2 OADHC genes in Sulfolobus solfataricus P2.  The numbers above the genes 
indicate the position of the gene relative to the end of the previous gene.  The -1 above 
the middle of the E2 gene indicates that there is a -1 frame-shift mutation in the middle of 
this gene sequence. 
 
There are also other sequences predicted to encode OADHC proteins located elsewhere in 
the genome.  Another E1α and E1β sequence is found approximately 170kbp upstream, 
and there are three other E3 genes, with one located 410kbp upstream, and the other 
two located 30 and 950kbp downstream of this predicted operon.  
8.3.2.2 Expression and characterisation of the S. solfataricus OADHC proteins 
The OADHC genes have been cloned into various pET-vectors for recombinant expression 
in E. coli.  The E1, E2 and E3 proteins were all recombinantly expressed, resulting in 
soluble E1 and E2 proteins, but insoluble E3 under all conditions tried.  The E1 has been 
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8.3.3 Characterisation of the S. solfataricus E2 
8.3.3.1 Expression and purification 
The S. solfataricus E2 protein was expressed from pET28a in E. coli Rosetta(DE3)pLysS 
cells; the protein was then purified by heat precipitation of the E. coli proteins and nickel 
affinity chromatography, resulting in a protein that was approximately 90% pure (Figure 
8.3). 
 
Figure 8.3 SDS-PAGE of the nickel affinity chromatography purification of the 
S. solfataricus E2. Lane 1: flow-through protein that did not bind to the column; lanes 2 to 
4: the his-bind buffer, 5% and 10% his-elute washes; lanes 5 to 9: his-elute wash collected 
in 1ml fractions.  The standard protein markers, with their molecular weights (kDa), are 
shown in the lane labelled M. 
 
8.3.3.2 E2 dihydrolipoamide acyltransferase enzyme assays 
The S. solfataricus E1 has been shown to utilise acetoin.  In this case, unlike other E1 
catalysed reactions, acetaldehyde is released rather than carbon dioxide; this leave an 
acetyl group attached to the lipoyl domain as would occur if pyruvate was the substrate.  
An acetoin specific OADHC would catalyse the following reaction (Payne et al., 2010): 
Acetoin + CoA + NAD+ → acetadehyde + acetyl-CoA + NADH + H+ 
The substrate specificity of the E1 enzyme indicates that the E2 will be able to catalyse the 
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Organism Specific activity (U/mg) kcat (min
-1) 
Tp. acidophilum E2 1.1 ± 0.1 48.9 ±2.3 
S. solfataricus E2 10.4 ± 0.6 678.7 ± 54.2 
 
Table 8.3 Specific activity and kcat values of the E2 dihydrolipoamide transacetylase from 
Tp. acidophilum and S. solfataricus at 55°C.  The specific activity is shown in U/mg of E2, 
where 1 Unit is described as the conversion of 1 μmol of acetyl-CoA to 1 μmol of acetyl-
dihydrolipoamide per min. The kcat value is the turnover number per min per E2 
monomer. 
 
The specific activity and kcat values of the non-lipoylated E2 enzymes from S. solfataricus 
and Tp. acidophilum, at 55°C, are shown in Table 8.3.  The S. solfataricus E2 has a higher 
specific activity and kcat than the Tp. acidophilum E2, even at 55°C a temperature that may 
be lower than S. solfataricus E2's optimum.  It is not unexpected that the S. solfataricus E2 
has a higher specific activity as the Tp. acidophilum is a branched-chain OADHC which only 
possesses low levels of activity with pyruvate. 
8.3.3.2 Molecular weight of the S. solfataricus E2 
The multimeric nature of the S. solfataricus E2 was investigated to determine if it 
assembled into a 24, 42 or 60-mer.  A sample of the S. solfataricus E2 was purified by 
nickel affinity chromatography and analysed by size-exclusion gel filtration in 50mM Tris-
HCl, pH 8.5, 200mM NaCl, and 100mM imidazole.  The E2 protein eluted from the column 
in a peak at 13.09 ml (Figures 8.4 and 8.5), this equates to a molecular weight of 
approximately 150 kDa.  The E2 monomers have a predicted molecular weight of 
46.4 kDa, and therefore the gel filtration results suggest that the S. solfataricus E2 
assembles into a structure comprising 3.3 subunits; this result must be viewed cautiously, 
as has been seen with the Tp. acidophilum E2, the E2's extended flexible linker regions can 






Figure 8.4 Gel filtration trace of the S. solfataricus E2 protein.  The A280 readings are 
shown in blue, and the 0.5ml fractions shown in red along the X-axis; no protein peaks 
were collected prior to those shown.  The column was equilibrated and run in 50mM Tris-
HCl, pH8.5, 200mM NaCl, and 100mM imidazole. 
 
 
Figure 8.5 SDS-PAGE of gel filtrations fractions. The lanes are labelled with the fraction 
number corresponding to Figure 8.4 The lane labelled M contains standard protein 
markers along with their molecular weights (kDa). 
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Dynamic light scattering was also used to determine the molecular weight of the 
S. solfataricus E2 protein.  The E2 protein in 50mM Tris-HCl, pH 8.5, 200mM NaCl, and 
100mM imidazole, was monodispersed, with a hydrodynamic radius of 5.84 nm; assuming 
that the E2 is a globular protein this size equates to a molecular weight of 209 kDa or 4.5 
monomers. 
 
Figure 8.6 DLS size distribution peak at 25°C.  The hydrodynamic radius of the protein 
sample is shown verses the signal intensity; duplicate measurements were taken and are 
shown in green and red. 
 
The molecular weight of the E2 protein determined by gel filtration and DLS equate to a 
structure comprising 3.3 and 4.5 monomers, respectively.  The variation between the two 
results means that the multimeric nature of the S. solfataricus cannot definitely be 
established; however, both results imply that the S. solfataricus E2 is not assembling into 
a large structure (24, 42 or 60-mer). 
 
8.3.4. Homologous expression of the S. solfataricus E3 
All attempts to recombinantly express the E3 gene, located 535bp upstream of the E1α 
gene, resulted in insoluble protein; all attempts to refold the insoluble E3 protein were 
unsuccessful.  As the E1 and E2 proteins were soluble and active, homologous expression 
of the his-tagged S. solfataricus E3 was attempted with assistance from Dr. Karl Payne 
(University of Bath) and Dr. Sonja-Verena Albers (Max Planck Institute for Terrestrial 
Microbiology, Marburg, Germany). 
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8.3.4.1 Cloning of the S. solfataricus E3 into pMJ0503 
The creation of the pMJ0503-E3 vector was completed by Dr. Karl Payne and the 
transformation of this plasmid into the S. solfataricus M16 homologous expression strain 
(Albers et al., 2006) was completed by Dr. Sonja-Verena Albers. 
8.3.4.2 Homologous expression of the S. solfataricus E3 
The homologous expression of the S. solfataricus E3 gene was induced with 0.2% (w/v) D-
arabinose.  The his-tagged E3 was purified from cell lysates by nickel-affinity 
chromatography (Figure 8.7); a protein with the expected molecular weight of a his-
tagged E3 was purified, and this putative E3 protein was soluble but very dilute 
(approximately 0.01mg/ml). 
 
Figure 8.7 SDS-PAGE nickel-affinity chromatography purification of the homologously 
expressed S. solfataricus E3.  Lane 1 contains the standard proteins along with their 
molecular weights (kDa); lane 2 contains the S. solfataricus cell lysate, and lane 3 contains 
protein the eluted from the nickel-affinity column with his-elute buffer.  The band on lane 
3 is very faint so its position has been highlighted with the adjacent arrow. 
 
8.3.4.3. E3 dihydrolipoamide dehydrogenase  
The putative E3 protein was assayed for dihydrolipoamide dehydrogenase activity with 
NAD+ and NADP+, but none was detected.  The protein was also incubated at 60°C and 
70°C with 0.05mg/ml FAD and FMN, but this also did not result in any detectable activity.  
Unsurprisingly, no OADHC activity was detected when the E3 was mixed with 
heterologously expressed E1 and lipoylated E2.  The lack of soluble and functional E3 may 
be due to the correct expression condition not yet being identified; however, it should 
also be noted that unlike several other species aerobic archaea dihydrolipoamide 













8.3.4.4 The OADHC from S. solfataricus 
The S. solfataricus E1 substrate specificity and E2 activity implies that this complex 
catalyses the following reaction: 
Acetoin + CoA + NAD+ → Acetaldehyde + Acetyl-CoA + NADH+H+ 
S. solfataricus also possess an acoX gene (SSO1527) in between the E1β and E2 genes,  the 
protein AcoX is predicted to be involved in the catabolism of acetoin (Priefert et al., 1991).  
These results possibly indicate that S. solfataricus may utilise acetoin as a carbon source; 
however, the source of this acetoin is not yet known.  The organism may convert pyruvate 
to acetoin, as a method of storing carbon and preventing over-acidification of the 
cytoplasm; the enzymatic steps required to convert pyruvate to acetoin are shown in 
Figure 8.8.  A gene annotated as encoding an acetolactate synthase (ALS) is present the 
S. solfataricus genome; however, no putative α-acetolactate decarboxylase (ADLH) has 
been identified (Payne et al., 2010).  The lack of this gene does not discount the possibility 
of this pathway existing in S. solfataricus, as this reaction can occur spontaneously at high 
temperatures (Kobayashi et al., 2005).  Acetoin production has not been detected in 
S. solfataricus, so the α-acetolactate may instead be diverted into the production of 
branched-chain amino acids rather than acetoin; if this is the case, then exogenous 
acetoin maybe the OADHC's physiological substrate, allowing the organism to utilise 
scavenged acetoin as an additional carbon energy source.  As no E3 or OADHC activity has 
been detected in cell lysate, it is not known if or under what conditions S. solfataricus 




Figure 8.8 Enzymatic conversion of pyruvate to acetoin.  Two pyruvate molecules can be 
converted via α-acetolactate into one acetoin molecule.  α-acetolactate is an unstable 















8.3.5 Cloning of the multienzyme complex genes from P. torridus  
Please note that some results included are from experiments completed by Isabel Diez-
Sevilla (Undergraduate student, University of Bath). 
The OADHC genes have been identified in the genome of P. torridus; this organism grows 
in conditions similar to those inhabited by Tp. acidophilum (Darland et al., 1970, Futterer 
et al., 2004).  The OADHC proteins from this organism may provide information regarding 
the evolutionary origins of the substrate specificity and structure of the Tp. acidophilum 
branched-chain OADHC. 
8.3.5.1 Identification of the OADHC genes in P. torridus 
The OADHC genes from P. torridus are located adjacent to each other, (Figure 8.9), in a 
similar arrangement to the Tp. acidophilum operon.  The putative P. torridus operon is 
flanked by the lipoic acid synthase (LipA) and protein N-octanoyltransferase (LipB) genes; 
these genes are not present in Tp. acidophilum, which utilises a lipoate protein ligase A 
(LplA) system instead (Posner et al., 2009). 
 
Figure 8.9 OADHC genes in P. torridus.  The numbers above the genes indicate the 
position of the gene relative to the end of the previous gene.  LipA is a predicted lipoic 
acid synthase and LipB is a protein N-octanoyltransferase. 
 
8.3.5.2 Cloning of OADHC genes 
The E1, E2 and E3 genes were successfully PCR-amplified from genomic DNA and ligated 
into pET28a (Figure 8.10).  There is a 4bp overlap between the E1α and E1β genes, and 
analysis of the sequence upstream of the E1β start codon revealed a possible ribosome 
binding site and TATA box within the E1α gene.  The E1α-E1β tandem (Figure8.10a) was 
cloned into pET28a, resulting in the co-expression of the his-tagged E1α and non-tagged 
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Figure 8.10 Agarose gel of A) the E1αβ tandem and B) the E2 PCR products.  The DNA 
marker ladder on both gels is a 1Kb ladder (Promega, U.K.)  The E1αβ has an expected size 
of 2.0kbp and the E2 has an expected size of 1.2kbp 
 
8.3.6 Expression of P. torridus complex proteins 
8.3.6.1 Expression E1 and E3 
Expression of the E1α and E1β genes from the tandem E1αβ plasmid construct resulted in 
soluble E1α protein but insoluble E1β (Figure 8.11).  Co-transformation of the pET28a-
E1αβ and pET19b-E1β resulted in soluble E1α, and again insoluble E1β.  Expression trials 
altering the expression strain and medium were conducted by Isabel Diez-Sevilla but did 
not result in the expression of any soluble E1β alone or in the presence of E1α.  All 
attempts to express P. torridus E3 protein from pET28 using a range of expression strains 
and media resulted in no expression of the E3 protein in either a soluble or insoluble 
form. 
 
Figure 8.11 SDS-PAGE of the soluble and insoluble fractions from a cell lysis containing 
the E1α and E1β proteins expressed from the E1αβ tandem.  Lane 1 contains the soluble 
cell lysate proteins, lane 2 contains the insoluble cell lysate proteins, and lane 3 contains 
the standard protein markers labelled with their molecule weights (kDa).  The expected 
molecular weight of the E1α and E1β are 40.4 kDa and 35.3 kDa respectively. 


























8.3.6.2 Expression E2 
The E2 protein with an N-terminal his-tag was successfully expressed in E. coli.  The 
protein was purified by nickel affinity chromatography, resulting in a final sample that was 
approximately 85% pure (Figure 8.12). 
 
Figure 8.122 SDS-PAGE of the purification of the E2 protein.  Lane 1: cell lysate loaded 
onto the column; lane 2: flow through; lanes 3: his-bind buffer wash; lanes 4 and 5: 5 and 
10% his-elute washes; lanes 6 – 10: 1ml fractions of 100% his-elute buffer.  The lane 
labelled M contains the standard protein markers, with their molecular weights (kDa).  
The his-tagged E2 protein has an expected molecular weight of 45.7 kDa. 
 
  






















8.3.7 Characterisation of P. torridus E2 
8.3.7.1 Sequence alignment of the P. torridus and Tp. acidophilum E2 
The P. torridus and Tp. acidophilum E2 protein sequences align with 43% identity, 62% 
similarity and 9% gaps.  The key residues involved in assembly and catalytic activity have 
been highlighted in Figure 8.13.  The flexible linker region that links the peripheral subunit 
binding domain (PSBD) and the catalytic domain appears to be significantly reduced in the 
P. torridus E2 protein; how the condensation of the PSDB and catalytic domains affects E1 
and E3 binding along with OADHC activity has not yet been investigated. 
 
Figure 8.13 Sequence alignment of the E2 proteins from P. torridus and Tp. acidophilum.  
Residues and sequences of known importance have been highlighted.  The yellow lysine 
(K) located in the lipoyl domain is the site of lipoylation.  The flexible linker regions of the 
Tp. acidophilum E2 have been highlighted in green (Lipoyl domain - PSBD) and cyan (PSBD 
- catalytic domain).  The residues highlighted in red are key residues required for 
acyltransferase activity.  The Ile highlighted in purple is the Tp. acidophilum anchor 




8.3.7.2 P. torridus E2 dihydrolipoamide transacetylase activity 
The P. torridus E2 was assayed using the coupled E2-PTA assay.  The enzyme had a specific 
activity and kcat that were approximately 1.6-fold higher than the Tp. acidophilum E2, but 
the values were significantly lower those of the S. solfataricus E2 (Table 8.4).  Comparing 
the kcat values of the P. torridus E2 with Tp. acidophilum and S. solfataricus values, it could 
be hypothesised that P. torridus OADHC may be specific for a substrate other than 
pyruvate; that is, as the rate of acetyl transfer is more similar to the Tp. acidophilum E2, 
than the S. solfataricus E2.  The P. torridus OADHC may be specific for either the 
branched-chain 2-oxoacids, or 2-oxoglutarate.  However, it is not possible to confirm this 
as the recombinant E1β is insoluble. 
Organism Specific activity (U/mg) kcat (min
-1) 
P. torridus 1.7 ± 0.1 76.4 ± 4.7 
Tp. acidophilum  1.1 ± 0.1 48.9 ±2.3 
S. solfataricus  10.4 ± 0.6 678.7 ± 38.3 
 
Table 8.4 Specific activity and kcat values of the E2 dihydrolipoamide transacetylase from 
Picrophilus torridus, Thermoplasma acidophilum and Sulfolobus solfataricus.  The 
specific activity is shown in U/mg of E2, where 1 Unit is described as the conversion of 1 
μmol of acetyl-CoA to 1 μmol of acetyl-dihydrolipoamide per min.  The kcat value is the 
turnover number per E2 monomer. 
 
8.3.7.4 Size determination of the P. torridus E2 
A purified sample of the P. torridus E2 was loaded onto a gel filtration column equilibrated 
with 20mM Tris-HCl, pH8.5, 300mM NaCl, and 50mM imidazole.  The E2 protein eluted 
from the column in the void volume of the column, from this, it can be concluded that the 
P. torridus E2 has assembled into a large structure but a precise molecular weight cannot 
be determined by this method (data not shown). 
Dynamic light scattering was used to determine the hydrodynamic radius of the protein 
and therefore predict the molecular weight of the assembled structure.  The 
hydrodynamic radius of the P. torridus E2 at 25°C in 20mM Tris-HCl, pH 8.5, 300mM NaCl, 
and 50mM imidazole, was 15.7 nm (Figure 8.14); assuming that the E2 forms a globular 
structure, this equates to a molecular weight of 2.1 MDa (the expected molecular weights 
of a 24, 42 and 60-mer are 1.1 MDa, 1.9 MDa and 2.7 MDa, respectively).  The molecular 
weight of the E2 protein calculated from the hydrodynamic radius is likely to be 
overestimated, as the algorithm that converts the radius into a Mw assumes that the 
proteins are both globular and solid.  The flexible arms of the E2 extend out from the 
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catalytic core, and this increases the hydrodynamic radius to a size above that which 
would be expected of a globular compact protein of the same molecular weight. 
 
Figure 8.14 DLS intensity graph of the P. torridus E2 protein at 25°C 
 
The hydrodynamic radius of the Tp. acidophilum E2 was determined by DLS to be 19.3 nm, 
which is larger than the radius of the P. torridus E2.  It is important to note that the 
flexible linker region between the P. torridus catalytic domain and PSBD is shorter than 
the equivalent Tp. acidophilum linker; shortening this region may reduce the distance that 
the flexible arms project outward and thus decrease the hydrodynamic radius of the 
protein.  The DLS result suggests that the P. torridus E2 is smaller than the Tp. acidophilum 
E2, but the exact number of monomers cannot be established.  To determine the 
structure of the P. torridus, the molecular weight would need to be accurately measured 
by analytical ultracentrifugation, or the structure ascertained by either SAXS or X-ray 
crystallography. 
8.3.7.5 Thermostability of the P. torridus E2 
The thermostability of the P. torridus E2 protein was studied by comparing the relative 
amounts of soluble and insoluble protein, after a 10 min incubation at a range of 
temperatures (Figure 8.15).  The P. torridus E2 is stable for up to 10 min at 80°C, but 
above this temperature the protein begins to precipitate; the majority of the protein is 
insoluble after 10 min at 95°C.  This result is similar to that seen for the Tp. acidophilum 
E2; this protein began to precipitate after 10 min at 80-85°C and had completely 





Figure 8.15 SDS-PAGE of A) the soluble and B) the insoluble E2 protein after a 10 min 
incubation over a range of temperatures.  The lanes are labelled with the temperatures 
(°C) at which the samples were incubated for 10 min in 20mM Tris-HCl, pH 8.5, 300mM 
NaCl, and 50mM imidazole.  The standard proteins are shown in the lanes labelled M 
along with their molecular weights (kDa). 
 
The thermostability of the P. torridus E2 was also studied by DLS.  The hydrodynamic 
radius of the E2 in 20mM Tris-HCl, pH 8.5, 300mM NaCl, and 50mM imidazole, was 
determined after one-minute incubations at a range of increasing temperatures between 
50°C and 90°C.  The average size begins to increase slightly between 75°C and 80°C, and 
then dramatically increases after 80°C, indicating that the protein had aggregated at this 
temperature (Figure 8.16).  The thermostability of the P. torridus and the Tp. acidophilum 
E2 proteins measured by DLS and SDS-PAGE are similar, this is not unexpected as both 
organisms inhabit similar environments; the effect that temperature has on the activity of 
the P. torridus E2 has not yet been studied. 
 
Figure 8.16 The hydrodynamic diameter of the P. torridus E2 across an increasing 

















































It is not possible, with the data currently available, to determine the metabolic role of the 
Tp. acidophilum branched-chain OADHC.  Several putative genes have been identified as 
encoding enzymes involved in the metabolism of the branched-chain amino acids, but as 
these enzymes and the pathways have not be characterised, it is not possible to draw any 
definitive conclusions.  The OADHC genes have been shown to be transcribed and 
translated in P. aerophilum and Tp. acidophilum (Cozen et al., 2009, Sun et al., 2011) but 
no OADHC activity has ever been detected in cell lysates.  The physiological role these 
complexes play in archaeal metabolism is further complicated by the fact that archaea 
appear to utilise the ferredoxin oxidoreductase to catalyse the conversion of 2-oxoacids 
to their corresponding acyl-CoA.  Nevertheless, as archaeal genomes have been 
streamlined during evolution (Csűrös and Miklós, 2009), and therefore these organisms 
do not maintain genes that are surplus to requirement, this suggests that the OADHC 
identified in Tp. acidophilum and the other aerobic archaea are likely to have a 
physiological function, otherwise functional E1, E2, E3 and the accessory OADHC specific 
protein lipoylation enzymes would not be so widely maintained. 
The E1α, E1β, E2, and E3 proteins from Tp. acidophilum have been recombinantly 
expressed and assembled into an active OADHC; however, thus far it has not been 
possible to replicate this from another thermophilic or hyper-thermophilic archaeon.  It 
seems most likely that this is due to the inability of the E. coli expression systems to 
express and fold these thermophilic proteins correctly, and although a S. solfataricus 
expression system has been developed (Albers et al., 2006) it is not yet as efficient as the 
E. coli system.  Further understanding of the thermostability of these complexes may be 
achieved by studying the proteins from thermophilic bacteria, such as the Geobacillus 
stearothermophilus PDHC (60°C) or other uncharacterised complexes. 
The nature of the P. torridus E2 assembly may provide some insights into the evolutionary 
origins of the novel Tp. acidophilum E2 42-mer structure. The P. torridus E2 has been 
recombinantly expressed in E. coli resulting in a functional enzyme that assembles into a 
multimeric structure, although the exact nature of this structure has not yet been 
determined.  The production and characterisation of the P. torridus E2 catalytic domain 





Chapter 9: Conclusions and future work 
9.1 The recombinant OADHC from Tp. acidophilum 
The Thermoplasma acidophilum OADHC enzymes have been recombinantly expressed in 
E. coli, resulting in a functional multienzyme complex (Heath, 2006); the assembled 
OADHC is both thermostable and thermoactive at temperatures above the organisms 
expected growth range.  The temperature optimum of the OADHC appears to be limited 
by the E1 component, an enzyme that has previously been suggested to be the rate 
limiting step of the overall oxidative decarboxylation reaction (Pei et al., 2008).  The 
assembled complex is less thermostable than the individual component enzymes; this 
insinuates that in this case it is the stability of the interactions of the E1/E3 with the E2, or 
between E2 trimers, that limits the thermostability of the complex.  Assuming that the 
thermostability and thermoactivity of the recombinant OADHC reflects those of the in 
vivo enzyme, these data suggest that the Tp. acidophilum branched-chain OADHC would 
be stable and functional at the temperatures at which this organism grows; therefore, 
despite the fact that OADHC activity has not be detected in vivo, this complex could 
theoretically be utilised by the organism. 
The assembly and the stability of the Tp. acidophilum OADHC have only briefly been 
studied in this project; the results suggest that the E1 and E3 do not bind strongly to the 
E2 core.  The weak binding of the E3 to the E2 was not unexpected, as proteomic studies 
of the large complexes (>1 MDa) in Tp. acidophilum have only identified the E1 associated 
with the E2 protein, and not the E3 (Sun et al., 2007).  One question that has not been 
answered is, in vivo could non-bound E3 enzymes re-oxidise the E2 lipoic acid moiety, and 
hence result in an E1 and E2 complex with E3 enzymes in close proximity?  The binding 
affinities of the E1/E3 for the E2-PSBD could be calculated using surface plasma 
resonance, to determine if and how tightly the E3 associates with the E2.  Weak 
interactions may be sufficient to achieve a functional complex within a cell lysate, but 
they may be easily broken during cell lysis, this may explain the lack of detectable OADHC 




9.2 The structure of E2 core of the archaeal OADHCs 
9.2.1 The novel 42-mer structure 
The structure of the Tp. acidophilum E2 catalytic domain has been solved by X-ray 
crystallography to 4 Å, and verified by small-angle X-ray scattering and equilibrium 
analytical ultracentrifugation.  The Tp. acidophilum E2 forms a novel arrangement 
comprising 42 monomers, arranged into a cage-like spheroid with both square and 
pentagonal faces.  The pentagonal faces of the 42-mer have similar dimensions to the 
pentagonal faces of the dodecahedral 60-mer; however, the square faces of the 42-mer 
are larger than those of the cubic 24-mer.  The evolutionary origins of this 42-mer 
structure are, as yet, unknown; solving the structures of other archaeal E2s, particularly 
the Picrophilus torridus E2, may provide some insights into the diversity of archaeal E2 
structures. 
The novel 42-mer E2 assembly does not conform to the strict rules thought to govern the 
assembly of E2 structures; Izard et al. (1999) describes how a cubic 24-mer can be 
converted into a dodecahedral 60-mer based using Euclidean principles, and the rules of 
quasi-equivalence.  These two structures contain identical trimeric subunits which all 
inhabit quasi-equivalent environments, unlike the Tp. acidophilum E2 trimers; the 
environment surrounding Tp. acidophilum E2 trimers and thus the ability to form different 
inter-trimer interactions varies depending upon if it is part of a square or pentagonal face.  
The differences between the Tp. acidophilum E2 trimer-trimer interfaces extend beyond 
the constraint of quasi-equivalence, as some bonds are not merely distorted by up to 5° 
rather they may only be present at some faces and not other.  Although this structure 
challenges some of the symmetry principles previously thought to govern protein 
assembly, it does support Casper and Klug hypothesis, that biological molecules do not 
have to be perfectly symmetrical structures, rather subunits may be arranged into the 
most stable assembly possible (Caspar and Klug, 1962).  Virus capsids are another 
example of protein assembly that do not always display perfect symmetry, in that it is not 
possible to arrange more than 60 subunits symmetrically; the Bacteriophage fr capsid is 
an example of a quasi-symmetrical structure comprising 180 identical subunits (Liljas et 
al., 1994).  If protein assemblies, like the virus capsids, are not restrained by the principles 
of Euclidean symmetry, then this massively increases the number of possible subunit 




9.2.2 A functional trimer multienzyme complex 
A functional trimeric Tp. acidophilum OADHC has been created by the removal of the Ile 
anchor residue at the C-terminus of the E2 polypeptide, a key residue in the formation of 
trimer-trimer interactions.  This trimeric complex is the first reported case of a functional 
E2 that is capable of binding the E1 and E3 enzymes, and catalysing the 2-oxoacid 
oxidative decarboxylation reaction.  This trimeric complex proves that it is not essential 
that these OADHCs form the large 24-, 42-, or 60-mer structures.  However, the fact that 
no naturally occurring OADHCs comprising less than 24 E2s have been described, strongly 
suggests that the larger assemblies are advantageous.  The ability to channel substrates 
around the complex during limited substrate conditions (Danson et al., 1978), may 
increase the efficiency of carbon metabolism and thus provide selective advantage to an 
organism. 
 
9.3 The roles of the OADHCs in archaea 
The role the OADHC plays in archaeal central metabolism remains unclear.  However, in 
all species of aerobic archaea sequenced, putative OADHC genes can be identified and in 
all cases are accompanied by a lipoylation system.  The maintenance of these genes and 
their essential protein motifs, throughout archaeal evolution, strongly implies that these 
complexes have a necessary function, as they would not be maintained if they were 
redundant. 
The substrate specify of only two archaeal OADHCs has been determined: the 
Tp. acidophilum OADHC is specific for branched-chain 2-oxoacids and also displays some 
minor activity with pyruvate, and the S. solfataricus OADHC appears to be specific for 
acetoin, based on the E1 specificity.  The genomes of these two organisms do not appear 
to contain an FOR annotated as specific for either the branched-chain 2-oxoacids or 
acetoin; however, it must duly be noted that substrate specificity and promiscuity of the 
other FORs have not determined.  The OADHCs and the FORs may provide 
complementary activities, increasing the range of substrates on which these organisms 
can survive. 
The role and evolutionary origins of the OADHC still require further investigation.  The size 
of the OADHC operon, and the additional requirement for either the LipA/LipB or LlpA 
lipoylation system, decreases the likelihood that all aerobic archaea independently 
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inherited the OADHC via lateral gene transfer from a cohabiting bacterium.  This, coupled 
with the recent discovery of a putative OADHC operon in the anaerobic methanogen, 
Methanocella sp. HZ254 (genes numbers: mtc1889-1893), may support a hypothesis that 
all archaea initially possessed both the FOR and OADHC genes, but these genes have not 
been retained by the majority of anaerobic species.  Growth studies, gene knock-outs and 
transcriptomics, may provide some insights into the regulation and role of these 
complexes.  Sisignano et al (2010) found that when the Haloferax volcanii branched-chain 
OADHC was knocked-out, the organism was unable to grow on isoleucine but could still 
grow on leucine and valine; another study by Cozen et al (2009) found that the 
Pyrobaculum aerophilum complex genes were up-regulated when the organism was 
cultured with oxygen or nitrate as the terminal electron acceptors compared to arsenate, 
or ferric iron-citrate. 
A final hypothesis can be proposed that all archaea initially possessed both the FORs and 
OADHC genes; however, as the organisms adapted and evolved into their niche 
environments; the anaerobic archaea lost the OADHCs, and the aerobic species 
maintained the genes.  The anaerobic archaea may have favoured the 2-oxoacid 
ferredoxin oxidoreductase, as this enzyme utilises ferredoxin rather than NAD+; whereas, 
the aerobic archaea have the electron transport chain, which is capable of regenerating 
NAD+, and therefore could use either the OADHCs or FORs.  The aerobic archaea may 
have exploited the complementary activities of the FORs and OADHCs in order to create a 
specialist and separate enzyme system capable of catabolising any scavenged 2-oxoacids, 
whilst leaving the FORs unaffected, thus providing a competitive advantage in the hostile 




Chapter 10. References 
AASS, H. C. (2003) Multienzyme complexes in the Archaea. M. Phil. Thesis, University of 
Bath. 
ÆVARSSON, A., SEGER, K., TURLEY, S., SOKATCH, J. R. & HOL, W. G. J. (1999) Crystal 
structure of 2-oxoisovalerate and dehydrogenase and the architecture of 2-oxo 
acid dehydrogenase multienzyme complexes. Nature Structural Biology, 6, 785-
792. 
AL-MAILEM, D. M., HOUGH, D. W. & DANSON, M. J. (2008) The 2-oxoacid dehydrogenase 
multienzyme complex of Haloferax volcanii. Extremophiles, 12, 89-96. 
ALBERS, S. V., JONUSCHEIT, M., DINKELAKER, S., URICH, T., KLETZIN, A., TAMPE, R., 
DRIESSEN, A. J. M. & SCHLEPER, C. (2006) Production of recombinant and tagged 
proteins in the hyperthermophilic archaeon Sulfolobus solfataricus. Applied and 
environmental microbiology, 72, 102-111. 
ALLEN, M. D., BROADHURST, R. W., SOLOMON, R. G. & PERHAM, R. N. (2005) Interaction 
of the E2 and E3 components of the pyruvate dehydrogenase multienzyme 
complex of Bacillus stearothermophilus. FEBS Journal, 272, 259-268. 
ARJUNAN, P., NEMERIA, N., BRUNSKILL, A., CHANDRASEKHAR, K., SAX, M., YAN, Y., 
JORDAN, F., GUEST, J. R. & FUREY, W. (2002) Structure of the pyruvate 
dehydrogenase multienzyme complex E1 component from Escherichia coli at 
1.85Å resolution. Biochemistry, 41, 5213-5221. 
BAILEY, S. (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr. 
D, 50, 760-763. 
BARNS, S. M., DELWICHE, C. F., PALMER, J. D. & PACE, N. R. (1996) Perspectives on 
Archaeal diversity, thermophily and monophyly from environmental rRNA 
sequences. Proceedings of the National Academy of Sciences of the United States 
of America, 93, 9188-9193. 
BELL, G. S., RUSSELL, R. J. M., CONNARIS, H., HOUGH, D. W., DANSON, M. J. & TAYLOR, G. 
L. (2002) Stepwise adaptations of citrate synthase to survival at life's extremes. 
European Journal of Biochemistry, 269, 6250-6260. 
BLOMQVIST, K., NIKKOLA, M., LEHTOVAARA, P., SUIHKO, M. L., AIRAKSINEN, U., STRÄBY, 
K. B., KNOWLES, J. K. & PENTTILÄ, M. E. (1993) Characterization of the genes of 
the 2, 3-butanediol operons from Klebsiella terrigena and Enterobacter 
aerogenes. Journal of bacteriology, 175, 1392-1404. 
BOUCHER, Y., KAMEKURA, M. & DOOLITTLE, W. F. (2004) Origins and evolution of 
isoprenoid lipid biosynthesis in archaea. Molecular microbiology, 52, 515-527. 
BRAUTIGAM, C. A., WYNN, R. M., CHUANG, J. L. & CHUANG, D. T. (2009) Subunit and 
catalytic component stoichiometries of an in vitro reconstituted human pyruvate 
dehydrogenase complex. Journal of Biological Chemistry, 284, 13086-13098. 
198 
 
BROCK, T. D., BROCK, K. M., BELLY, R. T. & WEISS, R. L. (1972) Sulfolobus: A new genus of 
sulfur-oxidizing bacteria living at low pH and high temperature. Archives of 
Microbiology, 84, 54-68. 
CAIVANO, A., DORIA-ROSE, N. A., BUELOW, B., SARTORIUS, R., TROVATO, M., D'APICE, L., 
DOMINGO, G. J., SUTTON, W. F., HAIGWOOD, N. L. & DE BERARDINIS, P. (2010) 
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from 
Geobacillus stearothermophilus induces sustained humoral and cellular immune 
responses in the absence of IFN production by CD4+ T cells. Virology, 407, 296-
305. 
CASPAR, D. L. (1980) Movement and self-control in protein assemblies. Quasi-equivalence 
revisited. Biophysical journal, 32, 103-138. 
CASPAR, D. L. & KLUG, A. (1962) Physical principles in the construction of regular viruses. 
Cold Spring Harbor Laboratory Press. 
CHABRIÈRE, E., CHARON, M.-H., VOLBEDA, A., PIEULLE, L., HATCHIKIAN, E. C. & 
FONTECILLA-CAMPS, J.-C. (1999) Crystal structures of the key anaerobic enzyme 
pyruvate:ferredoxin oxidoreductase, free and in complex with pyruvate. Nature 
Structural & Molecular Biology, 6, 182-190. 
CHAUHAN, H. J., DOMINGO, G. J., JUNG, H.-I. & PERHAM, R. N. (2000) Sites of limited 
proteolysis in the pyruvate decarboxylase component of the pyruvate 
dehydrogenase multienzyme complex of Bacillus stearothermophilus and their 
role in catalysis. European Journal of Biochemistry, 267, 7158-7169. 
COBUCCI-PONZANO, B., CONTE, F., BENELLI, D., LONDEI, P., FLAGIELLO, A., MONTI, M., 
PUCCI, P., ROSSI, M. & MORACCI, M. (2006) The gene of an archaeal -fucosidase 
is expressed by translational frameshifting. Nucleic Acids Research, 34, 4258-4268. 
COZEN, A. E., WEIRAUCH, M. T., POLLARD, K. S., BERNICK, D. L., STUART, J. M. & LOWE, T. 
M. (2009) Transcriptional map of respiratory versatility in the hyperthermophilic 
crenarchaeon Pyrobaculum aerophilum. Journal of Bacteriology, 191, 782-794. 
CRIPPS, R. E., ELEY, K., LEAK, D. J., RUDD, B., TAYLOR, M., TODD, M., BOAKES, S., MARTIN, 
S. & ATKINSON, T. (2009) Metabolic engineering of Geobacillus 
thermoglucosidasius for high yield ethanol production. Metabolic Engineering, 11, 
398-408. 
CSŰRÖS, M. & MIKLÓS, I. (2009) Streamlining and large ancestral genomes in Archaea 
inferred with a phylogenetic Birth-and-Death model. Molecular Biology and 
Evolution, 26, 2087-2095. 
DALMAU, M., LIM, S., CHEN, H. C., RUIZ, C. & WANG, S. W. (2008) Thermostability and 
molecular encapsulation within an engineered caged protein scaffold. 
Biotechnology and Bioengineering, 101, 654-664. 
DALMAU, M., LIM, S. & WANG, S. W. (2009) pH-Triggered disassembly in a caged protein 
complex. Biomacromolecules, 2306-2309. 
DANIEL, R. M. & DANSON, M. J. (2010) A new understanding of how temperature affects 
the catalytic activity of enzymes. Trends in Biochemical Sciences, 35, 584-591. 
199 
 
DANIEL, R. M., DANSON, M. J., HOUGH, D. W., LEE, C. K., PETERSON, M. E. & COWAN, D. 
A. (2008) Enzyme stability and activity at high temperatures. IN SIDDIQUI, K. S. & 
THOMAS, T. (Eds.) Protein adaptations in extremophiles. New York, Nova 
Biochemical Books. 
DANSON, M. J., EISENTHAL, R., HALL, S., KESSELL, S. & WILLIAMS, D. (1984) 
Dihydrolipoamide dehydrogenase from halophilic archaebacteria. Biochemical 
Journal 218, 811-818. 
DANSON, M. J., FERSHT, A. R. & PERHAM, R. N. (1978) Rapid intramolecular coupling of 
active sites in the pyruvate dehydrogenase complex of Escherichia coli: 
mechanism for rate enhancement in a multimeric structure. Proceedings of the 
National Academy of Sciences, 75, 5386-5390. 
DANSON, M. J., LAMBLE, H. J. & HOUGH, D. W. (2007) Central Metabolism, Washington, 
DC, ASM Press. 
DARLAND, G., BROCK, T. D., SAMSONOFF, W. & CONTI, S. F. (1970) A thermophilic, 
acidophilic mycoplasma isolated from a coal refuse pile. Science, 170, 1416-1418. 
DOMINGO, G. J., ORRU, S. & PERHAM, R. N. (2001) Multiple display of peptides and 
proteins on a macromolecular scaffold derived from a multienzyme complex. 
Journal of Molecular Biology, 305, 259-267. 
DUCKWORTH, H. W., JAENICKE, R., PERHAM, R. N., WILKIE, A. O. M., FINCH, J. T. & 
ROBERTS, G. C. K. (1982) Limited proteolysis and proton NMR spectroscopy of 
Bacillus stearothermophilus pyruvate dehydrogenase multienzyme complex. 
European Journal of Biochemistry, 124, 63-69. 
EISENTHAL, R., DANSON, M. J. & HOUGH, D. W. (2007) Catalytic efficiency and kcat/KM: a 
useful comparator? Trends in Biotechnology, 25, 247-249. 
EMSLEY, P. & COWTAN, K. (2004) Coot: model-building tools for molecular graphics. Acta 
Crystallographica Section D: Biological Crystallography, 60, 2126-2132. 
FERGUSON, N., SHARPE, T. D., SCHARTAU, P. J., SATO, S., ALLEN, M. D., JOHNSON, C. M., 
RUTHERFORD, T. J. & FERSHT, A. R. (2005) Ultra-fast barrier-limited folding in the 
peripheral subunit-binding domain family. Journal of Molecular Biology, 353, 427-
446. 
FRANK, R. A. W., PRATAP, J. V., PEI, X. Y., PERHAM, R. N. & LUISI, B. F. (2005) The 
molecular origins of specificity in the assembly of a multienzyme complex. 
Structure 13, 1119-1130. 
FRANK, R. A. W., TITMAN, C. M., PRATAP, J. V., LUISI, B. F. & PERHAM, R. N. (2004) A 
molecular switch and proton wire synchronize the active sites in thiamine 
enzymes. Science, 306, 872-876. 
FRANKE, D. & SVERGUN, D. I. (2009) DAMMIF, a program for rapid ab-initio shape 




FRIES, M., JUNG, H.-I. & PERHAM, R. N. (2003) Reaction mechanism of the 
heterotetrameric (22) E1 component of 2-oxo acid dehydrogenase multienzyme 
complexes Biochemistry, 42, 6996-7002. 
FRIES, M., STOTT, K. M., REYNOLDS, S. & PERHAM, R. N. (2007) Distinct modes of 
recognition of the lipoyl domain as substrate by the E1 and E3 components of the 
pyruvate dehydrogenase multienzyme complex. Journal of Molecular Biology, 
366, 132-139. 
FUTTERER, O., ANGELOV, A., LIESEGANG, H., GOTTSCHALK, G., SCHLEPER, C., SCHEPERS, 
B., DOCK, C., ANTRANIKIAN, G. & LIEBL, W. (2004) Genome sequence of 
Picrophilus torridus and its implications for life around pH 0. Proceedings of the 
National Academy of Sciences of the United States of America, 101, 9091. 
GASTEIGER, E., GATTIKER, A., HOOGLAND, C., IVANYI, I., APPEL, R. D. & BAIROCH, A. 
(2003) ExPASy: the proteomics server for in-depth protein knowledge and 
analysis. Nucleic Acids Research, 31, 3784-3788. 
GUEST, J. R. (1987) Functional implications of structural homologies between 
chloramphenicol acetyltransferase and dihydrolipoamide acetyltransferase. FEMS 
microbiology letters, 44, 417-422. 
HAWKINS, C. F., BORGES, A. & PERHAM, R. N. (1989) A common structural motif in 
thiamin pyrophosphate-binding enzymes. FEBS Letters, 255, 77-82. 
HEATH, C. (2006) A branched-chain 2-oxoacid dehydrogenase multienzyme complex from 
Thermoplasma acidophilum. Ph.D. Thesis, University of Bath. 
HEATH, C., JEFFRIES, A. C., HOUGH, D. W. & DANSON, M. J. (2004) Discovery of the 
catalytic function of a putative 2-oxoacid dehydrogenase multienzyme complex in 
the thermophilic archaeon Thermoplasma acidophilum. FEBS Letters, 577, 523-
527. 
HEATH, C., POSNER, M. G., AASS, H. C., UPADHYAY, A., SCOTT, D. J., HOUGH, D. W. & 
DANSON, M. J. (2007) The 2-oxoacid dehydrogenase multi-enzyme complex of the 
archaeon Thermoplasma acidophilum - recombinant expression, assembly and 
characterization. FEBS Journal, 274, 5406-5415. 
HIPPS, D. S., PACKMAN, L. C., ALLEN, M. D., FULLER, C., SAKAGUCHI, K., APPELLA, E. & 
PERHAM, R. N. (1994) The peripheral subunit-binding domain of the dihydrolipoyl 
acetyltransferase component of the pyruvate dehydrogenase complex of Bacillus 
stearothermophilus: preparation and characterization of its binding to the 
dihydrolipoyl dehydrogenase component. Biochemical Journal, 297, 137. 
HIROMASA, Y., FUJISAWA, T., ASO, Y. & ROCHE, T. E. (2004) Organization of the cores of 
the mammalian pyruvate dehydrogenase complex formed by E2 and E2 plus the 
E3-binding protein and their capacities to bind the E1 and E3 Components. Journal 
of Biological Chemistry, 279, 6921-6933. 
HOLM, L. & PARK, J. (2000) DaliLite workbench for protein structure comparison. 
Bioinformatics, 16, 566-567. 
201 
 
HOUGH, D. W. & DANSON, M. J. (1999) Extremozymes. Current opinion in chemical 
biology, 3, 39-46. 
HUBER, H., HOHN, M. J., RACHEL, R., FUCHS, T., WIMMER, V. C. & STETTER, K. O. (2002) A 
new phylum of Archaea represented by a nanosized hyperthermophilic symbiont. 
Nature, 417, 63-67. 
IZARD, T., ÆVARSSON, A., ALLEN, M. D., WESTPHAL, A. H., PERHAM, R. N., DE KOK, A. & 
HOL, W. G. J. (1999) Principles of quasi-equivalence and Euclidean geometry 
govern the assembly of cubic and dodecahedral cores of pyruvate dehydrogenase 
complexes. Proceedings of the National Academy of Sciences, 96, 1240. 
JACQUES, D. A. & TREWHELLA, J. (2010) Small-angle scattering for structural biology - 
Expanding the frontier while avoiding the pitfalls. Protein Science, 19, 642-657. 
JOLLEY, K. A., MADDOCKS, D. G., GYLES, S. L., MULLAN, Z., TANG, S. L., DYALL-SMITH, M. 
L., HOUGH, D. W. & DANSON, M. J. (2000) 2-Oxoacid dehydrogenase multienzyme 
complexes in the halophilic Archaea? Gene sequences and protein structural 
predictions. Microbiology 146, 1061. 
JUNG, H.-I., COOPER, A. & PERHAM, R., N. (2003) Interactions of the peripheral subunit-
binding domain of the dihydrolipoyl acetyltransferase component in the assembly 
of the pyruvate dehydrogenase multienzyme complex of Bacillus 
stearothermophilus. European Journal of Biochemistry, 270, 4488-4496. 
JUNG, H.-I., COOPER, A. & PERHAM, R. N. (2002) Identification of key amino acid residues 
in the assembly of enzymes into the pyruvate dehydrogenase complex of Bacillus 
stearothermophilus: A kinetic and thermodynamic analysis. Biochemistry, 41, 
10446-10453. 
JURGENS, G. (2002) Molecular phylogeny of Archaea in boreal forest soil, freshwater and 
temperate estuarine sediment. Department of Applied Chemistry and 
Microbiology University of Helsinki. 
KALIA, Y. N., BROCKLEHURST, S. M., HIPPS, D. S., APPELLA, E., SAKAGUCHI, K. & PERHAM, 
R. N. (1993) The high-resolution structure of the peripheral subunit-binding 
domain of dihydrolipoamide acetyltransferase from the pyruvate dehydrogenase 
multienzyme complex of Bacillus stearothermophilus. Journal of Molecular 
Biology, 230, 323-341. 
KARNER, M. B., DELONG, E. F. & KARL, D. M. (2001) Archaeal dominance in the 
mesopelagic zone of the Pacific Ocean. Nature, 409, 507-510. 
KATO, M., WYNN, R. M., CHUANG, J. L., BRAUTIGAM, C. A., CUSTORIO, M. & CHUANG, D. 
T. (2006) A synchronized substrate-gating mechanism revealed by cubic-core 
structure of the bovine branched-chain -ketoacid dehydrogenase complex. 
EMBO J, 25, 5983-5994. 
KERSCHER, L., NOWITZKI, S. & OESTERHELT, D. (1982) Thermoacidophilic archaebacteria 
contain bacterial-type ferredoxins acting as electron acceptors of 2-oxoacid: 
ferredoxin oxidoreductases. European Journal of Biochemistry, 128, 223-230. 
202 
 
KERSCHER, L. & OESTERHELT, D. (1981) The catalytic mechanism of 2-oxoacid: Ferredoxin 
oxidoreductases from Halobacterium halobium. European Journal of Biochemistry, 
116, 595-600. 
KERSCHER, L. & OESTERHELT, D. (1982) Pyruvate : ferredoxin oxidoreductase - new 
findings on an ancient enzyme. Trends in Biochemical Sciences, 7, 371-374. 
KNAPP, J. E., CARROLL, D., LAWSON, J. E., ERNST, S. R., REED, L. J. & HACKERT, M. L. (2000) 
Expression, purification, and structural analysis of the trimeric form of the 
catalytic domain of the Escherichia coli dihydrolipoamide succinyltransferase. 
Protein Science, 9, 37-48. 
KNAPP, J. E., MITCHELL, D. T., YAZDI, M. A., ERNST, S. R., REED, L. J. & HACKERT, M. L. 
(1998) Crystal structure of the truncated cubic core component of the Escherichia 
coli 2-oxoglutarate dehydrogenase multienzyme complex. Journal of Molecular 
Biology, 280, 655-668. 
KOBAYASHI, K., KUSAKA, K., TAKAHASHI, T. & SATO, K. (2005) Method for the 
simultaneous assay of diacetyl and acetoin in the presence of acetolactate: 
Application in determining the kinetic parameters for the decomposition of 
acetolactate. Journal of Bioscience and Bioengineering, 99, 502-507. 
KOIKE, K., SUEMATSU, T. & EHARA, M. (2000) Cloning, overexpression and mutagenesis of 
cDNA encoding dihydrolipoamide succinyltransferase component of the porcine 
2-oxoglutarate dehydrogenase complex. European Journal of Biochemistry, 267, 
3005-3016. 
KONAREV, P. V., VOLKOV, V. V., SOKOLOVA, A. V., KOCH, M. H. J. & SVERGUN, D. I. (2003) 
PRIMUS: a Windows PC-based system for small-angle scattering data analysis. 
Journal of Applied Crystallography, 36, 1277-1282. 
LENGYEL, J. S., STOTT, K. M., WU, X., BROOKS, B. R., BALBO, A., SCHUCK, P., PERHAM, R. 
N., SUBRAMANIAM, S. & MILNE, J. L. S. (2008) Extended polypeptide linkers 
establish the spatial architecture of a pyruvate dehydrogenase multienzyme 
complex. Structure, 16, 93-103. 
LESSARD, I. A. & PERHAM, R. N. (1995) Interaction of component enzymes with the 
peripheral subunit-binding domain of the pyruvate dehydrogenase multienzyme 
complex of Bacillus stearothermophilus: stoichiometry and specificity in self-
assembly. Biochemical Journal, 306, 727. 
LI, W. F., ZHOU, X. X. & LU, P. (2005) Structural features of thermozymes. Biotechnology 
Advances, 23, 271-281. 
LILJAS, L., FRIDBORG, K., VALEGARD, K., BUNDULE, M. & PUMPENS, P. (1994) Crystal 
Structure of Bacteriophage fr Capsids at 3.5Å Resolution. Journal of Molecular 
Biology, 244, 279-290. 
LONG, F., VAGIN, A. A., YOUNG, P. & MURSHUDOV, G. N. (2007) BALBES: a molecular-
replacement pipeline. Acta Crystallographica Section D: Biological 
Crystallography, 64, 125-132. 
203 
 
MANDE, S. S., SARFATY, S., ALLEN, M. D., PERHAM, R. N. & HOL, W. G. J. (1996) Protein-
protein interactions in the pyruvate dehydrogenase multienzyme complex: 
dihydrolipoamide dehydrogenase complexed with the binding domain of 
dihydrolipoamide acetyltransferase. Structure, 4, 277-286. 
MARROTT, N. L., MARSHALL, J. J. T., SVERGUN, D. I., CRENNELL, S. J., HOUGH, D. W., 
DANSON, M. J. & VAN DEN ELSEN, J. M. H. (2012) The catalytic core of an archaeal 
2-oxoacid dehydrogenase multienzyme complex is a 42-mer protein assembly. 
FEBS Journal, 279, 713-723. 
MATTEVI, A., OBMOLOVA, G., KALK, K. H., TEPLYAKOV, A. & HOL, W. G. J. (1993) 
Crystallographic analysis of substrate binding and catalysis in dihydrolipoyl 
transacetylase (E2p). Biochemistry, 32, 3887-3901. 
MATTEVI, A., OBMOLOVA, G., SCHULZE, E., KALK, K. H., WESTPHAL, A. H., KOK, A. D. & 
HOL, W. G. J. (1992) Atomic structure of the cubic core of the pyruvate 
dehydrogenase multienzyme complex. Science, 255, 1544-1550. 
MATTEVI, A., SCHIERBEEK, A. J. & HOL, W. G. (1991a) Refined crystal structure of 
lipoamide dehydrogenase from Azotobacter vinelandii at 2.2Å resolution. A 
comparison with the structure of glutathione reductase. Journal of Molecular 
Biology, 220, 975. 
MATTEVI, A., SCHIERBEEK, A. J. & HOL, W. G. J. (1991b) Refined crystal structure of 
lipoamide dehydrogenase from Azotobacter vinelandii at 2.2 Å resolution : A 
comparison with the structure of glutathione reductase. Journal of Molecular 
Biology, 220, 975-994. 
MCMANUS, E., LUISI, B. F. & PERHAM, R. N. (2006) Structure of a Putative Lipoate Protein 
Ligase from Thermoplasma acidophilum and the Mechanism of Target Selection 
for Post-translational Modification. Journal of Molecular Biology, 356, 625-637. 
MORRIS, T. W., REED, K. E. & CRONAN, J. E. (1994) Identification of the gene encoding 
lipoate-protein ligase A of Escherichia coli. Molecular cloning and characterization 
of the lplA gene and gene product. Journal of Biological Chemistry, 269, 16091-
100. 
NEMERIA, N. S., ARJUNAN, P., CHANDRASEKHAR, K., MOSSAD, M., TITTMANN, K., FUREY, 
W. & JORDAN, F. (2010) Communication between thiamin cofactors in the 
Escherichia coli pyruvate dehydrogenase complex E1 component active centers. 
Journal of Biological Chemistry, 285, 11197-11209. 
OGATA, H., GOTO, S., SATO, K., FUJIBUCHI, W., BONO, H. & KANEHISA, M. (1999) KEGG: 
Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research, 27, 29-34. 
OZAWA, Y., NAKAMURA, T., KAMATA, N., YASUJIMA, D., URUSHIYAMA, A., YAMAKURA, F., 
OHMORI, D. & IMAI, T. (2005) Thermococcus profundus 2-ketoisovalerate 
ferredoxin oxidoreductase, a key enzyme in the archaeal energy-producing amino 
acid metabolic pathway. Journal of Biochemistry, 137, 101-107. 
PACKMAN, L. C., PERHAM, R. N. & ROBERTS, G. C. (1984) Domain structure and 1H-nmr 
spectroscopy of the pyruvate dehydrogenase complex of Bacillus 
stearothermophilus. Biochemical Journal, 217, 219. 
204 
 
PARK, Y., YOO, C., CHOI, S. Y. & LEE, H. (2006) Purifications and characterizations of a 
ferredoxin and its related 2-oxoacid: Ferredoxin oxidoreductase from the 
hyperthermophilic Archaeon, Sulfolobus solfataricus P1. Journal of Biochemistry 
and Molecular Biology, 39, 46. 
PAYNE, K. A. P., HOUGH, D. W. & DANSON, M. J. (2010) Discovery of a putative acetoin 
dehydrogenase complex in the hyperthermophilic archaeon Sulfolobus 
solfataricus. FEBS letters, 584, 1231-1234. 
PEI, X. Y., TITMAN, C. M., FRANK, R. A. W., LEEPER, F. J. & LUISI, B. F. (2008) Snapshots of 
catalysis in the E1 subunit of the pyruvate dehydrogenase multienzyme complex. 
Structure, 16, 1860-1872. 
PENG, T., LEE, H. & LIM, S. (2012) Isolating a trimer intermediate in the self-assembly of E2 
protein cage. Biomacromolecules, 13, 699-705. 
PERHAM, R. N. (1991) Domains, motifs, and linkers in 2-oxo acid dehydrogenase 
multienzyme complexes: a paradigm in the design of a multifunctional protein. 
Biochemistry, 30, 8501-8512. 
PERHAM, R. N. (2000) Swinging arms and swinging domains in multifunctional enzymes: 
catalytic machines for multistep reactions. Annual review of biochemistry, 69, 
961-1004. 
PETOUKHOV, M. V. & SVERGUN, D. I. (2005) Global rigid body modeling of 
macromolecular complexes against small-angle scattering data. Biophysical 
journal, 89, 1237-1250. 
POSNER, M. G. (2009) Lipoylation and assembly of a 2-oxoacid dehydrogenase 
multienzyme complex from Thermoplasma acidophilum. Biology and 
Biochemistry. Ph.D. Thesis, University of Bath. 
POSNER, M. G., UPADHYAY, A., BAGBY, S., HOUGH, D. W. & DANSON, M. J. (2009) A 
unique lipoylation system in the Archaea. Lipoylation in Thermoplasma 
acidophilum requires two proteins. The FEBS journal, 276, 4012. 
PRATT, K. J., CARLES, C., CARNE, T. J., DANSON, M. J. & STEVENSON, K. J. (1989) Detection 
of bacterial lipoic acid. A modified gas-chromatographic-mass-spectrometric 
procedure. Biochemical Journal, 258, 749. 
PRIEFERT, H., HEIN, S., KRÜGER, N., ZEH, K., SCHMIDT, B. & STEINBÜCHEL, A. (1991) 
Identification and molecular characterization of the Alcaligenes eutrophus H16 
aco operon genes involved in acetoin catabolism. Journal of Bacteriology, 173, 
4056-4071. 
RADESTOCK, S. & GOHLKE, H. (2010) Protein rigidity and thermophilic adaptation. 
Proteins: Structure, Function, and Bioinformatics, 79, 1089-1108. 
RECHE, P. & PERHAM, R. N. (1999) Structure and selectivity in post-translational 
modification: attaching the biotinylate-lysine and lipoylated-lysine swinging arms 
in multifunctional enzymes. The EMBO journal, 18, 2673-2682. 
205 
 
REED, L. J., KOIKE, M., LEVITCH, M. E. & LEACH, F. R. (1958) Studies on the nature and 
reactions of protein-bound lipoic acid. Journal of Biological Chemistry, 232, 143-
158. 
RHODES, G. (1993) Crystallography made crystal clear:  a guide for users of 
macromolecular models, Academic Press Inc. California. 
ROESSLE, M. W., KLAERING, R., RISTAU, U., ROBRAHN, B., JAHN, D., GEHRMANN, T., 
KONAREV, P., ROUND, A., FIEDLER, S. & HERMES, C. (2007) Upgrade of the small-
angle X-ray scattering beamline X33 at the European Molecular Biology 
Laboratory, Hamburg. Journal of Applied Crystallography, 40, s190-s194. 
ROUND, A. R., FRANKE, D., MORITZ, S., HUCHLER, R., FRITSCHE, M., MALTHAN, D., 
KLAERING, R., SVERGUN, D. I. & ROESSLE, M. (2008) Automated sample-changing 
robot for solution scattering experiments at the EMBL Hamburg SAXS station X33. 
Journal of Applied Crystallography, 41, 913-917. 
RUEPP, A., GRAML, W., SANTOS-MARTINEZ, M.-L., KORETKE, K. K., VOLKER, C., MEWES, H. 
W., FRISHMAN, D., STOCKER, S., LUPAS, A. N. & BAUMEISTER, W. (2000) The 
genome sequence of the thermoacidophilic scavenger Thermoplasma 
acidophilum. Nature, 407, 508-513. 
SEARCY, D. G. (1976) Thermoplasma acidophilum: Intracellular pH and potassium 
concentration. Biochimica et Biophysica Acta (BBA) - General Subjects, 451, 278-
286. 
SHARPE, T. D., FERGUSON, N., JOHNSON, C. M. & FERSHT, A. R. (2008) Conservation of 
transition state structure in fast folding peripheral subunit-binding domains. 
Journal of Molecular Biology, 383, 224-237. 
SISIGNANO, M., MORBITZER, D., GÄGENS, J., OLDIGES, M. & SOPPA, J. (2010) A 2-oxoacid 
dehydrogenase complex of Haloferax volcanii is essential for growth on isoleucine 
but not on other branched-chain amino acids. Microbiology, 156, 521-529. 
SMITH, L. D., BUNGARD, S. J., DANSON, M. J. & HOUGH, D. W. (1987) Dihydrolipoamide 
dehydrogenase from the thermoacidophilic Archaebacterium Thermoplasma 
acidophilum. Biochemical Society Transactions, 15, 1097 - 1097. 
SPECTOR, S., KUHLMAN, B., FAIRMAN, R., WONG, E., BOICE, J. A. & RALEIGH, D. P. (1998) 
Cooperative folding of a protein mini domain: the peripheral subunit-binding 
domain of the pyruvate dehydrogenase multienzyme complex. Journal of 
Molecular Biology, 276, 479-489. 
SRERE, P. A. & KOSICKI, G. W. (1961) The purification of citrate-condensing enzyme. The 
Journal of biological chemistry, 236, 2557. 
SUN, N., BECK, F., KNISPEL, R. W., SIEDLER, F., SCHEFFER, B., NICKELL, S., BAUMEISTER, W. 
& NAGY, I. (2007) Proteomics analysis of Thermoplasma acidophilum with a focus 
on protein complexes. Molecular & Cellular Proteomics, 6, 492. 
SUN, N., PAN, C., NICKELL, S., MANN, M., BAUMEISTER, W. & NAGY, I. N. (2011) 
Quantitative proteome and transcriptome analysis of the Archaeon 
206 
 
Thermoplasma acidophilum cultured under aerobic and anaerobic conditions. 
Journal of Proteome Research, 9, 4839-4850. 
SVERGUN, D., BARBERATO, C. & KOCH, M. H. J. (1995) CRYSOL-a program to evaluate X-
ray solution scattering of biological macromolecules from atomic coordinates. 
Journal of Applied Crystallography, 28, 768-773. 
SVERGUN, D. I. (1992) Determination of the regularization parameter in indirect-
transform methods using perceptual criteria. Journal of Applied Crystallography, 
25, 495-503. 
SVERGUN, D. I. (1999) Restoring low resolution structure of biological macromolecules 
from solution scattering using simulated annealing. Biophysical journal, 76, 2879. 
THOMPSON, M. J. & EISENBERG, D. (1999) Transproteomic evidence of a loop-deletion 
mechanism for enhancing protein thermostability. Journal of Molecular Biology, 
290, 595-604. 
THORPE, C. & WILLIAMS JR, C. H. (1981) Lipoamide dehydrogenase from pig heart. 
Pyridine nucleotide induced changes in monoalkylated two-electron reduced 
enzyme. Biochemistry, 20, 1507-1513. 
VIEILLE, C. & ZEIKUS, G. J. (2001) Hyperthermophilic enzymes: sources, uses, and 
molecular mechanisms for thermostability. Microbiology and Molecular Biology 
Reviews, 65, 1-43. 
VOLKOV, V. V. & SVERGUN, D. I. (2003) Uniqueness of ab initio shape determination in 
small-angle scattering. Journal of Applied Crystallography, 36, 860-864. 
WINKER, S. & WOESE, C. R. (1991) A Definition of the Domains, Archaea, Bacteria, and 
Eucarya in Terms of Small Subunit Ribosomal RNA Characteristics. Systematic and 
applied microbiology, 14, 305-310. 
YU, X., HIROMASA, Y., TSEN, H., STOOPS, J. K., ROCHE, T. E. & ZHOU, Z. H. (2008) 
Structures of the human pyruvate dehydrogenase complex cores: a highly 







Chapter 11: Appendixes 
Appendix 1 E2 and E2 catalytic domain sequence 
The Tp. acidophilum E2 sequence is shown below with the sequence complementary to 
the E2 catalytic domain shown in italics and highlighted in grey. 
























Appendix 2: Sulfolobus solfataricus E3-pMJ0503 sequence  
The pMJ0503 viral vector (orange) containing the S. solfataricus E3 gene is shown in black, 
with the start ATG underlined, the his-tag (His) originally from pET28a is shown in green, 
the arabinose promoter (AraS) is shown in blue, and the marker gene PyrEF that 
complements the uracil auxotrophic mutant S. solfataricus strain is shown in red.  The 






































Appendix 3: Picrophilus torridus OADHC genes 
The bases at the end and beginning of genes which overlap with the adjacent gene have 
been underlined. 




















































































































Appendix 4: Publication 
